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Justification
At the time this study was 
planned, there was not yet a consen­
sus about dietary recommendations to 
decrease the risk of heart disease. 
There was considerable controversy 
about the efficacy of moderate 
changes in dietary fat, and there was 
very little information about the 
responses of women to dietary 
change.
The NC-167 Regional Technical 
Committee includes scientists 
experienced with dietary studies with 
normal humans and with various 
animal models. It was deemed 
economical and efficient to have a 
human study conducted with analytic 
expertise contributed by all members 
of the committee. Thus, a direct 
comparison of the whole diet, rather 
than each component as is studied in 
more controlled animal experiments, 
was planned.
Objectives
1. To compare in normal human 
subjects the effects of two laboratory- 
controlled diets, one with dietary fat 
and cholesterol patterned after the 
“usual” U.S. diet identified in the 
Health and Nutrition Examination 
Survey, or HANES (US74 diet), and 
the other modified to meet 1977 U.S. 
Dietary Guidelines/Goals (MOD 
diet).
2. To use animal models to 
determine the impact of the US74 diet 
and the MOD diet on metabolic 
parameters not easily measured in 
human subjects.
Human Core Study
The project consisted of two 
identical studies in fall, 1983, 
involving 10 female subjects each. 
One study was conducted at the 
University of Nebraska and involved 
4 Caucasians, 5 Chinese, and 1 
Iranian; the other study was con­
ducted at Iowa State University and 
involved 10 Caucasians. Each 70-day 
study was divided into a 7-day 
prestudy period, a 56-day experimen­
tal period, and a 7-day poststudy 
period.
During the pre- and post-study 
periods, subjects consumed self­
selected, self-recorded diets and made 
complete collections of urine and 
stools. During the experimental 
period, subjects consumed laboratory 
diets and continued to make complete 
urine and fecal collections.
The experimental period was 
divided into parts A and B, each 
composed of four 7-day segments. 
During one part, subjects received a 
diet designed to match the “usual” 
U.S. diet (US74) in fat content in 
accord with HANES I (40% of energy 
from fat, 600 mg cholesterol, and 
polyunsaturated to monounsaturated 
to saturated fatty acids in a ratio of 4 
to 14 to 14). During the other part, 
subjects received a similar diet 
modified (MOD) to meet the 1977 
U.S. Dietary Goal recommendations 
regarding fat (30% of energy from fat, 
less than 300 mg cholesterol/day, and 
polyunsaturated to monounsaturated 
to saturated fatty acids in a ratio of 10 
to 10 to 10) (Table 1).
In a crossover design, one-half of 
the subjects received the US74 diet 
followed by the MOD diet (sequence 
1) while the reverse order was 
followed for the other subjects 
(sequence 2). The two diets diverged 
from target values only in terms of 
cholesterol content (e.g., the US74 
diet contained 115% of target 
cholesterol content, and the modified 
diet contained 33% of the target 
value).
Blood, urine, and fecal samples 
were made available to members of 
the USDA, C.S.R.S Regional 
Research Technical Committee NC- 
167 for a wide variety of analyses. 
Altogether, 179 variables were 
measured by 10 of the participating 
stations and by the USDA laboratory 
in Beltsville, MD. Results for 163 of 
these variables are summarized in 
Chapter 15. Dietary treatment had a 
significant effect on 47 variables.
Animal Studies
Concomitantly with the human 
dietary study, several laboratories 
conducted experiments with animal 
models by using purified diets de­
signed to mimic the human study di­
ets. The animal studies were per­
formed to add analyses of tissues im-
6
possible to obtain in humans and, 
thereby, enable elucidation of pos­
sible mechanisms of any metabolic 
changes observed in the human popu­
lation.
Statistical Analysis
Statistical analysis of the data 
from the human core study was per­
formed by the Iowa group. A general 
linear models procedure (SAS) was 
used with the following sources of 
variation: group (or site), race, sub­
ject, diet, and residual effects (or diet 
carry-over effect).
A modified crossover design was
Breakfast 
Orange juice - 6 oz.
Whole wheat bread - 2 slices 
Margarine - 2 pats 
Milk (full fat) - 8 oz.
40% Bran Flakes -1 oz.
Sucrose -1 tsp.
Lunch
Sandwich:
eggs - 2 medium hard-cooked 
whole wheat bread - 2 slices 
mustard - 2 tsp 
Peas (Del Monte ) - 8 oz. 
Peaches (Del Monte) - 5 oz.
Milk (full fat) - 8 oz.
Supper
Frankfurters - 2
Sweet pickle relish -1 pkg.
Whole wheat bread - 2 slices
Margarine - 2 pats
Tomatoes - 8 oz
Milk (full fat) - 8 oz.
Green beans (Del Monte) - 8 oz. 
Lorna Doone cookies - 4
used in this regional study. The peri­
ods when the US74 and MOD diets 
were fed constituted the crossover 
design. In a modified design, a 
baseline period (self-selected diet, SS) 
preceded the experimental diets as 
shown:
Sequence 1 : SS US74 MOD 
Sequence 2: SS MOD US74
Analysis of variance was used to test 
for residual or diet carry-over effect, 
which measures the combined 
responses to the following questions: 
(a) Is the response to the US74 
diet different when it follows the self- 
selected rather than the MOD diet?
Breakfast 
Orange juice - 6 oz.
Whole wheat bread - 2 slices 
Jelly - 2 pkgs.
Milk (skim) - 8 oz.
40% Bran Flakes -1 oz.
Sucrose -1 tsp.
Lunch
Sandwich:
tuna - water pak, 50 g 
whole wheat bread - 2 slices 
salad dressing (Kraft) -12  g 
Peas (Del Monte) - 8 oz.
Peaches (Del Monte) - 5 oz.
Milk (skim) - 8 oz.
Sunflower seeds (Fisher) - 7/8 oz.
Supper
Frankfurters - 2
Sweet pickle relish -1 pkg.
Whole wheat bread - 2 slices 
Jelly -1 pkg.
Tomatoes - 8 oz.
Milk (skim) - 8 oz.
Green beans (Del Monte) - 8 oz. 
Fruit cup (Del Monte) - 5 oz. 
Potato chips -1 oz.
(b) Is the response to the MOD 
diet different when it follows the self- 
selected rather than the US74 diet?
A significant residual effect indicates 
that the response measured is not only 
a response to the present diet but also 
to the previous diet. Therefore, 
significant effects of the experimental 
diets may be masked by significant 
residual diet effects. Details are given 
in Chapter 14.
Summary
The MOD diet significantly 
lowered serum total cholesterol and 
LDL-cholesterol concentrations but 
had no effect on total HDL- 
cholesterol. Chinese subjects had a 
greater response than did Caucasians. 
Total fecal bile acid excretion was 
reduced by the MOD diet. Several 
significant dietary effects (for 
example, on white blood cells and 
some fatty acid parameters) were 
related to differences between self- 
selected and experimental diets rather 
than to differences between the two 
experimental diets. Many parameters 
were affected by the race of the 
participants. Both temporal effects of 
the change from self-selected to 
controlled diets and diet carry-over 
effects were identified.
Effects on parameters of choles­
terol metabolism were clearly observ­
able within the 4 weeks of each con­
trolled diet. Effects upon eicosanoid 
parameters were different, depending 
on the order of the controlled diets. 
Depletion of linoleate products 
seemed to occur more rapidly than 
repletion when the diets were altered.
Retention of mineral elements 
tended to be lower when subjects con­
sumed the MOD diet. Other nutri­
ents, as measured, were not affected 
by diet.
M e n u s  fo r e xp e rim e n ta l periods*  
US74 MOD
*The same menu was served every day during each 
of the 28-day experimental periods.
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List of va ria b le s , th e ir a b b re v ia tio n s , and  
the  s ta tio n (s ) that s u p p lie d  the  data
SVITA Serum Vitam in A (ng/ml), W l
SVITE Serum Vitam in E (|ig/m l), Wl
SYSBP Systolic Blood Pressure (mm Hg), IA
DIABP Diastolic Blood Pressure (mm Hg), IA
HT Height, cm
W T W eight, kg
RACE IR = Iranian, CA = Caucasian, CH = Chinese
KCAL Dietary Energy (Kcal/day), IA
PROTG Dietary Protein (g/day), IA
FATG Dietary Fat (g/day), IA
CARBOG Dietary Carbohydrate (g/day), IA
FIBERG Dietary Fiber (g/day), IA
ASHG Dietary Ash (g/day), IA
CAMG Dietary Calcium (mg/day), IA
FEMG Dietary Iron (mg/day), IA
PMG Dietary Phosphorus (mg/day), IA
KMG Dietary Potassium (mg/day), IA
NAMG Dietary Sodium (mg/day), IA
ASCACID Dietary Ascorbic Acid (mg/day), IA
THIAM Dietary Thiam in (mg/day), IA
RIBO Dietary Riboflavin (mg/day), IA
NIAC Dietary Niacin (mg/day), IA
VITA Dietary Vitam in A (lU /day), IA
TOTSAT Dietary Total Saturated Fat (g/day), IA
OLEIC Dietary O leic Acid (g/day), IA
LINO Dietary Linoleic Acid (g/day), IA
CHOL Dietary Cholesterol (mg/day), IA
P/S Dietary Polyunsaturated/Saturated Ratio, IA
PROTCAL Dietary % Calories as Protein, IA
CARBCAL Dietary % Calories as Carbohydrates, IA
FATCAL Dietary % Calories as Fat, IA
GLUCOSE Blood Fasting G lucose (mg/dl), NE, IA
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List of va ria b le s , th eir a b b re v ia tio n s , and  
the s ta tio n (s ) that s u p p lie d  the  data
BUN Blood BUN (mg/dl), NE, IA
CREAT Blood Creatinine (mg/dl), NE, IA
SODIUM Blood Sodium (meq/l), NE, IA
POTASS Blood Potassium (meq/l), NE, IA
CHLORIDE Blood Chloride (meq/l), NE, IA
TG Blood Triglyceride (mg/dl), NE, IA
URIC Blood Uric Acid (mg/dl), NE, IA
CALCIUM Blood Calcium (mg/dl), NE, IA
PHOSP Blood Phosphorus (mg/dl), NE, IA
T PROT Blood Total Protein (g/dl), NE, IA
ALBUMIN Blood A lbum in (g/dl), NE, IA
CHOLEST Blood Cholesterol (mg/dl), NE, IA
BILI T Blood Total Bilirubin (mg/dl), NE, IA
ALKPHOS Blood A lkaline Phosphatase (IU/1), NE, IA
SGOT Blood SGOT AST (IU/1), NE, IA
SGPT Blood SGPT AHT (IU/1), NE, (alt, IA)
LDH Blood LDH (IU/1), NE, IA
IRON Blood Iron (pg/dl), NE, IA
BILI DIR Blood Bilirubin Direct (mg/dl), NE, IA
BILI IND Blood Bilirubin Indir (mg/dl), NE, IA
GLOBULIN Blood G lobulin (g/dl), NE, IA
AG RATIO Blood A lbum in/G lobulin Ratio, IA
BUN CR R Blood BUN/Creatinine Ratio, IA
CA ION Blood Ionized Calcium (mg/dl), NE, IA
CL P R Blood Cl/P Ratio, IA
W BC Blood W BC (cells/|il), NE, IA
RBC Blood RBC (cells/jj-l), NE, IA
SEGNEUT Blood Segm ented Neutrophils %, IA
MONO Blood Lym phocytes %, IA
EOS Blood Eosinophils %, IA
BASO Blood Basophils %, IA
BLIPO Blood Beta-Lipoproteins %, IA
List of v a ria b le s , th e ir a b b re v ia tio n s , and  
th e  s ta tio n (s ) that s u p p lie d  the  data
PREBLIP Blood Pre-Beta-Lipoprotein %, IA
ALIPO Blood Alpha Lipoproteins %, IA
UR CREA Urine Creatin ine (g/day), NE, IA
FE MAN Iron Manual (pg/dl), NE
FE BIND Iron Binding Capacity (pg/dl), NE
HDL High Density Lipoprotein (mg/dl), NE
FEC W T Total Fecal Dry W eight (g/period), NE, IA
FEC NA Fecal Sodium (mg/period), NE
FEC K Fecal Potassium (m g/period), NE
UR NA Urine Sodium (mg/period), NE
UR K Urine Potassium (mg/period), NE
FEC MG Fecal M agnesium (mg/period), NE
FEC MN Fecal M anganese (mg/period), NE
UR MG Urine M agnesium (mg/period), NE
UR MN Urine Manganese (mg/period), NE
HGB Blood Hem oglobin (g/dl), NE
HEMO Blood Hem oglobin (g/day), IA
HCT Hem atocrit %, NE
MCV
3
Mean Corpuscular Volum e p, , NE
MCH Mean Corpuscular Hem oglobin p.p.g, NE
MCHC Mean Corpuscular Hemoglobin Concentration %, NE
F E C W W T Fecal W et Wt. (g/period ), NE
SERUM Serum Throm boxane (ng TX/m l -10 min), CO
WB1 Unchallenged W hole Blood (ng TX/m l • 4 min), CO
W B2 5m M Ca+Collagen (ng TX/m l • 4 min), CO
W B3 5m M Ca+Throm bin (ng TX/m l • 4 min), CO
W B4 lO m M Ca+Collagen (ng TX/m l • 4 min), CO
W B5 lO m M Ca+Throm bin (ng TX/m l • 4 min), CO
FECAL EN Fecal Energy (kcal/period), Ml
NOREPI F Urine Free Norepinephrine (mg/day), Ml
NOREPI T Urine Total Norepinephrine (mg/day), Ml
NOREPI P Free Norepinephrine %, Ml
List of va ria b le s , th e ir a b b re v ia tio n s , a n d  
the s ta tio n (s ) that s u p p lie d  the data
EPI F Urine Free Epinephrine (mg/day), Ml
EPI T Urine Total Epinephrine (mg/day), Ml
EPI P Free Epinephrine %, Ml
DOPA F Urine Dopam ine (mg/day), Ml
D O P A T Urine Total Dopam ine (mg/day), Ml
D O P A P Free Dopam ine %, Ml
TBARS Thiobarbituric Acid React. Subst. (nmol/m l), IL
T3 Serum T3 (ng/ml), OH
T4 Serum T4 (pg/dl), OH
PROLACTIN Serum Prolactin (ng/ml), OH
FERRITIN Serum Ferritin (ng/ml), OH
TAURINE Urinary Taurine (mg/day), OH
CARNI FR Plasma Free Carnitine (nmol/m l), W l
CARNI T Total P lasma Carnitine (nmol/m l), W l
GROUP Site of Feeding
COPRNOL Coprostanol (mg/d), IN
C CHOLES Ratio Chol/Cholestanol, IN
COPRNONE Coprostanone (mg/d), IN
TOTAL Total Neutral Steroid (mg/g feces), IN
LC Lithocholic Acid (mg/g feces), IN
DC Deoxycholic Acid (mg/g feces), IN
CDC Chenodeoxycholic Acid (mg/g feces), IN
CHOLIC Cholic Acid (mg/g feces), IN
UDC Ursodeoxycholic Acid (mg/g feces), IN
A M U R Alpha-m uricholic Acid (mg/g feces), IN
0  MUR Om ega-m uricholic Acid (mg/g feces), IN
B MUR Beta-m uricholic Acid (mg/g feces), IN
TO T CHOL Plasma Total Cholesterol (mg/dl), OR
VLDL VLDL Cholesterol (mg/dl), OR
LDL LDL Cholesterol (mg/dl), OR
h d l 2
h d l 3
HDLp Cholesterol (mg/dl), OR 
HDLo Cholesterol (mg/dl), OR
List of va ria b le s , th e ir a b b re v ia tio n s , and  
the  s ta tio n (s ) that s u p p lie d  the  data
TO T HDL Total HDL Cholesterol (mg/dl), OR
TO T TG Total P lasma TG (mg/dl), OR
VLDL TG VLDL TG (mg/dl), OR
APO A1 Plasma Apoprotein A1 (mg/dl), OR
APO A2 Plasma Apoprotein A2, (mg/dl), OR
TG140 Plasma TG Fatty Acid 14:0 %, ND
TG141 Plasma TG Fatty Acid 14:1 %, ND
TG160 Plasma TG Fatty Acid 16:0 %, ND
TG161 Plasma TG Fatty Acid 16:1 %, ND
TG180 Plasma TG Fatty Acid 18:0 %, ND
TG181 Plasma TG Fatty Acid 18:1 %, ND
TG182 Plasma TG Fatty Acid 18:2 %, ND
TG203 Plasma TG Fatty Acid 20:3 %, ND
TG204 Plasma TG Fatty Acid 20:4 %, ND
FFA140 Plasma Free Fatty Acid 14:0 %, ND
FFA141 Plasma Free Fatty Acid 14:1 %, ND
FFA160 Plasma Free Fatty Acid 16:0 %, ND
FFA161 Plasma Free Fatty Acid 16:1 %, ND
FFA180 Plasma Free Fatty Acid 18:0 %, ND
FFA181 Plasma Free Fatty Acid 18:1 %, ND
FFA182 Plasma Free Fatty Acid 18:2 %, ND
FFA203 Plasma Free Fatty Acid 20:3 %, ND
FFA204 Plasma Free Fatty Acid 20:4 %, ND
PLA T140 Platelet Fatty Acid 14:0 %, ND
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List of va ria b le s , th eir a b b re v ia tio n s , and  
the s ta tio n (s ) that s u p p lie d  the  data
RBC140 RBC M embrane Fatty Acid 14:0 %, ND
RBC141 RBC Mem brane Fatty Acid 14:1 %, ND
RBC160 RBC Mem brane Fatty Acid 16:0 %, ND
RBC161 RBC M embrane Fatty Acid 16:1 %, ND
RBC180 RBC M embrane Fatty Acid 18:0 %, ND
RBC181 RBC M embrane Fatty Acid 18:1 %, ND
RBC182 RBC M embrane Fatty Acid 18:2 %, ND
RBC203 RBC Mem brane Fatty Acid 20:3 %, ND
RBC204 RBC Mem brane Fatty Acid 20:4 %, ND
RBCPL160 RBC-Phospholipid Fatty Acid 16:0 %, MN
RBCPL180 RBC-Phospholipid Fatty Acid 18:0 %, MN
RBCPL181 RBC-Phospholipid Fatty Acid 18:1 %, MN
RBCPL182 RBC-Phospholipid Fatty Acid 18:2 %, MN
RBCPL203 RBC-Phospholipid Fatty Acid 20:3 %, MN
RBCPL204 RBC-Phospholipid Fatty Acid 20:4 %, MN
RBCPL205 RBC-Phospholipid Fatty Acid 20:5 %, MN
RBCPL224 RBC-Phospholipid Fatty Acid 22:4 %, MN
RBCPL226 RBC-Phospholipid Fatty Acid 22:6 %, MN
RBCPL241 RBC-Phospholipid Fatty Acid 24:1 %, MN
TBAC Total Bile Acid Excretion (mg/g fee), IN
TBAD Total Bile Acid Excretion (mg/day), IN
TNSD Total Neutral Sterol Excretion (mg/day), IN
TSC Total Steroid Excretion (mg/g fee), IN
TSD Total Steroid Excretion (mg/day), IN
p g i2 Urinary Prostaglandin l2  (ng/day),IA
PG E1 Urinary Prostaglandin E 1 (ng/day), IA
p g e 2 Urinary Prostaglandin E2  (ng/day), IA
t x b 2 Urinary Throm boxane B2  (ng/day), IA
p g f 92a Urinary Prostaglandin F2a (ng/day), IA
PGMF02a Urinary Prostaglandin m et-F2a (ng/day), IA
NA Urinary Sodium Excretion (mg/day), IA
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Studies of Women 
Eating Diets with 
Different Fatty Acid 
Composition
I. Plasma Lipoproteins and Steroid Excretion
Abstract
Moderate changes in dietary 
fat composition have been recom­
mended to improve plasma choles­
terol status. Such changes have not 
been studied extensively in women. 
This research evaluates plasma li­
poprotein and steroid excretion 
changes in young women who con­
sumed a diet similar to US average 
consumption in 1974 [40 en% fat, 
polyunsaturated (P) to saturated fatty 
acid (S) ratio, P/S = 0.3, US74] or a 
diet modified to contain 30 en% fat, 
P/S = 1.0 (MOD). Following a 
preexperimental period of self-se­
lected diets, young women were fed 
the diets for 28-day periods in a cross­
over design with 10 women at the 
University of Nebraska, Lincoln, and 
10 at Iowa State University, Ames.
Plasma lipoproteins and 
steroid excretion were quantitated and 
the compositions determined. Data 
were analyzed for race (5 Chinese, 14 
Caucasians) and for diet carryover 
effects, as well as for primary diet 
effects. In the Chinese women, the 
US74 diet raised total and very-low- 
density lipoprotein (VLDL) choles­
terol compared to prior self-selected 
or modified diets; in the Caucasian 
women the MOD diet lowered total, 
low-density lipoprotein (LDL), and 
VLDL cholesterol. The diet carryover 
was evident in total high-density 
lipoprotein (HDL) and HDL3 
cholesterol. Total HDL and HDL3 
cholesterol in response to the US74 
diet were unchanged from the MOD 
diet when the US74 diet followed the
MOD diet, but were lower than 
modified when the US74 diet fol­
lowed self-selected diets. The US74 
diet resulted in greater neutral sterol 
excretion than the MOD diet; this 
response was more marked in the self- 
selected, US74, MOD sequence than 
in the self-selected, MOD, US74 
sequence. A relatively small adapta­
tion of the diet may effect beneficial 
changes in blood lipids of young 
women. Racial differences should be 
studied further.
Introduction
Substitution of polyunsatu­
rated fatty acids (PUFA), containing 
predominantly linoleic acid in mixed 
triglycerides (TG), for saturated fat in 
the diet lowers serum cholesterol [1- 
4], The effects of diet on regulation of 
cholesterol metabolism, including 
absorption, synthesis, transport, and 
excretion, have been reviewed [5,6]. 
Grundy [7] summarized the data 
showing that saturated fatty acids 
(SFA) raise cholesterol concentration, 
mainly in low-density lipoproteins 
(LDL); substitution of mono unsatur­
ated fatty acids (MUFA) or carbohy­
drate for the SFA lowers plasma 
cholesterol. Substitution with PUFA 
lowers cholesterol more than can be 
accounted for by replacement of SFA. 
Plasma lipoproteins respond to 
changes in dietary fat saturation [8- 
101.
Most studies of human 
responses to diet in relation to
Originally published in: Journal of the American 
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cholesterol metabolism have been 
conducted with men, using diets with 
extreme differences in fat composi­
tion, and under conditions of abnor­
mal lipid metabolism [6]. As pointed 
out by McNamara [6], there is a 
paucity of data describing dietary 
changes which are within a reason­
able range (for acceptance as a 
habitual diet) in normal humans, 
especially women. One study of 
normal men, whose dietary fat was 
reduced from customary (normal 
food) intake of 35-40% of energy 
(en%) to 25 en% and the PUFA to 
SFA ratio (P/S) was either 0.3 or 1 
[10], showed significant reductions in 
total and esterified plasma choles­
terol; in LDL total lipid, free choles­
terol, and phospholipid; in HDL2, 
total lipid, TG, and phospholipid; in 
HDL3 total lipid, cholesterol, and TG. 
There were also significant reductions 
in HDL2 and HDL3 apo-A2. When 
the 25 en% from fat had a P/S of 1, 
total plasma cholesterol was lower
than that found with a self-selected 
diet; with a P/S of 0.3 there was no 
difference between self-selected and 
25 en% fat diet. P/S did not affect 
lipoprotein composition.
Excretion of cholesterol and 
bile acids is a major factor in regula­
tion of plasma cholesterol. McNamara 
[6] predicts that a reduction of fat 
calories from 40 to 30 en% will 
increase biliary cholesterol and bile 
acid flow. He notes that few studies 
have been reported in which the 
effects of a fat-modified diet within 
the ranges of a “prudent diet” have 
been investigated. The present study 
investigates the effect on plasma 
lipoproteins and steroid excretion in 
normal young women eating normal 
foods.
Materials and Methods
Subjects
Twenty healthy adult women 
aged 19-35 years (mean age 23) 
participated in two concurrent studies
(10 in Iowa and 10 in Nebraska, Table 
1-1). They were instructed to abstain 
from all medications during the study; 
“cold remedies” and antibiotics for 
skin rashes were used occasionally. 
The two laboratories followed 
identical experimental protocols, and 
samples were sent to other collaborat­
ing experiment stations for analyses 
(lipoprotein went to Oregon State 
University, Corvallis; fecal steroid to 
Purdue University, West Lafayette, 
IN). The study protocol was approved 
by the respective University Review 
Committee on the use of human 
subjects in research.
Experimental Feeding
The 70-day study period 
included 7-day pre- and 7-day post- 
experimental periods on self-selected 
and self-recorded diets. During the 
experimental period of 56 days, two 
nutritionally adequate diets consisting 
of ordinary foods (Table 1-2) were 
fed in a controlled environment: the 
US74 diet designed to conform to the 
average US dietary fat intake based 
on the HANES I survey [11] and the 
MOD diet designed to meet the fat 
intake of the US Dietary Goal 
Recommendations [12].
The US74 diet was calcu­
lated to supply 40% of total energy 
(en%) as fat, with a 
PUFA:MUFA:SFA (P:M:S) ratio of 
4:14:14 and about 600 mg choles­
terol; the MOD diet was calculated to 
provide 30 en% fat, a P:M:S of 
10:10:10, and less than 300 mg 
cholesterol per day. A modified 
crossover (without switchback) 
feeding design was used, with half of 
the subjects given the US74 diet for 
the first 28 days followed by the 
MOD diet for the next 28 days. Other 
subjects followed the reversed feeding 
pattern: MOD diet followed by the 
US74 diet.
Subjects were randomly 
assigned to treatment sequences. They 
were given detailed instructions on 
keeping of food records by use of 
food models and standard measuring 
tools. Subjects recorded their actual 
intakes (self-selected diet, SS) which 
preceded either the US74 or MOD 
diet. Individual daily energy intakes
Icffl ■ 1
Nebraska
Subject Age [yr] Height [cm] Weight1 [kg] Ethnic/Race2
60 23 162.5 60.0 Iranian
61 33 155.0 59.0 Caucasian
62 25 157.0 52.0 Chinese
63 25 150.0 57.0 Chinese
64 30 160.0 58.0 Chinese
65 25 168.0 52.0 Chinese
66 35 145.0 42.5 Chinese
67 22 155.0 45.0 Caucasian
68 21 157.0 49.0 Caucasian
69 19 162.5 60.0 Caucasian
Mean 25.8 157.2 53.4
± SEM ±1.7 ±2.1 ±2.0
iowa 70 20 167.7 66.5 Caucasian
71 19 164.0 47.3 Caucasian
72 23 169.7 67.0 Caucasian
73 19 164.2 64.9 Caucasian
74 22 184.5 88.0 Caucasian
75 19 168.0 61.7 Caucasian
76 19 165.8 55.8 Caucasian
77 22 171.4 63.9 Caucasian
78 19 175.0 76.2 Caucasian
79 19 163.0 63.6 Caucasian
Mean 20.1 169.3 65.5
± SEM ±0.5 ±2 .0 ±3.4
Overall Mean 23.0 163.3 59.5
± SEM ±1.1 ±2.0 ±2.4
11nitial body weights for heights were within the recommended ranges.
2The Iranian volunteer was not included in the Caucasian grouping because of 
ethnic differences. Members of the "Caucasian" group were Americans of 
European descent.
during the experimental periods were 
adjusted for body weight maintenance 
with the use of hard candy consumed 
in 100-kcal portions. These calorie 
adjustments were minor and had no 
discernible effect.
During the experimental 
period, fasting venous blood samples 
were drawn at the beginning, mid­
point, and end of the 56-day period. 
Complete fecal collections were 
composited into 7-day period lots for 
each subject and were made during 
the weeks just prior to blood collec­
tions. Fecal markers were brilliant 
blue (FD and C Blue No 1, Neumann- 
Buslee and Wolf, Des Plaines, IL) 
with methyl cellulose (M-280, 400 
centipoises, Fisher Scientific, Chi­
cago, IL) and colored beads (local 
craft shop). Composites of fecal 
samples were stored as homogenates 
or were lyophilized.
Assays
The blood samples were 
collected in EDTA vacutainer tubes, 
which were centrifuged at 100 x g for 
10 min at 4°C or at room temperature. 
After centrifugation, the platelet-rich 
plasma from all tubes of each subject 
was pooled and recentrifuged at 3000 
x g for 10 min at 4°C or at room 
temperature to pellet the platelets. The
platelet-poor plasma was shipped on 
ice to Oregon (S. Y. 0.) for subse­
quent analyses or immediately frozen 
for all other analyses. Total plasma 
cholesterol was determined by an 
enzymatic method using cholesterol 
oxidase [13,14]. Concentrations of 
plasma TG were measured in an 
Autoanalyzer II (Technicon,
Tarry town, NY) by procedures 
described in The Manual of Opera­
tions, Lipid Research Clinics [15]. 
Plasma lipoproteins were isolated by 
sequential ultracentrifugation [ 16] and 
quantified by chemical analysis. Total 
protein concentrations were assayed 
by the Lowry method [17]. Plasma 
concentrations of apoprotein A i and 
A2 were measured by an immuno- 
turbidimetric assay [18] with some 
modifications.
Fecal samples were shipped 
to Purdue University (J. A. S.). 
Steroids were extracted from the 
homogenized or lyophilized fecal 
samples with toluene after digestion 
with acetic acid [19]. After hydrolysis 
of conjugated bile acids by treatment 
with choloyglycine hydrolase, neutral 
steroids were extracted with petro­
leum ether at pH 10 and acidic 
steroids with ethyl acetate and ethyl 
ether after reducing the pH to 1.0. 
Neutral steroids were quantified by 
gas-liquid chromatography as
trimethylsilyl ethers by using 3% OV- 
17 on 100/120-mesh Supelcoport 
(Supelco, Bellefonte, PA) and by 
using 5a-cholestane as an internal 
standard. Bile acids were quantitated 
similarly as methyl acetates by using 
3% SP-2100 on 100/200-mesh 
Supelcoport and 23-nordeoxycholic 
acid as an internal standard [20].
Fecal energy was determined by 
bomb calorimetry.
Nutrient Composition 
of the Diets
All items in the self-selected 
diets and experimental menus were 
coded by use of the USDA Lipid 
Laboratory Data Base (USDA Human 
Nutrition Research Center, Beltsville, 
MD). The nutritive values of these 
diets were calculated by computer 
using the Statistical Analysis System 
[21] (SAS Institute, Cary, NC).
Statistical Analysis
A modified crossover design 
was used in which there was a 
baseline period (self-selected diet) 
preceding the experimental diets. 
Statistically significant differences 
were determined by multivariate 
analysis of variance (ANOVA). 
Sources of variation included state, 
race, diet, and residual or carry-over 
effects. Although both states followed 
the same protocol, the Caucasian 
group in Iowa was physically larger 
(mean body weight 65.5 kg) than the 
racially mixed group in Nebraska 
(mean body weight 53.4 kg) (Table 
1-1). For some parameters, differ­
ences by race accounted for the 
differences between states; for others, 
there was simply a difference by state 
not accounted for by race. In addition 
to the main effects of diets, a residual 
effect was tested. This measured the 
extent to which the previous diet 
influenced the response to the present 
diet. Sequence 1 was self-selected 
(SS), US74, MOD; sequence 2 was 
SS, MOD, US74. A significant 
residual effect indicated that the 
response was not a simple response to 
the experimental diet but was affected 
by the previous diet. Thus, significant 
effects of the experimental diets may 
be masked by significant residual diet 
effects. When there was no significant 
residual effect, differences between 
diets were further examined by using
j | | g P H  C y
Self-selected (n = 10)1 Experimental (n = 20)
Iowa Nebraska US74 MOD
2216 + 159 1773± 145 2044± 11 2062 ± 16
Food energy [kcal] 83.7 ±5.2 70.9 ±6.5 76.2 ± 0 86.5 ± 0
Protein [g] 275.2 ± 19.6 218.3± 12.1 245.8 ± 3.3 305.0 ± 4.9
Carbohydrate [g] 91.9 + 7.9 72.3 ± 11.2 91.8 ± 0 65.5 ± 0
Fat [g] 32.5 ±2.5 23.5 ±3.6 35.0 ± 0 18.6 ± 0
Saturated fatty acids [g] 31.7 ±3.2 25.6 ±4.0 34.4 ± 0 19.9 ± 0
Oleic acid [g] 15.5 ± 1.9 14.6 ±3.5 10.4 ± 0 19.2 ± 0
Linoleic acid [g] 371 ± 66 362 ± 54 687 ± 0 98 ± 0
Cholesterol [mg] 0.47 ± 0.04 0.62 ± 0.07 0.30 ± 0 1.04 ± 0
P/S2 37.3 ± 1.7 34.2 ± 3.0 40.7 ±0.2 28.6 ± 0.2
Fat [%] 15.2 ±0.3 16.2 + 1.2 14.9 ±0.1 16.8 ± 0.1
Protein [%] 49.7 ± 1.6 51.6 ±3.0 48.4 ±0.3 58.8 ± 0.4
Carbohydrate [%] 
Crude fiber [g]
4.6 ±0.5 5.0 ±0.5 9.6 ± 0 11.4 ± 0
1 Dietary intakes before the experimental period. 
Calculated as linoleic acid/saturated fatty acids.
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Tukey’s procedure to estimate least 
significant differences [21]. Several 
significant dietary effects were related 
to differences between SS and 
experimental diets rather than to 
differences between the two experi­
mental diets.
When the ANO VA is calcu­
lated, the division of the sums of 
squares is unchanged when residual is 
replaced by a diet-by-sequence 
interaction. We have chosen to 
interpret the results using the residual 
or carry-over terminology for two 
reasons. First, the ANOVA that tests 
for interactions between factors is 
appropriate for a factorial design 
which has, for example, two factors 
each at two levels. These factors are 
independent and combine to give four 
distinct treatment combinations. Our 
design does not have two distinct 
treatments which can be varied 
independently. Second, a residual or 
carry-over effect implies that, if the 
length of feedings is extended, we 
may be able to measure a response to 
the experimental diet that is not 
influenced by the previous diet. A 
diet-by-sequence interaction implies 
that the responses are a result of the 
sequence in which the diets were fed 
as much as responses to the diets 
themselves and would not be changed 
by a longer feeding period.
For this study, our design 
and analysis eliminated the need for 
either establishing a baseline or 
including a washout period. If the 4- 
week feeding period was adequate for 
the parameter to respond to the 
experimental diet, the response was 
the same regardless of whether it 
followed the self-selected diet or the 
other experimental diet, and the 
residual effect was not significant. 
However, if the parameter did not 
fully respond within 4 weeks, the 
response to the experimental diet was 
not the same following the self- 
selected diet as following the other 
experimental diet, and the residual 
effect was significant. When evaluat­
ing, for example, the extent to which 
dietary modifications may affect 
blood lipid changes, the time required 
for complete response may be as 
important as the degree of change 
achieved, particularly for determining 
the frequency of follow-up assess­
ments.
Results
Concentrations of plasma 
lipoproteins and lipids are shown in 
Table 1-3. There were significant race 
effects in all components; the Chinese 
women consistently had higher values 
than the Caucasian women. When 
compared to their self-selected diet, 
the Caucasian women showed no 
changes in response to the US74 diet; 
the MOD diet significantly decreased 
total, very-low-density lipoproteins 
(VLDL), and LDL cholesterol. In the 
Chinese women, the MOD diet 
resulted in values not different from 
their self-selected levels, but the 
US74 diet significantly increased total 
and VLDL cholesterol. The changes 
in total cholesterol were mostly 
accounted for by changes in LDL 
cholesterol.
Total high-density lipopro­
tein (HDL) and HDL, cholesterol 
showed effects of a diet carryover.
The US74 diet increased HDL, and 
total HDL if it was fed after the MOD 
diet but had no effect if it was fed 
after the self-selected diet. The MOD 
diet slightly reduced HDL3 and total 
HDL if consumed after the self- 
selected diet, but caused a slight 
increase following the US74 diet. In 
the Caucasian women apo-Aj was 
lower when the MOD diet was eaten 
as compared with either of the other 
diets. No significant diet responses 
were seen in the Chinese women. 
Apo-A2 and TG concentrations were 
not affected by the diets but did show 
significant state as well as race 
differences.
Fecal energy and steroid 
excretion data are given in Table 1-4. 
The MOD fat diet caused greater fecal 
energy excretion than the US74 diet 
(p < 0.05). The difference averaged 
349 kcal/week. The fecal energy was 
positively correlated with dietary 
protein, carbohydrate, and fiber (r =
0.59. 0.48. 0.59, respectively, p < 
0.002). The value was negatively 
correlated with dietary fat, saturated 
fat, and cholesterol (all r = -0.59, p = 
0.0001).
Total neutral sterols were 
significantly affected by both state 
and diet carryover. When the US74 
diet followed the self-selected diet, 
sterol excretion increased but then 
decreased when the MOD diet was
fed. Sterol excretion did not increase 
when the MOD diet followed the self- 
selected diet, but did increase in 
response to the US74 diet. The state 
differences in total neutral sterols 
were reflected in the coprostanone 
fraction. A diet effect was seen in the 
coprostanol portion of neutral sterol.
Only state differences were 
found in total bile acid excretion. This 
difference was reflected in lithocholic 
acid and deoxycholic acid, the major 
components of total bile acids. The 
other major bile acid excreted, 
chenodeoxycholic acid, was affected 
by race. Only cholic acid was affected 
by diet changes. The dilution of n by 
these multiple effects makes interpre­
tation of the main effects equivocal.
Discussion
Race was not intended to be 
a variable, but because of clearly 
identifiable effects it was necessary to 
interpret the results on that basis. 
When compared to baseline values 
during self-selected diets, the Chinese 
responded more to the US74 diet than 
to the MOD diet, and the Caucasians 
responded more to the MOD diet.
This may reflect the degree of 
similarity between the self-selected 
diets and the MOD diet for the 
Chinese and between the self-selected 
and US74 diets for the Caucasian 
women. Several plasma lipoproteins 
showed significant state differences 
which were not accounted for by 
racial differences.
The prediction of McNamara 
[6] that the change from a US74 type 
diet to a modified type diet would 
increase biliary cholesterol and bile 
flow did not prove correct if that 
increase would be accompanied by 
increased excretion. The results of 
this study extend the results reported 
by Judd et al. [10] showing a reduc­
tion in plasma lipids in men by a 
reduction in dietary fat accompanied 
by an increase in PUFA and a 
decrease in saturated fat. Young 
women responded in the same way, 
indicating beneficial effects from 
realistic dietary changes.
The diet carryover effects 
could mean a temporal response to a 
change from a self-selected to an 
experimental diet having a complete
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Concentrations of plasma lipoproteins and lipids (mg/dl) of Caucasian (Ca, n »13  or 14) 
Chinese (Ch, n = 5) women consuming diets containing different amounts and types of U
Fecal energy (kcal/period) and steroid excretioi 
containing different amounts and types of fa t1
Fecal Energy 2,3 
Total bile acids 
Lithocholic 4 
Deoxycholic 4 
Chenodeoxycholic2 
Cholic3
Ursodeoxycholic
SS_______________________
Iowa____________ Nebraska
114.19 ± 42.84 58.55 ± 8.89
12.54 ± 2.60 7.65 ± .53
58.62 ± 26.05 21.58 ± 3.28
32.01 ± 8.16 21.97 ± 3.88
4.19 + 3.32 2.18 ± 0.84
5.34 ± 4.54 1.74 ± 1.00
Total Neutral Steroids4,5 
Coprostanol 3 
Coprostanone 4
247.67 ± 39.06 a 
5.44 ± 1.05 a 
2.0510.43 a,b
156.76 + 28.68 a,b 
4.56 + 1.54 a,b 
1.13 + 0.18 a,b
394.94 + 45.53 b 
10.15 + 1.77b 
3.39 ±0.61 a
265.46 ± 35.98 a 
9.10 + 2.08 a 
1.5 + 0.23 a
170.49 + 12.363 
4.14 + 1.06 a 
1.24 + 0.21 b
Total Steroids 4 361.86 + 69.63 a 215.31 +33.26 a,b 470.17 + 47.41 a 323.62 ± 36.48 a 240.55 ± 25.36 b
Nebraska_____
1,302.80 + 111.26 i f  
60.61 ± 8.66 
6.42 + 1.07 
22.67 ± 3.70 
25.03 ± 5.66
1.35 ± 0.40 
1.5510.84
107.71 ± 27.84b 
2.57 + 1.12b
0.68 + 0.08 b
168.32 + 26.51b!
SS US74 MOD
CA(n=14) CH(n=5) CA(n=13) CH(n=5) CA(n=13)
Total cholesterol 2,3 154.93 + 7.34 4,a 166.20 + 11.95 a 163.43 + 8.77a 195.20 + 15.23 b 138.71 + 7.25 b
VLDL cholesterol 2 14.19 ± 1.47 a 10.52+ 1.02 a 15.87 + 1.55a 16.56+ 1.47 b 10.57 + 1.42 b
LDL cholesterol 2,3 85.62 ± 4.54 a 97.50+ 9.28 88.93 ± 4.97a 104.24+ 8.27 74.98 + 4.34 b
HDI-2 cholesterol,5 24.21 ± 1.04 26.34 + 2.81 25.12 + 1.28 26.36+ 3.09 23.28 ± 1.57
HDL-2 cholesterol2,6 20.04 + 0.94 21.28 + 1.74 a 20.68 ± 1.03 24.74+ 3.04 b 20.82 + 1.25
Total HDL cholesterol 2,5,6 44.25 + 1.71 47.66 ± 4.43 45.85 ± 1.98 51.10+ 6.09 44.04 ± 2.40
Total TG 2,5 52.78 ± 6.33 64.20 ± 9.83 58.01 ±4.61 a 69.12 + 19.67 48.36 + 3.42 b
VLDLTG 2,5 36.68 ± 4.85 45.36 ± 7.99 38.92 + 3.14 50.34+13.88 33.50 ± 2.66
Apo A2 2,5 129.89 + 3.71 a 148.10 + 12.63 133.94 + 3.79a 156.22 + 17.55 123.58 + 5.29 b
Apo A2 2,5 43.55 ± 1.65 44.56 ± 3.33 43.67 ± 1.34 45.74 ± 4.03 41.95 + 1.79
1 Mean ± SEM.
2 ANOVA indicated significant race effect for combined data, p < 0.05.
3 ANOVA indicated significant diet effect for combined data, p < 0.05.
4 Values with different superscripts are significantly different (p < 0.05) within race.
5 ANOVA indicated significant state effect for combined data, p < 0.05.
6 ANOVA indicated significant carryover effect for combined data, p < 0.05.
CH(n=5) <
158.80 ± 6.973 
10.90 + 1.323 
85.66 + 4.84 
25.98 ± 1.75
23.16 + 1.05a,b(
49.14 + 2.79
60.74 ± 8.66 
44.98 ± 6.48
143.02 + 11.53 
41.82 + 2.68
US74
Iowa
876.40 ± 41.676,a
75.24 + 13.77
11.52 ± 2.62
38.33 ± 7.05
23.06 ± 6.21
0.32 ± 0.11
0.45 ± 0.16
Nebraska______
1,013.20 + 93.843 
58.16 + 8.63
7.36 ± 1.20 
21.63 + 3.68
23.36 ± 5.44 
1.24 ± 0.37 
1.64 + 0.71
Iowa_________
1285.80 + 37.47 b 
70.06 + 18.29 
9.08+ 1.51 
37.45 + 10.20 
20.32 ± 8.48 
1.30 + 0.87 
0.23 + 0.14
MOD
1 Mean ± SEM.
2 ANOVA indicated significant race effect for combined data, p < 0.05.
3 ANOVA indicated significant diet effect for combined data, p < 0.05.
4 ANOVA indicated significant state effect for combined data, p < 0.05.
5 ANOVA indicated significant diet carryover effect for combined data, p < 0.05.
6 Values with different superscripts are significantly different (p < 0.05) within states.
e#
and adequate nutrient content, or it 
could indicate that the changes in 
HDL and neutral sterol excretion 
require more than 4 weeks to be 
expressed.
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Studies of Women —  
Eating Diets with 
Different Fatty Acid 
Composition
II. Urinary Eicosanoids and Sodium, and Blood Pressure
Abstract
Dietary fatty acid composi­
tion is known to affect various aspects 
of eicosanoid metabolism. This 
research was conducted to evaluate 
effects of a diet similar to the US 
average consumption in 1974 (40 
en% fat, polyunsaturated to saturated 
fatty acid ratio, P/S = 0.3) or a diet 
modified to contain 30 en% fat, P/S = 
1.0, on eicosanoid metabolism in 
young women. Following a period on 
self-selected diets, women in Ne­
braska and Iowa were fed the diets for 
28-day periods in a crossover design. 
Urinary eicosanoids, sodium (Na) 
excretion, and blood pressure were 
determined. Diet effects were 
confounded by carry-over effects. For 
urinary eicosanoids the sequence of 
higher saturated fat (SFA) followed 
by lower SFA resulted in significantly 
greater excretion, whereas the reverse 
order of diets did not cause significant 
changes. Diastolic blood pressure was 
not affected by diet, but systolic 
pressure was lower with the modified 
diet in the lower to higher SFA 
sequence. The change from self- 
selected to experimental diets does 
not seem to account for the carry-over 
effects. The interpretation is that 
linoleate is depleted from tissues 
more slowly than it is repleted.
Effects upon Na excretion were
Originally published in:
Journal of the American College of Nutrition, Vol. 10 
No. 4, 322-326 (1991). ©1991 John Wiley & Sons, Inc.
related to SFA more than to linoleate 
in the diet.
Introduction
Humans depend upon dietary 
sources for essential fatty acids 
(EFA). Linoleate is the precursor of 
C20:3n-6 (dihomogammalinolenic 
acid, DHGLA) and C20:4n-6 (arachi- 
donic acid, AA), precursors for the 
prostaglandins (PG), thromboxanes 
(TX), etc., collectively called 
eicosanoids. DHGLA gives rise to the 
1-series and AA gives rise to the 2- 
series.
Accumulation of PG precur­
sors in tissue lipids is a key regulatory 
point for PG biosynthesis. Mathias 
and Dupont [ 1 ] have estimated that 
the average US diet contains less than
0.2% of energy (en%) as AA and 
about 6 en% linoleate, so that most of 
the tissue AA is derived from 
desaturation and elongation of dietary 
linoleate. Thus, the mechanism by 
which dietary linoleate affects PG 
production may be by alteration of 
precursor pools. Because PG may me­
diate renal blood flow, glomerular 
filtration, renin release, diuresis, and 
perhaps, urinary sodium (Na) excre­
tion, a relative PG deficiency has 
been proposed as a cause of hyperten­
sion [2].
Fourteen-week-old Dahl salt- 
sensitive rats on a 0.11% sodium 
chloride (NaCl) diet (normotension) 
or a 0.3% NaCl diet (borderline hy­
pertension) had significantly less vas­
cular prostacyclin (PGI2) production 
compared with Dahl salt-resistant rats 
[3]. Vascular PGI2 was returned to 
normal levels, with the blood pressure
(BP) elevation induced by a high-salt 
(4% NaCl) diet. All the diet groups of 
Dahl salt-sensitive rats had increased 
vascular TXA2.
Measurement of PG and 
their metabolites in urine is a 
noninvasive way to assess PG biosyn­
thesis. Indirect evidence suggests that 
TXB2 primarily comes from the kid­
ney [4], although urinary TXB2 may 
be increased when extrarenal TXA2 
synthesis is increased [5]. Six-keto- 
PGFla (met-PGI2), the hydration 
product of unstable PGI2, is more 
likely to reflect renal biosynthesis 
than are other PGI2 metabolites [5,6]. 
Circulating PGI2 may contribute, 
however, to urinary met-PGI2 [6-8]. 
Urinary PGE2 probably originates in 
the kidney [5,6,9]. Urinary PGF2(X 
may also originate in the kidney [6,9], 
as may PGE, [6].
Adam et al. [10] fed female 
volunteers liquid diets containing 0, 4, 
or 20 en% linoleate. The average 
amounts of PG metabolites converted 
to urinary tetranorprostanedioic acid 
(reflective of PGE1+2 and PGF1+2) 
were increased after 3-4 days as di­
etary linoleate increased. Seyberth et 
al. [11] fed ethyl arachidonate to four 
male volunteers, and three of four 
subjects had markedly increased uri­
nary PGE metabolites. Adam and 
Wolfram [12] found a dose-response 
relationship between dietary linoleate 
and PGE biosynthesis, creatinine ex­
cretion, and Na excretion, but PGF2a 
excretion was not significantly 
changed by linoleic acid intake.
Few studies have been re­
ported in which small changes in diet 
appropriate to meeting suggested 
guidelines were undertaken, espe­
cially in women. The research re­
ported here evaluates the effects upon 
BP and urinary eicosanoid excretion 
of moderately different diets. Chang­
ing from a 40 en% fat diet with a 
polyunsaturated to saturated fatty acid 
ratio (P/S) of 0.3 to a 30 en% fat diet 
with a P/S of 1.0 caused favorable 
changes in young women.
Methods
Subjects
Twenty adult women 
participated in the 10-week study: 10 
undergraduate students at Iowa State 
University and 10 graduate students at
the University of Nebraska, Lincoln. 
Descriptions of the subjects have been 
published elsewhere [13]. According 
to medical personnel, the subjects 
were in good health. The project was 
approved for human subject participa­
tion by the institutional review 
committees at both Iowa State 
University and the University of 
Nebraska. The data of PG metabolism 
were significantly affected by race in 
the Nebraska group; therefore, only 
data from 14 women, all Caucasians, 
were used for this report.
The women were fed a diet 
designed to duplicate the average US 
diet in 1974 [14] during one of the 4- 
week experimental periods: 40 en% 
fat, polyunsaturated (PUFA) to 
monounsaturated (MUFA) to satu­
rated fatty acid (SFA) proportions of 
1:3.3:3.4, and approximately 600 mg 
cholesterol (US74). During the other 
4-week experimental period, the 
women were fed a diet modified to 
meet US dietary goal recommenda­
tions regarding fat [15]: 30 en% fat, 
PUFA:MUFA:SFA of 1:1:1, and less 
than 300 mg cholesterol. Six women 
were fed the US74 diet regimen for 
the first 4-week period and then the 
modified regimen for the second 4- 
week period. The other eight women 
were fed the diets in reverse order. 
The women were allowed free access 
to table salt.
Sample Collection
Urine composites used for 
analyses were sampled from week 0 
(self-selected diet period, SS), week 
4, and week 8 (last weeks of modified 
diet or US74 diet period). Urine 
samples were collected in individual 
containers. Each subject’s daily urine 
collection was measured; an aliquot 
exceeding 0.1 of the final adjusted 
volume was taken and stored at 
-15°C. A 7-day composite of each 
subject’s urine was made by combin­
ing 0.1 of the final volume of each 
day’s collection. The Nebraska 7-day 
composites were packed in dry ice 
and shipped overnight to Iowa.
BP Measurement 
(Iowa Only)
BP was measured before 
fasting blood samples were taken 
from each subject. A registered nurse 
at the University Student Health
Center measured the subjects BP once 
(on either arm) while the person was 
seated. A standard mercury sphygmo­
manometer and cuff were used.
Radioimmunoassay 
of Prostaglandins
A double antibody procedure 
described by McCosh et al. [16] was 
used to measure PG in the unextracted 
urine samples. The PGEj antiserum 
had a crossreactivity of 17% with 
PGE2; the PGE2 antiserum had a 
crossreactivity of 18% with PGEj.
The TXB2 and 6-keto-PGFj antisera 
had crossreactivities of 20 and 3% 
with their respective dinor metabolites 
[17]. The other PG antisera did not 
significantly crossreact with each 
other. No corrections were made for 
crossreactivity. All percentage 
binding curves were parallel for the 
concentrations measured.
Urinary Creatinine 
Determination
Urinary creatinine levels 
were measured by using the Folin 
method [18] as given in ‘’Hawk’s 
Physiological Chemistry” [19].
Na Analysis
Na in the composited urine 
samples was measured by use of 
flame (absorption) photometry. A 
Lab-trol chemistry control (Dade 
Diagnostics, Aguada, PR) was run at 
the beginning and end of the sample 
run. Na values were calculated by use 
of linear regression of a standard 
curve.
Statistical Analysis
Data were analyzed by use of 
analysis of variance (ANOYA), the 
Tukey range test, and Pearson 
correlation coefficients (SAS Insti­
tute, Cary, NC). Data were not paired 
in the analyses and are reported as 
mean ± SEM.
Results
Self-Selected Diets
Mean nutritive values of the 
self-selected diets (preexperimental 
week 0) chosen by the Iowa and 
Nebraska subjects and the experimen­
tal diets are reported elsewhere [13].
It is difficult to make conclusive 
statements about the subjects’ Na
21
intakes because discretionary addi­
tions of table salt were not recorded. 
Urinary Na excretion is perhaps a 
better indicator of the subjects’ actual 
total Na intake [20,21], but there 
probably were additional fecal and 
cutaneous losses of Na [20]. Fatty 
acid compositions of the diets are 
reported elsewhere [22].
Na Excretion
There were diet carry-over 
effects on Na excretion, as shown by 
a statistically significant residual 
factor in the ANOVA. When the 
US74 diet followed the modified diet, 
there was significantly greater Na 
excretion with the US74 diet (Table 
2-1, p = 0.0005); urinary Na did not 
change in the other sequence.
Blood Pressure
The subjects studied in Iowa 
(n = 10, five for each sequence) had 
BP measured (Table 2-1). Diastolic 
BP was not affected by diet (61.65 ± 
3.7 mm Hg). Systolic BP was affected 
by diet, and there was a carry-over 
effect of diet. The modified diet
resulted in lower BP compared with 
the US74 diet when it preceded the 
US74 diet (100 vs 119 mm Hg, p < 
0.029). Values were not different 
between the two experimental diets in 
the other sequence, but the US74 diet 
resulted in lower values than the self- 
selected diet (p < 0.04).
Urinary Eicosanoids
There were diet carry-over 
effects on all of the urinary PG except 
PGE2 and TXB2 (Table 2-1). When 
the modified diet followed the US74 
diet, PGE! and PGI-, were signifi­
cantly greater with consumption of 
the higher-linoleate diet. With the 
reverse sequence differences were 
slight and not significant, except that 
MPGF->a excretion was greater with 
the US74 diet.
Correlations Among Variables 
Excretion of some PG was 
related to dietary fat. Urinary PGF-, 
and MPGF-,a were positively corre­
lated with total fat consumed (r =0.36, 
p < 0.02, and r = 0.38, p <0.014, re­
spectively) and to dietary oleate
(r = 0.31, p < 0.043, and r = 0.43, 
p < 0.038, respectively). Urinary PGE 
and PGI2 were positively correlated 
with linoleate consumption (r = 0.68, 
p < 0.0001, and r = 0.53, p < 0.0003, 
respectively).
Discussion
Diet Sequence Effects
These results have demon­
strated that the length of time required 
to reach a plateau of effects of fatty 
acids on PG metabolism in humans is 
longer than 4 weeks if a reduction in 
linoleate is made. Effects upon cho­
lesterol metabolism do not seem to be 
as sensitive to such a time factor [13]. 
For urinary PG excretion, the se­
quence of higher-SFA followed by 
lower-SFA and an increased P/S ratio 
resulted in significant changes, 
whereas the reverse order of diets did 
not result in significant changes. The 
carryover effects include those of the 
self-selected diets, but there was no 
consistent temporal effect. The 
change from self-selected to a nutri­
tionally complete diet did not seem to
_  ,  i  Blood pressures and urinary sodium and prostaglandin excretions of human Table 2*1 , suN©cts fed diets differing in fatty acid composition in a crossover design.
SS US74 MOD US74 Diet Effect
Systolic blood pressure (mm Hg) 1
Sequence 1 (n = 5) 113 ± 3 2 , a 10 01 3b 1 0 8 1 4a,b 0.042
Sequence 2 (n = 5) 115 ± 3 a,b 10014a 11915b 0.029
Sodium (meq/day)l
Sequence 1 (n = 6 ) 3637 ± 338 2,7261483 3,7831364 NS
Sequence 2 (n = 8 ) 23731278a 2 ,9431232a 4,0901274 b 0.001
PGE-| (ng/day) 1
Sequence 1 (n = 6 ) 821 ± 98a 222147 b 622161a 0.001
Sequence 2 (n = 8 ) 525186 464131 329134 NS
PGE2 (ng/day)
Sequence 1 (n = 6 ) 192138 a 115139b 114142b 0.005
Sequence 2 (n = 8 ) 3401179 185158 208168 NS
PGI2 (ng/day) 1
Sequence 1 (n = 6 ) 717184 a 407139 b 6 3 6 1 39a 0.007
Sequence 2 (n = 8 ) 569150 487131 5251 40 NS
PGF2a (ng/day) 1
Sequence 1 (n = 6 ) 1,5861232 a 504181 b 7491152b 0 .0 0 2
Sequence 2 (n = 8 ) 844175 570179 7841118 NS
MPGF2a (ng/day) 1
Sequence 1 (n = 6 ) 2981 50 a 101 123 b 174141 a,b 0 .0 1 2
Sequence 2 (n = 8 ) 174118 a 112114b 185117a 0.011
TXB2 (ng/day)
Sequence 1 (n = 6 ) 460134 341 161 513192 NS
Sequence 2 (n = 8 ) 444162 329 131 322139 NS
1 ANOVA indicated significant residual effects for combined data (p < 0.05).
-Values on the same line with different superscripts are significantly different (p < 0.05).
account for the observed carry-over 
effects. A possible interpretation of 
the carry-over effect is that linoleate 
is depleted from tissues more slowly 
than it is repleted by dietary changes. 
Others have noted this phenomenon 
[10]. Increasing linoleate from ~2-3 to 
-5-6 en% has been shown to decrease 
PG excretion, whereas increases >5-6 
en% have caused increases in excre­
tion [23].
Na excretion was less when 
the higher-linoleate diet was fed as 
compared with the US74 diet. Sys­
tolic BP Was higher if the US74 diet 
followed the higher-linoleate diet, 
indicating more rapid effect of reduc­
tion than increase of linoleate in this 
case. The opposite sequence effects 
upon urinary PG vs Na excretion and 
BP suggest that SFA is the direct ef­
fector of the latter.
Some research has linked 
dietary linoleic acid to decreased BP 
in humans [24-26], but not all re­
search supports this association [27]. 
The potential importance of this link 
gives much credence to further re­
search investigating dietary EFA and 
BP. The complexity of effects of 
small changes in diet associated with 
a series of depletion-repletion effects 
prevents conclusions regarding 
mechanisms of effects. It is clear, 
however, that changes of the magni­
tude made will cause changes in me­
tabolism.
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Studies of Women 
Eating Diets with 
Different Fatty Acid 
Composition
III. Fatty Acids and Prostaglandin Synthesis by Platelets 
and Cultured Human Endothelial Cells
Abstract
The aim of this study was to 
determine how plasma fatty acids 
(FA) of subjects eating either a diet 
designed to match the US diet 
consumed in 1974 in fat content and 
composition in accord with the 
HANES I survey (US74) or a diet 
modified to meet the US Dietary Goal 
Recommendations (MOD) are altered, 
and how the changes affect platelet 
thromboxane (TXB9) synthesis, and 
prostacyclin (PGI-,) and prostaglandin 
E9 (PGE9) synthesis by cultured 
human endothelial cells. Following a 
period of recorded self-selected diets, 
10 women ate the US74 diet for 4 
weeks, changing to the MOD diet for 
the next 4 weeks (sequence 1), and 10 
ate the MOD diet followed by the 
-US74 diet (sequence 2). Plasma 
triglycerides, free FA, platelet FA 
composition, and red blood cell 
phospholipids responded to the 
change from self-selected to con­
trolled diets, but differences in 
responses were not seen between 
US74 and MOD diets. Red blood cell 
total FA did not respond to dietary 
changes. Under collagen but not 
thrombin stimulation, platelet TXB9 
synthesis was correlated with platelet 
arachidonate concentration but not 
serum cholesterol. Endothelial cells 
were isolated from umbilical cord 
veins and incubated for 72 hours with 
a 20% medium of the women’s 
plasma. In sequence 1 (high saturated 
FA to high polyunsaturated fatty 
acids), but not in 2 (reverse order), 
plasma from subjects eating the MOD 
diet decreased (p < 0.05) basal and 
thrombin-stimulated PGI9 and PGE9 
synthesis by the cells. These cells had
a higher content of linoleic acid than 
cells from subjects eating the US74 
diet. Thus, our study suggests that an 
increase in the intake of linoleic acid 
from 4.8 to 7.6 en% decreases PGI9 
and PGE2 synthesis by human 
endothelial cells, and supplementation 
of the diet with linoleic acid has a 
longer period of effectiveness than its 
decrease in the diet.
Introduction
Prostacyclin (PGL) and 
prostaglandin E2 (PGE2), as well as 
other eicosanoids of the 2 series 
(diene) such as thromboxane A9 
(TXA9), are cyclooxygenase products 
of arachidonic acid [1,2]. In most 
tissues, this fatty acid (FA) is synthe­
sized by elongation and desaturation 
of linoleic acid [1,2]. Dietary linoleic 
acid affects FA composition of blood 
plasma [3,4]. Those changes affect 
tissue FA and eicosanoid synthesis 
[5]. Platelets reflect the linoleate in 
the diet of rats [6] and men [7].
The aortas of rats fed diets 
with more than 3.5% of the total 
energy (en%) as C18:2n-6 synthe­
sized slightly less PGI2 than aortas of 
rats fed diets with less than 3.5 en% 
C18:2n-6 [8], and rabbits fed diets 
with 11 en% C18:2n-6 had more 
linoleic acid and less C20:4n-6 in 
platelets and aortic phospholipids than
Originally published in:
Journal of the American College of Nutrition, Vol. 10 
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rabbits fed a diet with 2.2 en% 
C18:2n-6 [9]. The synthesis of 
prostacyclin-like material by aortas of 
rabbits eating diets high in C18:2n-6 
was also decreased [10,11].
PGI-, which in the blood 
vessels is synthesized mainly by 
endothelial cells, produces vasodila­
tion and inhibits platelet aggregation 
[12]. TXA„ which is synthesized 
mainly by platelets, causes vasocon­
striction and stimulates platelet 
aggregation [ 13]. It has been postu­
lated that a balance between PGI2 
synthesis by endothelial cells and 
TXAt synthesis by platelets is 
necessary to avoid damage to the 
endothelium by platelets, thrombosis, 
or bleeding problems [13]. In normal 
endothelial cells, synthesis of PGE-, is 
less than that of PGI?, and the PGE2/ 
PGI7 ratio is larger in smooth muscle 
cells, and it is even greater in fibro­
blasts than in endothelial cells 
[12,14]. This ratio is also increased in 
atherosclerotic lesions and in endothe­
lial cells incubated with high levels of 
cholesterol [15,16]. A change in the 
PGE^/PGI-, ratio in endothelial cells 
may be the first sign of an endothelial 
lesion.
We incubated cultured 
human endothelial cells with a 
medium supplemented with plasma 
obtained from subjects eating either a 
diet designed to match the average US 
diet consumed in 1974-77 (US74) in 
fat content and composition in accord 
with the HANES I survey [17] or a 
diet modified (MOD) to meet the US 
Dietary Goal Recommendations in fat 
content and composition [18]. FA 
compositions of the diets, plasma 
triglycerides (TG), free fatty acids 
(FFA), red blood cells (RBC), 
platelets, and incubated endothelial 
cells were determined. Basal and 
thrombin-stimulated PGI-, and PGE-, 
synthesis by the endothelial cells were 
measured. Collagen- and thrombin- 
stimulated TXA9 synthesis was 
measured in platelets.
Materials and Methods
Chemicals
Sources of supplies were: 
medium 199, heat-inactivated fetal 
bovine serum (FBS), streptomycin, 
Fungizone, trypsin, BME aminoacids, 
and BME vitamin solution (GIBCO, 
Grand Island, NY); N’-2-hydroxy- 
ethyl-piperazine-N’-ethanesulfonic 
acid (HEPES) and glucose (Sigma 
Chemical, St Louis, MO); 6-keto- 
(3H)-prostaglandin F ,a (Upjohn, 
Kalamazoo, MI); FA-poor bovine 
serum albumin (Miles Laboratories, 
Research Products, Elkhart, IN); 
Thrombostat, thrombin USP bovine 
origin (Parke-Davis, NJ); sterile 
disposable filters (Gelman Sciences, 
Ann Arbor, MI); heparinized 
vacutainer tubes (Monoject,
Sherwood Medical, St Louis, MO); 
boron trifluoride methanol and 
methylated FA standards (Applied 
Science Labs, Alltech Associates, 
Deerfield, IL); culture flasks and 
sterile disposable tubes (Coming 
Glass Works, Corning, NY).
Subjects and Diets
Details of the study, ap­
proved by the university committees 
on the use of human subjects in 
research, appear in paper I of this 
series [19] and in chapter 1 of this 
bulletin. In brief, 20 volunteers, 
female students 18-30 years of age, 
were studied. Effects of diet upon FA 
composition of serum TG, FFA, and 
RBC total lipids are reported for all 
20 volunteers; only 10 of the subjects, 
those in Iowa, were used in studies of 
platelets and endothelial cells.
There was a 7-day pre- 
experimental period during which the 
subjects consumed self-selected diets 
and recorded their intakes. After the 
initial period, half the subjects 
received a diet designed to match the 
average US diet in 1974 (US74) [17] 
in fat content and composition (40 
en% fat, 4 en% as linoleate) for 4 
weeks. Then the subjects received a 
similar diet modified (MOD) to meet 
the US Dietary Goal Recommenda­
tions [18] in fat content and composi­
tion [30 en% fat, < 10 en% saturated 
fat (SFA), 10 en% linoleic acid 
(PUFA)] for 4 weeks (sequence 1).
The other half of the subjects received 
the MOD diet during the first 4 weeks 
and then the US74 diet during the 
next 4 weeks (sequence 2). Choles­
terol content of diets provided: US74, 
687 mg/day; MOD, 98 mg/day; Iowa 
self-selected, 371 mg/day; Nebraska 
self-selected, 362 mg/day.
Fasting blood samples were 
drawn into sterile heparinized 
vacutainer tubes the day the subjects 
started to receive the experimental 
diets, at the end of the first 4 weeks 
(the day they changed diets), and at 
the end of the 8-week study. The 
samples were all drawn on the same 
day and thus represented random days 
of the menstrual cycle.
Harvesting of Endothelial Cells
Endothelial cells were 
harvested by methods described 
previously [20,21]. The umbilical 
cord was severed from the placenta 
soon after birth and placed in a sterile 
container of buffer containing 137 
mM NaCl, 4 mM KC1, 0.5 mM 
Na2HP04, 0.15 mM KH2P 0 4, 11 mM 
glucose, pH 7.4, and 20,000 units/L 
penicillin (base), 20,000 [ig/L 
streptomycin (base), and 25 |ig/L 
Fungizone. Nontraumatized portions 
of the cord were incubated at 37°C in 
a water bath for 10 minutes; the blood 
was washed out with buffer, a 0.25% 
sterile trypsin solution was infused 
and incubated at 37°C for 15 minutes. 
The cells were collected from the cord 
in a modified medium 199 (MM 199) 
with 10% FBS [21]. The cells were 
sedimented by centrifugation at 250 x 
g for 10 minutes. The cell pellet was 
resuspended in MM 199 with 20% 
FBS. Between 0.5 and 1.5 x 106 cells 
were seeded into 25-cm2 culture 
flasks and incubated at 37°C. After 24 
hours the culture medium was 
discarded, and the cells were washed 
with buffer, prewarmed at 37°C, and 
relayered with MM 199 with 20%
FBS.
25
Preparation of Plasma and 
Culture Medium
Blood samples were centri­
fuged at 600 x g for 10 minutes at 
4°C. After centrifugation, the plasma 
was separated, heat-inactivated at 
37°C for 1 hour, and mixed with 
MM 199 at a final proportion of 20%. 
The mixture was sterilized by 
membrane filtration using a 0.2 pm 
sterile disposable filter. The sterile 
mixture was collected in sterile 
disposable tubes and kept under 
nitrogen at -70°C for further use.
Incubation and Stimulation 
of the Cells
When the cells reached 
confluence, the culture medium was 
discarded; the confluent cells were 
washed with buffer and then relayered 
with culture medium containing 20% 
heat-inactivated plasma prepared as 
described. At the end of a 72-hr 
incubation period, the culture medium 
was collected, and the monolayer of 
cells was washed twice with buffer 
containing 8.6 g/L bovine serum 
albumin-FA poor. One milliliter of 
thrombin solution (0.125 unit/ml) was 
added to the cells, and the mixture 
was incubated with continuous 
agitation at 37°C for 5 minutes. At the 
end of this period, the thrombin 
solution was collected and stored 
under nitrogen at -70°C for further 
analysis. The cells were recovered, 
suspended in cold buffer, sedimented 
at 600 x g for 10 minutes at 4°C, and 
resuspended in cold buffer; the 
number of cells per flask was deter­
mined, and the cells were stored 
under nitrogen at -70°C for further 
analysis.
In preliminary experiments, we 
observed great variability in pros­
taglandin synthesis between endothe­
lial cells isolated from different 
umbilical cords [21]. Gender of the 
baby, but not FA composition, 
contributed to the variability. To 
correct for variability between 
umbilical cords, a donor plasma 
sample was incubated twice, and the 
samples were paired by subject and
umbilical cord. Because of this, the 
number of cells incubated is twice the 
number of plasma samples that we 
had.
Thromboxane (TX) Synthesis 
by Stimulated Platelets
Aliquots of citrated blood 
were pipetted into siliconized glass 
cuvettes containing stirring bars 
(Sienco, Morrison, CO). Samples 
were preincubated to 37°C for 1 
minute in a multicavity heated stirrer, 
developed specifically for our studies 
by Sienco and set at 1200 rpm. After 
preincubation, appropriate amounts of 
calcium (Ca) (0, 5, or 10 mM Ca 
final) and collagen suspension [22] or 
thrombin (1 unit/ml final) were added. 
At the end of 4 minutes of incubation, 
TXB2 synthesis was stopped by 
addition of 420 pM aspirin, which 
inhibits TXB2 synthesis by 99% [23]. 
The samples required clotting for 1 
hour at room temperature to collect 
serum. Serum was obtained by 
centrifugation at 1,000 x g for 7 
minutes at 4°C, and samples were 
frozen until assayed. Platelet-derived 
TXB2 was determined as described 
below. The rate of TXB2 formation is 
expressed per milliliter of serum.
Measurement of 
Prostaglandins (PGs)
Prostaglandins were mea­
sured by using a radioimmunoassay 
procedure. The methodology, 
specificity of the antibodies, and 
validation of the assay have been 
published [24.25]. PGI2 was mea­
sured as its stable product 6-keto- 
PGFla, TXA2 as its product TXB2, 
and PGE2 was determined directly. 
The PGs were assayed in unextracted 
serum or culture medium before and 
after stimulation of the cells. No 
statistical differences were found 
between either the total protein 
content (0.2-0.3 mg) or the number of 
cells (0.7-0.9 x 106) in the endothelial 
cell flasks assigned to the different 
treatments; therefore, results are 
expressed as PG synthesis in either 
nanograms or picograms per flask of 
cells. The concentration of PG in the 
culture medium before incubation
represented less than 0.0001% of the 
concentration found after incubation 
with the cells.
FA Analysis
To determine FA composi­
tion of the endothelial cells, they were 
first thawed and sonicated for 5 
minutes. Then an aliquot was taken to 
measure the protein content by using 
the method of Lowry et al. [26]. The 
cell suspension was then saponified, 
the nonsaponifiable fraction removed, 
and the FA were extracted from the 
acidified residue. The FA were 
methylated by using boron- 
triflouride-methanol [27], and the FA 
methyl esters were quantitated by gas- 
liquid chromatography. FA composi­
tions of the experimental diets, 
plasma TG, and erythrocytes were 
determined by using similar methods 
[28-30],
Statistical Analysis
Statistically significant 
differences were determined by 
multivariate analysis of variance 
(ANOVA) without paired compari­
sons. Effects tested included a 
residual, which measured the extent to 
which the previous diet influenced the 
response. When this factor was not 
significant, differences between diets 
were examined further by using 
Tukey’s procedure to estimate least 
significant differences [31]. For the 
statistical analysis of PG a square-root 
transformation of the data was 
performed. The actual data did not 
have a normal distribution, but the 
square roots were normally distrib­
uted.
Results
FA Compositions
The self-selected diet records 
were analyzed for total SFA, mono- 
unsaturated fatty acids (MUFA), and 
PUFA (Table 3.1). Composites of 
each experimental diet were analyzed 
in the same way as tissues (Table 
3.1). The analyzed values for SFA 
and linoleate were close to the 
planned composition: P/M/S = 7.8/ 
12.2/10.0 for the MOD diet and 16/ 
18.6/5.2 for the US74 diet. The
■  RISIHI HI H
SS(Calculated)2 US74 (Analyzed) MOD (Analyzed)
Iowa Nebraska
Fatty Acid1
12:0 4.26 2.49
14:0 1.35 0.87
16:0 23.79 21.70
18:0 10.99 8.27
18:1 34.5 35.4 46.48 40.66
18:2 16.9 20.2 11.91 25.50
18:3 1.07 0.47
20:4 0.17
20:5 0.05
Total saturated 35.3 32.5 40.40 33.30
1 Number of carbons: number of double bonds.
2USDA Lipid Laboratory Data Base (Beltsville Human Nutrition Center) 
contributed by Mary Marshall.
Fatty acid composition of plasma triglycérides 
1  of women consuming diets containing different 
* .  fatty acid concentrations (°ô of total).1
SS US74 MOD
Fatty Acid 2
14:0 2.52 ± 0.28 3.28 ± 0.54 2.98 1 0.51
16:0 27.49 ± 1.65 28.49±0.95 29.341 0.90
18:03 14.77 ± 0.50 a-4 13.451 0.36 b 13.41 1 0.38 b
18:15 31.24 ± 1.79 a 2 1 .3 0 1 1.78 b 2 1 .5 5 1 1.48 b
18:23 18.12 ± 1.76a 23.0711.38 a,b 23.5411.56 b
20:3 0.47 + 0.21 0.7710.25 0.91 10.35
20:46 3.68 ± 0.60 a 8.1710.72 b 7.201 0.70 b
1 Mean 1 SEM (n = 20).
2 Number of carbons: number of double bonds.
3ANOVA indicated significant diet effect, p < 0.05.
4 Values with different superscripts are significantly different (p < 0.05) among diets.
5 ANOVA indicated significant diet effect, p < 0.01.
6 ANOVA indicated significant residual effect, p < 0.05.
mUSSSSmass| ■ 1i f IB B fii
SS MOD US74
Fatty acid 2
14:0 17.6412.36 14.0611.96 12.9912.18
16:0 21.8211.07 26.3011.33 23.3311.18
18:03 11.9511.46 9.4511.10 13.3911.41
18:14 23.2211.61 a,5 27.76 1 1 .05b 3 1 .1 7 1 1.29b
18:26 2 1 .5 6 1 1.37 a 1 8 .8911.05a>b 15.981 0.96 b
20:3 0.2610.18 0.1810.18 0.061 0.06
20:4 3.5311.02 2.82 1 0.84 1.39 1 0.40
1 Mean ± SEM (n = 20).
2 Number of carbons:number of double bonds.
3 Significant residual effect, p < 0.05.
4 Significant effect of diet, p < 0.01.
5 Values with different superscripts are significantly different (p < 0.05) among diets.
6 Significant effect of diet, p < 0.05.
database for the diet record analysis 
did not allow estimation of C18:3n-3 
(oc-linolenate), but C18:3n-3 was 
present in the experimental diets and 
undoubtedly was consumed during 
the usual eating pattern.
In Table 3.2 are shown the 
FA compositions of plasma TG.
There were significant (p < 0.05) diet 
effects upon C 18:0, C 18:1, and 
C l8:2. Furthermore, there was a 
significant diet carry-over effect (p < 
0.05) on arachidonic acid (C20:4n-6), 
as illustrated in Figure 3.1. Diet had a 
significant effect on FFA C 18:1 and 
C l8:2 (Table 3.3). Total FA composi­
tion of RBC was unresponsive to diet 
(Table 3.4). For Iowa subjects, FA 
composition of RBC phospholipids is 
shown in Table 3.5. There were 
significant diet effects on C l6:0,
C l8:0, and C l8:2. The ANOVA 
indicated a significant diet carry-over 
effect for C 18:1, C20:5, and C22:6. 
All main diet effects reflect a change 
from self-selected diet to one of the 
experimental diets; responses to US74 
and MOD diets were not different 
(Tables 3.2, 3.3, and 3.5). FA 
composition of the platelet total lipid 
is shown in Table 3.6. No significant 
direct dietary effects were observed, 
but there were significant diet carry­
over effects.
With the exception of 
linoleic acid, no statistically signifi­
cant differences were observed in the 
FA composition of endothelial cells 
(Table 3.7). Endothelial cells incu­
bated with plasma from subjects 
eating the self-selected diet and the 
MOD diet had a higher percentage of 
linoleic acid (p < 0.05) than did cells 
incubated with plasma from subjects 
eating the US74 diet irrespective of 
the sequence in which the diets were 
eaten. However, no significant 
correlations were found between 
either basal or thrombin-stimulated 
prostaglandin (PGI2 or PGE2) 
synthesis and the percentage of either 
linoleic or arachidonic acid present in 
the cells.
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Fatty acid composition o! red blood cell total 
lipid of women consuming diets containing
SS US74 MOD
Fatty acid 2 
14:0 0.18 + 0.13 0.40 + 0.11 0.35 + 0.12
16:0 32.01 ±0.84 31.16 + 0.86 32.60 ± 0.76
18:03 22.52 ± 0.67 22.00 ± 0.43 22.45 ± 0.65
18:13 20.951 0.45 23.06 ± 0.82 21.26 + 0.86
18:2 14.54 + 0.33 13.34 + 0.62 13.66 + 0.64
20:33 0.65 ± 0.24 0.61 ±0.16 0.72 + 0.16
20:4 8.89 + 0.34 8.27 + 0.81 8.34 + 0.55
1 Mean ± SEM; n = 10 for all self-selected and 14:0 modified diets; 
n = 20 for ail of US74 and modified diets > 16:0.
2 Number of carbons: number of double bonds.
3 ANOVA indicated significant residual effect, p < 0.05.
TX Synthesis by 
Stimulated Platelets
Data showing TXB2 synthe­
sis by platelets under various stimu­
lating conditions are shown in Table 
3.8. Under conditions of maximum 
stimulation with thrombin plus Ca, 
there were no significant effects of 
diet. With milder conditions of 
stimulation, there was a significant 
carry-over effect of diet. When the 
MOD diet followed the US74 diet 
(sequence 1), there was a greater 
TXB2 synthesis response to the MOD 
diet in platelets stimulated by 5 mM 
Ca plus collagen and 10 mM Ca plus
Fatty acid composition of red blood cell phospholipids of worn« 
consuming diets containing different fatty acid concentrations
j a g g s US74 MOD US74
Fatty Acid 2
16:03 24.84 ± 0.92 23.20 ± 1.20 24.18 + 1.47
Sequence 1 
Sequence 2
26.04 ± 0.54 23.10 + 1.22 23.10 + 1.22
18:03 16.26 + 0.54 3 15.02+ 0.17 a,b 13.94 + 0.62 b
Sequence 1 
Sequence 2
16.54 + 0.453 14.78 +0.54 b 13.32 + 0.40b
18:14 16.46 + 0.86 15.62 + 0.52 16.98 + 1.07
Sequence 1 
Sequence 2
17.14 + 0.303 14.78 +0.64 b 16.46 ±0.41 a,b
18:25 11.00 + 0.98 12.22 + 0.70 13.86 + 1.30
Sequence 1 
Sequence 2
11.24 + 0.53 13.04 + 1.15 14.86 + 1.14
20:3 2.44 ± 0.20 2.60 ± 0.39 1.72 ± 0.53
Sequence 1 
Sequence 2
2.16 + 0.25 1.76 + 0.54 2.00 ± 0.42
20:4 10.64 + 1.15 12.20 + 1.31 11.14 + 1.45
Sequence 1 
Sequence 2
8.94 ± 0.32 10.12 + 0.62 12.28 + 1.44
20:54 6.68 ± 0.29 6.65 ± 0.43 5.26 ± 0.44
Sequence 1 
Sequence 2
6.42 ±0.47 a,b 7.40 +0.65 a 5.48 ± 0.29b
22:4 3.00 ±0.51 3.12 + 0.59 3.04 + 0.71
Sequence 1 
Sequence 2
2.56 ± 0.33 3.04 ± 0.30 2.74 ± 0.33
22.66 2.08 ± 0.59 1.65 + 0.59 2.73 ± 0.77
Sequence 1 
Sequence 2
1.40 + 0.123 2.58 +0.35 a-b 3.00 ± 0.59b
24:1 6.68 ± 0.33 7.52 ± 0.89 6.42 ± 0.86
Sequence 1 
Sequence 2
7.34 ± 0.95 7.46 ± 0.87 6.66 ± 0.87
1 Mean ± SEM (n = 5 except Sequence 1 US74 n = 4).
2 Number of carbons: number of double bonds.
3 ANOVA indicated significant diet effect, p < 0.01.
4 ANOVA indicated significant residual effect, p < 0.01.
5 ANOVA indicated significant diet effect, p < 0.05.
6 ANOVA indicated significant residual effect, p < 0.05.
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collagen. Only in unchallenged whole 
blood did the US74 diet result in 
greater TXB2 synthesis when it 
followed the self-selected diet. The 5 
mM Ca plus collagen stimulation 
resulted in greater TXB2 synthesis 
than the US74 diet when the US74 
diet was fed after the MOD diet 
(sequence 2), but in all other condi­
tions there was no significant differ­
ence found when that diet sequence 
was followed. The values for the 
MOD diet (sequence 2) TXB2 
synthesis with collagen challenge 
seem to be anomalously low.
Platelet Cl8:2n-6 concentra­
tion was negatively correlated with 
total dietary fat, SFA, and C l8:1 
consumption (r = -0.26, p < 0.049; 
r = -0.32, p < 0.015; and r = -0.30, 
p < 0.023, respectively). Other 
platelet FA were correlated with 
TXB2 synthesis by platelets chal­
lenged with Ca plus collagen but not 
when they were challenged with Ca 
plus thrombin (Table 3.9). C16:0,
C l8:0, and C l8:1 concentrations were 
negatively correlated with TXB2 
synthesis under collagen stimulation. 
C18:2n-6 and dihomogamma- 
linolenate (C20:3n-6) were positively 
correlated with TXB2 synthesis by 
unchallenged whole blood, the 
mildest stimulatory condition. 
C20:4n-6, the immediate precursor of 
PG, was highly correlated with TXB2 
synthesis by platelets stimulated with 
Ca plus collagen only. Total serum
cholesterol [19] was not significantly 
correlated with TXB2 synthesis 
(Table 3.9).
PG Synthesis by 
Endothelial Cells
There was a statistically 
significant effect (p < 0.05) of diet 
upon basal and thrombin-stimulated 
PGI2 synthesis when endothelial cells 
were incubated with plasma from 
subjects eating their diets in sequence 
1 (Figure 3.1). The values from 
subjects eating the MOD diet were 
lower than those observed from 
endothelial cells incubated with 
plasma from subjects eating the self- 
selected diet (p < 0.05). PGI2 synthe­
sis by endothelial cells incubated with 
plasma from the subjects eating the 
US74 diet was not statistically 
different from that in cells incubated 
with plasma from subjects eating the 
self-selected or the MOD diet. No diet 
effect was observed when endothelial 
cells were incubated with plasma 
from subjects eating their diets in 
sequence 2 (Figure 3.1).
Changes similar to those 
observed in PGI2 synthesis were seen 
in PGE2 synthesis (Figure 3.2), but 
there were no changes in the PGE2/ 
PGI2 ratio. There was a significant (p 
< 0.001) correlation between PGI2 
and PGE2 synthesis in both basal and 
thrombin-stimulated cells (r = 0.771 
and r= 0.812, respectively).
Discussion
The purposes of our study were 
to determine whether moderate 
changes in dietary fat would change 
FA patterns and, if so, whether 
autologous platelets or endothelial 
cells from human umbilical cord 
veins incubated with plasma obtained 
from subjects eating the different 
diets would alter their eicosanoid 
syntheses. The dietary FA content had 
pronounced effects on plasma TG FA 
composition. The linoleate composi­
tion of plasma was carried over to the 
endothelial cell linoleate concentra­
tion when the cells were incubated 
with medium containing 20% plasma. 
In sequence 1 the self-selected diets 
contained 17 or 20% of linoleate, 
which was decreased to 11.9% when 
the US74 diet was consumed. That 
decrease resulted in no change in 
plasma TG C l8:2, but an increase in 
C20:4 in all subgroups. The observa­
tion that C 14:0, present in the diets in 
very small amounts, made up 7-20% 
of plasma FFA could have implica­
tions for relative pathways of FA 
oxidation.
In sequence 1 we found that 
cells incubated with plasma of 
subjects consuming more C18:2n-6 
(MOD) synthesized less PGI2 and 
PGE2 than did cells incubated with 
plasma from the same subjects 
consuming less C18:2n-6 (US74 diet); 
in the opposite sequence 2, PGI2 and
Fatty acid composition of platelets of women consuming 
containing different fatty acid concentrations (% of total
m m
s i |
s s SS US74 US74 MOD MOD
Iowa Nebraska________Iowa_________  Nebraska________Iowa___________ Nebraska
Fatty acid2
14:0 0.09 ±0.09
16:03 23.50 ±0.81 22.51 ± 0.83 21.42 ±
18:0 31.08 ±0.994, a 26.06 ± 0.67a 26.31 ±
18:15 20.85 ± 0.70 20.69 ± 0.38 20.49 ±
18:2 8.36 ±0.59a 10.80 ±0.30 9.42 ±
20:3 0.27 ± 0.27 0.50 ± 0.25 0.99 ±
20:4 15.87 ±0.80 18.82 ±1.42 21.30±
0.24 ±0.13 0.10±0.10
0.92 22.39 ± 1.29 20.77 ± 0.89 23.61 ±1.11
0.91 b 26.00 ±1.53 25.80 ± 0.83b 26.44 ±1.02
0.59 24.74 ± 1.26 b 20.28 ± 0.59 22.07 ± 1.54a, b
0.40a,b 9.33 ±1.01 10.34 ± 0.35 b 11.93 ±1.33
0.25 0.40 ±0.17 1.15 ±0.32 0.55 ± 0.24
1.89 15.67 ±2.18 21.47 ±2.12 14.89 ±1.83
1 Means ± SEM (n = 10 except self-selected Iowa means for n = 6).
2Number of carbons: number of double bonds.
3ANOVA indicated significant residual effect (p < 0.05).
4Values with different superscripts are significantly different (p < 0.05) within states. 
5ANOVA indicated significant state difference, p < 0.01.
Sequence 1 
Sequence 2 
18:0
40.0 ± 2.4(9) 
33.712.1(10)
37.9 1 2.3(8) 34.8 1 2.6(6) 
32.812.0(10) 31.412.0(10)
Sequence 1 
Sequence 2 
18:1
11.611.5 
13.211.4
13.511.5 12.611.6 
14.211.3 15.311.4
Sequence 1 
Sequence 2 
18:23
15.0 11.6 
16.811.4
17.011.6 16.511.7 
17.911.3 15.811.3
Sequence 1 
Sequence 2 
20:3
8.310 .8a  
10.21 0.7a
7.810.8b 9.810.9a 
10.21 0.7a 8.31 0.7 b
Sequence 1 
Sequence 2 
20:4
3.1 1 1.1
2.1 10.5
2.411.4 2.411.4 
2 .810.9 2.010.71
Sequence 1 
Sequence 2
20.211.6 
24.511.4
19.411.6 20.511.7 
19.211.3 21.511.3
1 Mean 1 SEM (n)
2 Number of carbons: number of double bonds.
3Values with different superscripts are significantly different within sequence (p < 0.05).
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Fig. 3-1. Effect of diet and sequence upon 
basal and thrombin-stimulated prostacyclin 
synthesis by endothelial cells and plasma 
triglyceride arachidonate. Values not 
sharing a common superscript are signifi­
cantly different. PG data are means ±SEM 
(n = 10) of the square root of the actual 
values.
Thrombin Stimulated PGE2
Fig. 3.2. Effect of diet and sequence upon 
basal and thrombin-stimulated prosta­
glandin E2 synthesis by endothelial cells. 
Values are means ± SEM (n = 10) of the 
square root of the actual values.
PGE2 syntheses were similar for the 
MOD and US74 diets. The response 
to increasing dietary linoleate was 
more rapid than the response to 
decreasing it, suggesting a conserva­
tion of linoleate or its products in 
pools related to eicosanoid synthesis.
Our results agree with the 
work of other groups [8,11 ], who 
have shown that the synthesis of PGI-, 
by aortas of animals eating a diet with 
more than 4% C18:2n-6 is lower or 
not different from the synthesis 
observed in aortas of animals eating a 
diet with less than 4% C18:2n-6. 
Experiments using cultured endothe­
lial cells also have shown that there is 
a decrease in the synthesis of PGI-, 
when the concentration of C18:2n-6 is 
increased in the culture medium 
(32,331.
The mechanism by which 
C18:2n-6 decreases PGI-, synthesis 
has not been completely elucidated. 
We observed an increase in plasma 
TG C20:4n-6 with decreased PG syn­
thesis, but no consistent effects on 
endothelial cell C20:4n-6. Others 
have reported an increase in the per­
centage of C18:2n-6 associated with a 
decrease in C20:4n-6 in the phospho­
lipid fraction and in the capacity of 
cultured endothelial cells to synthe­
size PGI0 [32,33]. This finding sug­
gested that C18:2n-6 inhibits PGI-, 
synthesis by decreasing the amount of 
C20:4n-6. That synthesis of PGI^ , also 
decreased when cells were stimulated 
with C20:4n-6 [33] and that C20:4n-6 
was not reduced in our study suggest 
that the availability of C20:4n-6 is not 
the factor responsible for this effect. 
Linoleic acid inhibits the activity of 
cyclooxygenase in microsomal prepa­
rations of human skin [34], rat stom­
ach [35], and sheep vesicular gland 
[35]. Therefore, a direct inhibitory 
effect of C18:2n-6 upon 
cyclooxygenase activity could have 
been responsible for the results ob­
served.
The concentration of 
cholesterol in plasma from subjects 
eating the MOD diet was lower than
30
that found in the same subjects eating 
the US74 diet [19] (169.9 ± 7.9 vs. 
143.3 ± 5.7). Other studies [15,16] 
have shown that high levels of 
cholesterol inhibit prostaglandin 
synthesis. Thus, the changes in PGI2 
and PGE2 syntheses observed in this 
study cannot be explained by the 
changes observed in the concentra­
tions of cholesterol in plasma.
Linoleic acid also inhibits 
PGE2 and PGI2 syntheses when added
to the culture medium of bovine 
pulmonary artery endothelial cells 
[32]. Inhibition of the synthesis of 
both prostaglandins is important 
because it has been shown [16] that, 
in aortas with atherosclerotic lesions, 
there is an increase in PGE2 synthesis 
and a decrease in PGI2 synthesis. 
Unlike PGI2, PGE2 induces platelet 
aggregation, inhibits in vitro 
cholesteryl ester hydrolase activity 
[36-38], and consequently may favor
the development of atherosclerosis. 
Because diet had a significant effect 
only upon the FA composition of total 
serum TG, but not upon the composi­
tion of nonesterified FA, our results 
suggest that C18:2n-6 associated with 
TG may have been more important in 
determining the FA composition and 
the capacity of PG synthesis by 
endothelial cells than C18:2n-6 in the 
nonesterified FA fraction.
Thromboxane synthesis by stimulated platelets1 from human subjects fed 
diets differing in fatty acid composition (ng TXB^mM min).2
ss US74 MOD US74 effect 3
Platelet Stimulus 
Unchallenged whole blood4
2.51 ± 0.50b 1.82 ± 0.21b 0.001Sequence 1 0.24 ± 0.093
1.71 ± 0.60Sequence 2 0.87 ± 0.40 3.16 ± 0.98 NS
5mM Ca + collagen 4
102.56 ±  30.49 b 0.003Sequence 1 25.89 ± 8.64a 21.68 ± 7.42a
109.77 ±23.80bSequence 2 37.33 ± 9.68a 12.00 ± 2.39 a 0.001
10mM Ca + collagen4
148.68 ± 30.96 b 0.002Sequence 1 28.23 ± 16.15a 26.04 ± 6.11a
97.72 ± 19.22Sequence 2 79.06 ± 41.54 39.01 ± 15.94 NS
5mM Ca + thrombiri
NSSequence 1 74.91 ± 9.82 93.64 ± 9.52 121.53 ±32.45
Sequence 2 145.04 ±44.52 71.89 ± 15.39 72.45 ± 23.49 NS
10mM Ca + thrombin
NSSequence 1 189.57 ±36.35 125.82 ±44.87 164.51 ±28.64
Sequence 2 211.07 ± 44.26 
1 Data from Iowa subjects only.
143.52 ±31.47 129.25 ±27.05 NS
2 MeanS ± SEM, n = 5.
3 ANOVA indicated significant diet effect, p < 0.01. 
4ANOVA indicated significant residual effect, p < 0.01. 
5 ANOVA indicated significant residual effect, p < 0.05.
Fatty Acid 1 r P r P
16:0 -0.27 0.186 -0.55 0.004
18:0 -0.47 0.016 -0.55 0.004
18:1 -0.14 0.486 -0.56 0.003
18:2 0.39 0.047 -0.10 0.624
20:3 0.46 0.017 0.38 0.053
20:4 0.26 0.207 0.69 0.001
Lipid
cholesterol -0.03 0.889 -0.21 0.270
1 Number of carbons: number of double bonds.
r P r P r P
-0.57 0.002 -0.12 0.549 0.03 0.873
-0.57 0.002 -0.13 0.535 -0.05 0.792
-0.49 0.011 0.01 0.952 -0.09 0.648
0.16 0.444 0.16 0.432 0.01 0.956
0.34 0.095 0.03 0.883 -0.01 0.986
0.63 0.001 0.07 0.747 0.03 0.892
-0.13 0.509 -0.04 0.830 0.07 0.715
During the postabsorptive 
state, TG in serum are associated 
mainly with very-low-density 
lipoproteins (VLDL) [39]. Bovine 
aortic endothelial cells in culture are 
able to take up TG from VLDL: the 
uptake increases when the lipoprotein 
concentration is increased, and, in 24 
hours, up to 60% of the FA of those 
TG are incorporated into phospholip­
ids and other cell lipids [40]. FA from 
cholesteryl esters present in high- 
density lipoproteins or low-density 
lipoproteins can be incorporated into 
cell phospholipids and C20:4n-6 can 
be used as a substrate for pros­
taglandin synthesis [41-43], FA 
bound to albumin, which represent the 
nonesterified FA fraction in the 
plasma, are also incorporated into cell 
lipids and can modify the capacity of 
the cells to synthesize PG [30-33].
The relative importance of the 
different lipoproteins in determining 
the FA composition of endothelial 
cells is not known, but it is likely that 
all may contribute to it and that, under 
normal conditions, the FA composi­
tion of the cells determines their 
capacity to synthesize PG.
Platelet TXB-, synthesis in 
this study tended to respond posi­
tively to increased dietary linoleate 
when the MOD diet followed the 
US74 diet, suggesting that the 
platelets were not saturated with 
linoleate. This increase is consistent 
with the findings of Tremoli et al.
[44]. In female subjects from North 
Karelia, there was a trend toward 
increased TXB? production after 
dietary intervention to induce a higher 
P/S ratio. Neither these researchers 
nor ourselves found a significant 
correlation with serum cholesterol. 
These conclusions appear to be true 
only for females; males [44] show 
opposite responses. Attributing 
dietary linoleate responses to pertur­
bation of C20:4n-6 pools has been 
fraught by constraints due to sampling 
and physiological parameters 
[5,23,45]. The recalcified whole 
blood sampling protocol when 
stimulated with collagen shows some 
promise. Negative correlations with 
platelet C18:2n-6 concentration and 
strong positive correlations with 
C20:4n-6 were observed. The 
downregulation of PGI9 synthesis in 
endothelial cells by increasing dietary
linoleate and the upregulation in 
TXB7 synthesis in platelets suggest 
that factors other than plasma lipid 
composition may be active.
The net effect of changing 
the dietary fat content to approximate 
changes recommended to the public 
was to change the FA composition of 
plasma TG, RBC phospholipids, and 
FFA. The platelet FA response 
seemed to require a longer dietary 
change duration to reach a stable 
state. The plasma FA changes were 
reflected in PG synthesis effects on 
cultured endothelial cells. The 
changes were correlated with platelet 
TXB0 synthesis. It is important that 
small changes can effect metabolic 
adaptations.
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Effect of Dietary Fat — 
Modification on Urinary 
Taurine Excretion in 
Healthy Women
Introduction
Taurine, or 2-aminoethane- 
sulfonic acid, is found in all animal 
species as a free amino acid that is 
rarely incorporated into proteins; it 
occurs to only a limited extent in 
plants (1,2). Taurine is synthesized in 
several mammalian tissues from 
methionine (3). The most adequately 
documented metabolic reaction in 
which taurine participates is conjuga­
tion of bile acids (1), although a 
number of investigators have raised 
other possibilities, for instance that 
taurine is a neurotransmitter (4). Bile 
acids conjugated with glycine or 
taurine are superior to those with 
other neutral or basic amino acids; 
indeed, it has been suggested that the 
taurine conjugate is the most efficient 
digestive detergent (5).
The main route for the 
removal of taurine from the body is 
by urinary excretion (6). Previous 
work in our laboratory has indicated 
that urinary taurine excretion de­
creases when polyunsaturated fat 
replaces saturated fat isocalorically in 
the diet (7,8). A possible explanation 
is that polyunsaturated fat may 
increase synthesis of bile acids and, in 
doing so, may divert taurine from the 
urine. To gather more information on 
this phenomenon, we investigated 
urinary taurine excretion in the 
women participating in the regional 
study described in the introduction of 
this bulletin.
Procedures
Composite urine samples 
collected during the 7-day pretreat­
ment period, the last week of dietary 
period 1, and the last week of period 2 
were analyzed for taurine by the 
method of Sorbo (9) as modified by 
Mercer (10). Briefly, taurine was 
isolated from other urinary constitu­
ents with cation and anion exchange 
resins. Ninhydrin was used to 
measure the taurine concentration in 
each sample. Criteria for acceptance 
of a run included a 90-110% recovery 
of an internal taurine standard and a 
precision of 2% between duplicates. 
Statistical analysis of the data was 
performed by Iowa State University 
as described earlier (Chapter 1).
Results
Chinese subjects had more (p <
0.01) urinary taurine excretion than 
did American subjects (Table 4-1). 
Compared with the self-selected diet, 
both experimental diets produced 
significantly less taurine excretion in 
Chinese subjects. There was no 
significant effect of diet in American 
subjects.
Urinary taurine excretion 
was significantly correlated with 23 
of the 179 variables studied. The 
strongest correlations were with
urinary manganese in Nebraska 
subjects (r = 0.62) and mean corpus­
cular hemoglobin ( r = -0.51). Taurine 
had weak to moderate associations 
with dietary protein en% (r = 0.33), 
dietary calcium ( r = -0.45), dietary 
riboflavin (r = -0.42), dietary phos­
phorus (r = -0.31), and dietary iron (r 
= -0.25). There were weak relation­
ships with thromboxane formation in 
unchallenged whole blood (r = -.39), 
urinary total norepinephrine (r =
0.32), serum prolactin (r = 0.26), and 
fecal a-muricholate concentration (r =
0.28), as well as a variety of other 
variables.
Discussion
Because the study was not 
designed to examine urinary taurine 
concentrations specifically, many 
factors have to be taken into consider­
ation when interpreting the results. 
Three variables reported to affect 
urinary taurine excretion—kind and 
amount of dietary fat and amount of 
dietary taurine—were not manipu­
lated separately. For example, we 
have estimated that the MOD diet 
provided from 10-15 mg per day more 
taurine than the US74 diet because of 
the substitution of tuna for eggs. 
Seafood is an excellent dietary source 
of taurine. In addition, the higher fat 
content of the US74 could have 
increased fecal taurine excretion 
while reducing excretion of urinary 
taurine. Taurine excretion was not 
significantly different when the two 
experimental diets were fed at either 
station. The data in this study did not 
support the hypothesis that an 
increase in polyunsaturated fat 
consumption reduces urinary taurine 
while increasing excretion of conju­
gated bile salts. The lack of a 
consistent relationship between 
urinary taurine and fecal bile salt 
concentrations also is contrary to the 
hypothesis. The weak but significant 
relationships between urinary taurine 
excretion and concentrations of 
norepinephrine and prolactin in the 
serum support the general concept 
that taurine metabolism is under 
hormonal control.
Race____________________SS__________ US74_______MOD
CA (n = 14)mg/day 53.5a 42.6a 52.8a
CH (n = 5)mg/day 145.6a 69.5^ 59.8^
1 Significant race effects, p < 0.01; within race values with 
different superscripts are significantly different (p < 0.0001).
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Plasma Carnitine - 
Levels of Women 
Eating Diets with 
Different Fatty Acid 
Composition
Carnitine plays a central role 
in fatty acid oxidation. Because of its 
reduced fat content, it was of interest 
to examine the effect of the modified 
fat diet (MOD) on plasma carnitine 
levels.
Methods
Acid-soluble (free and short- 
chain) and total carnitine levels of 
plasma and of the diets were deter­
mined according to the procedure 
developed by McGarry and Foster (1). 
Carnitine acetyl transferase and 
[14C]-acetyl CoA required for the 
assay were purchased from Sigma 
Chemical Company, St. Louis, MO, 
and New England Nuclear, Boston, 
MA.
(764 nmol/g). Acid-soluble carnitine 
accounted for more than 98% of the 
total in each diet.
Carnitine levels were 
determined in plasma obtained at the 
pretest screen and at the end of each 
4-week part of the crossover protocol. 
Diet, race, and site did not influence 
plasma carnitine (Table 5-1).
Discussion
Acid-soluble and total 
carnitine levels of the subjects were in 
the range for normal adults. There 
was no evidence that the test diets 
influenced the carnitine status of these 
subjects.
Reference
Results
The US74 diet (884 nmol 
camitine/g dry matter) was 16% 
richer in carnitine than the MOD diet
1. McGarry JD, Foster DW:
An improved and simplified radio­
isotopic assay for the determination of 
free and esterified carnitine. J Lipid 
Res 17:277-281, 1976.
M iM m m
Plasma acid-soluble and total carnitine 
concentrations (nmol/ml) of subjects con­
suming diets containing different amounts 
and types of fat (mean ± SEM, n = 20).
SS U S 7 4 M O D
Acid-soluble
Total
43.2 ± 3.2 
54.6 ± 3.7
40.0 ± 0.4 
53.1+2.2
40.3 ± 0.4 
53.412.6

Serum Vitamins ------
A and E and Thiobar- 
bituric Acid-Reacting 
Substances of Women 
Eating Diets with 
Different Fat Content 
and Fatty Acid 
Composition
Because of our concern that 
the modified diet (MOD), with its 
reduced fat content, might be limiting 
in micronutrients, we analyzed 
plasma samples for vitamins A and E 
contents after the subjects had been 
acclimated to the diets.
Methods
Plasma retinol and a- 
tocopherol levels were assayed 
according to the isocratic high 
performance liquid chromatography 
(HPLC) method described by Miller 
and Yang (1). Specifically, 100 pi 
ethanol containing an internal 
standard of a-tocopherol acetate was 
added to 100 pi plasma. After 
mixing, 230 pi hexane was added, the 
mixture was vortexed for 2 minutes, 
and 150 pi of the hexane was re­
moved and taken to dryness under Nr; 
the residue was dissolved in 50 pi 
ethanol. A 40-pl aliquot was injected
into the HPLC equipped with a 
Waters Radial Pak C18 column (8mm 
x 10cm). The column was eluted 
isocratically with methanol: 
acetonitrilexhloroform (25:60:15) at 
a flow rate of 1.5 ml per minute. The 
eluant was monitored at 280 nm. 
Retinol and a-tocopherol standards 
and the internal standard, a-toco­
pherol acetate, were purchased from 
Sigma Chemical Company, St. Louis, 
Mo. Extraction efficiency was 
calculated on the basis of the recovery 
of the internal standard.
Thiobarbituric acid-reacting 
substances (TBARS) were determined 
by using the fluorometric assay of 
Yagi (2). 20 pi of plasma were 
diluted with 4.0 ml of 0.08 N H9S04. 
To this was added 0.5 ml of 10% 
phosphotungstic acid. After sitting at 
room temperature for 5 minutes, the 
samples were centrifuged at 1,000 x g 
for 10 minutes. The pellet was 
resuspended with 2.0 ml of H7S04 
and 0.3 ml of phosphotungstic acid 
and was centrifuged again. The pellet
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was then suspended in 4.0 ml of 
distilled water and 1.0 ml TB A 
reagent (l:l(v/v) thiobarbituric acid 
and glacial acetic acid). After 
incubation for 1 hour at 95°C, the 
tubes were cooled under tap water and
5.0 ml of n-butanol was added. The 
tubes were shaken and centrifuged at
1.000 x g for 15 minutes. The butanol 
layer was taken for fluorometric 
measurement at 553 nm, with 
excitation at 515 nm. Standards of
0.5 nmole tetramethoxypropane in 4.0 
ml distilled water were incubated with
1.0 ml TBA reagent, extracted, and 
read at the same time as the samples. 
The amount of TB ARS was deter­
mined by the equation (Iu/Is) x 25 = 
nmoles/ml of plasma, where Iu = 
fluorescence intensity of the sample 
and Is = fluorescence intensity of the 
standard.
Results
There were no differences in 
calculated intake of vitamin A by diet. 
Plasma retinol levels are shown in 
Table 6-1. Subjects 64, 72, 73, 74, 
and 75 had consistently low plasma 
retinol levels (<330 ng/ml). Subjects 
67, 70, 72, and 79 had consistently 
high a-tocopherol levels (>11 jig/ml) 
(Table 6-2). The significant diet 
effect reflects the changes between
self-selected (SS) and experimental 
diets, not between US74 and MOD 
diets.
The TBARS level in the test 
subjects ranged from 2.41 to 13.27 
nmoles/ml plasma. Most showed 
small to moderate changes in TBARS 
during the course of the experiment, 
but these changes were random, and 
no statistical significance was found 
in any of the changes.
Discussion
The diets supported uniform 
plasma levels of retinol and a-toco­
pherol.
Five of the subjects showed 
initial TBARS levels in excess of 10 
nmoles/ml. This level has been asso­
ciated with pathological states includ­
ing heart disease (3), liver damage 
(4), blood diseases (5), and trauma 
such as bums (2). The TBARS of all 
these subjects was reduced in subse­
quent samplings. Hyperlipidemia and 
an elevation in TBARS have been 
found to be correlated (6). No corre­
lation was found here between the 
TBARS and either the triglycerides or 
a-tocopherol levels of those subjects. 
In general all the values, with the ex­
ceptions just noted, fell within the 
normal range for TBARS in healthy 
individuals.
Eüf3 Serum retinol (ng/ml) of women eating |  .d ifferent dietary (ate (mean ±  SEM. n = 10 L’
SS US74 MOD
Iowa 423.8 ± 29.7 357.1 +15.8 362.4 ± 22.9
Nebraska 396.7 + 15.1 421.1 ±26.4 413.5 + 24.8
Significant site difference (p < 0.01).
Serum a-tocopherol (ug/ml) of women eating 
2  B different dietary fats (mean ± SEM, n = 20).1
5S _______________US74_____________MOD
8.75 ± 0.56 9.541 0.41 9.681 0.49
Significant diet effect (p < 0.05).
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Iron Status of Healthy — 
Adult Females as 
Affected by Dietary 
Fat Modification,
Race, and Blood Loss
Abstract
Effects of feeding of laboratory- 
controlled diets altered in dietary fat 
level and composition on iron status 
of healthy adult women were investi­
gated. Effects of race (U.S. Cauca­
sian and Asian Chinese) also were 
studied. The study used a crossover 
design with 20 subjects at two sites. 
Subjects were fed experimental, 
laboratory-controlled diets modeled to 
resemble the usual American diet 
according to HANES I (US74 diet) or 
to resemble recommendations to 
improve total fat, cholesterol, and 
fatty-acid composition (MOD diet). 
Fasting blood samples were drawn at 
the beginning of the study (self- 
selected diets, SS) and at the end of 
each experimental period.
Variations in diet signifi­
cantly affected some of the param­
eters of iron status. In general, iron 
status of subjects was superior when 
the US74 diet was used than when the 
MOD diet was fed.
Introduction
Ferritin is present in plasma 
or serum in very small amounts, 
ranging in healthy subjects from 
about 20 to 300 ng/ml (1). Serum 
ferritin serves as a sensitive indicator 
of iron status in that it reflects the 
state of iron stores, whereas a more 
common measure such as hemoglobin 
is only reduced when frank iron- 
deficiency anemia appears. A value
for serum ferritin less than 12 ng/ml is 
indicative of depleted iron stores 
(2,3).
Serum ferritin concentrations 
increase in several disease states, in­
cluding infections, cancer, inflamma­
tory disorders, and liver disease, in 
which it has been known to increase 
up to 10,000 ng/ml as a result of re­
lease from damaged liver cells (1-3). 
Thus, disease processes have the po­
tential for masking iron deficiency 
when serum ferritin is used as the in­
dicator.
Other commonly used 
indices of iron status are blood 
hemoglobin concentration, blood 
hematocrit levels, and blood serum 
iron levels. Iron balances, as calcu­
lated by subtraction of iron losses in 
urine and stools from dietary iron 
intakes or fecal iron losses as percent­
ages of iron intakes have been 
employed as methods of estimating 
iron bioavailability.
There is a possibility that a 
MOD fat diet calling for reduced 
intake of meat may be detrimental to 
iron status (4). The object of measur­
ing serum ferritin and iron status in 
subjects in this regional project was to 
determine if the MOD diet influenced 
iron status compared with the usual 
U.S. diet.
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Materials and Methods
Biological samples used for 
analyses in this study were those 
collected from the NC-167 coopera­
tive human feeding project at Iowa 
State University and at the University 
of Nebraska. Details concerning 
experimental plan, laboratory- 
controlled diet, descriptions of 
subjects at both sites, and procedures 
used for collection of urine, feces, 
blood, and food samples have been 
presented in earlier chapters of this 
bulletin.
Iron contents of feces and 
food were analyzed by use of a 
Varian Atomic Absorption Spectro­
photometer and using instrument-
supplied methods. Hemoglobin, 
hematocrit, and erythrocyte differen­
tials were measured at the Nebraska 
site with a Coulter Counter Model F.
Serum ferritin was measured 
by radioimmunoassay by using a kit 
from Micromedic Systems, Inc. 
(Horsham, PA). Calibration was 
established with standards consisting 
of eight levels of ferritin. Sensitivity 
of the assay is 2 ng/ml.
Results and Discussion
Serum ferritin decreased 
steadily throughout the study (Table 
7-1). This decrease was indicative of 
a deterioration of iron stores, probably 
due to the repeated blood draws.
R U S S Effect of period on serum ferritin _ concentration (ng/ml) (mean ± SEftm
Week 0 Week 4 Week 8
Site
Iowa 54.40 + 17.40 45.10 ±12.33 35.15 ±7.40
Nebraska 61.67 ±12.44 46.80 ±8.65 37.00 ±6.24
Effect of diet on Serum ferritin 
concentration (ng/ml) (mean ±
__________________________ SS_______________MOD_____________ US74
Site
Iowa 54.40 ±17.40 34.80 ±7.34 45.45 ±12.33
Nebraska 61.67 ±12.44 41.10 ±6.87 42.70 ±8.47
Sources of vari
Table 7~3»concentratior,‘
at 0■ n serum fegfjffilllllS
F Value Probability
Site 1.05 NS
Subject within site 21.43 0.0001
Diet 17.25 0.0001
Residual effects 10.17 0.0005
Serum ferritin did not vary 
significantly between groups (sites), 
but there was a significant effect of 
diet and previous diet (residual effect) 
on this parameter (Tables 7-2 and 
7-3). Because of the significant 
carry-over effect of previous diet, the 
significant diet main effect was 
probably meaningless (see Chapter 
14). The usual U.S. diet seemed to 
produce higher serum ferritin levels, 
however, especially in Iowa subjects. 
This is interesting, especially in view 
of the fact that the two diets provided 
similar amounts of iron and iron 
absorption-enhancing factors (meat 
and ascorbic acid).
Serum ferritin was signifi­
cantly associated with 16 of the 179 
variables included in the correlation 
matrix. No significant correlations 
were noted between serum ferritin 
and other measures of iron status, 
either with serum iron (r = 0.41) or 
with hemoglobin (r = 0.37). The 
strongest correlation (r = 0.60) was 
with serum uric acid; the explanation 
for this association is not clear, 
especially considering that subjects 
tended to have lower serum uric acid 
levels on the self-selected diet (SS) 
when serum ferritin levels were 
highest. Moderate associations were 
noted between serum ferritin and 
serum transaminases (GOT: r = 0.35; 
GPT: r = 0.46). Again, the nature of 
the association is unclear.
Iron contents of the US74 
and the MOD diets were not identical; 
the US74 diet supplied significantly 
less iron than did the MOD diet 
(Table 7-4). Fecal iron losses also 
were significantly less when subjects 
at both sites received the US74 diet 
than when the MOD diet was fed 
(Table 7-4). Urinary losses of iron 
were measured, but were very small 
and did not significantly vary with 
variation of dietary treatment. Iron 
absorptions (% apparent) were 
calculated by subtracting the fecal 
iron excretion from the iron intake, 
dividing this by the iron intake and 
multiplying by 100.
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Apparent iron absorptions 
were significantly greater when the 
US74 diet was fed than when the 
MOD diet was fed (Table 7-4). These 
results suggest that the higher dietary 
fat level, higher cholesterol level, or 
the greater intake of saturated fatty 
acids had a positive effect on iron 
absorption; but other dietary alter­
ations made concurrently to achieve 
the changes of dietary fat may have 
been the true causative factor. For 
example, dietary phytate levels were 
higher when the MOD diet was fed 
than when the US74 diet was fed. 
Dietary phytate has been found to 
inhibit iron absorption.
Erythrocyte differentials 
were measured only in the subjects at 
the Nebraska site. The mean corpus­
cular volume (MCV) and mean 
corpuscular hemoglobin (MCH) 
levels, but not the mean corpuscular 
hemoglobin concentration (MCHC) 
levels, were affected by the race of 
the subjects (Table 7-5). Only MCH 
levels were affected by dietary 
alterations or by residual effects. The 
MCH levels were higher when
subjects received either of the 
experimentally controlled diets than 
when the self-selected diets were 
consumed.
Blood hemoglobin levels 
were significantly affected by the 
dietary variations in the Iowa sub­
jects. In the Nebraska subjects, both 
hemoglobin and hematocrit levels 
were affected by race but not by the 
dietary variations. Hematocrit levels 
were not measured in the Iowa 
subjects.
Blood serum iron levels were 
significantly affected by the site at
which the study was conducted, by 
subject, by race of subjects, and by 
dietary variation. But no statistically 
significant residual effects were 
found. Although mean blood serum 
levels were higher in the Iowa 
subjects on a self-selected diet than in 
the Nebraska subjects on their self- 
selected diets, both groups of subjects 
had less blood serum iron when 
receiving the MOD diet than when the 
US74 diet was given (Table 7-5). 
These results suggest that iron was 
more efficiently absorbed from the 
US74 diet than from the MOD diet.
« ►
PIIHHIIIIl i l S n H l i a r ......■
MOD US74
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Parameter 
Iron intake 2, mg/day 
Fecal iron loss, mg/day 
Apparent absorption, %
21,85a 
20.23a 
7.41a
20.19b 
17.83b 
11,70b l *
1 Mean value of 20 subjects. Values with different letter superscripts 
are significantly different (p < 0.05).
2Analyzed data.
I
SS1 MOD1 US741
Parameter 
Serum Iron (pg/dl) 
Iowa 126.0a ± 17.44 77.0b± 8.10 96.9ab±  7.95
Nebraska 97.9 ± 9.90 77.1 ±5.10 96.1 ±7.67
Hemoglobin (g/dl) 
Nebraska 13.5 ±0.19 14.0 ±0.30 13.8 ±0.27
Iron binding capacity (pg/dl) 
Nebraska 300 ± 11.49 325 ± 19.19 305 ± 8.62
Hematocrit (%) 
Nebraska 40.3 ± 0.69 41.1 ±1.17 40.4 ± 0.87
Differentials (Nebraska) 
MCV-p3 90 ± 1.63 91 ± 1.24 91 ±2.03
MCH-ppg 30.2a ± 0.47 31,5b ±0.52 31.5b ±0.59
MCHC-% 33.9 ± 0.30 34.1 ±0.32 34.2 ± 0.24
Red blood cell count (106/mm3) 
Nebraska 4.47 ±0.11 4.45 ±0.14 4.41 ±0.14
4  ft
«ft
«ft
1Mean ± SEM (n = 10). Values with different letter superscripts are significantly different within each horizontal line of data (p < 0.05).
4»
4 ft
42 4 ft
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Effect of Dietary Fat —  
Modification on Serum 
Concentrations of 3,5,3' 
Triiodothyronine (T3) 
and Thyroxine (T4) of 
Healthy Women
Introduction
Because thyroid hormones 
play an important role in regulating 
thermogenesis, the influence of 
nutrition on concentrations of 
thyroxine (T4) and triiodothyronine 
(T3) metabolism is of interest (1-3). 
T4 deiodination is strikingly de­
pressed during starvation. In caloric 
deprivation, the metabolism of 
thyroxine shifts from generating 
metabolically more active T3 to 
generating the calorigenically inactive 
form, reverse T3. When fasted 
subjects were fed hypocaloric diets of 
different compositions, the serum 
concentration of T3 in the subjects 
who received a diet containing at least 
50 g carbohydrate increased, whereas 
serum T3 levels were still very low in 
those who received an isocaloric 
carbohydrate-free diet (1). These 
results suggest that both calories and 
dietary carbohydrate are important 
regulatory factors in the metabolism 
of thyroid hormones.
It is not clear if small 
changes in dietary carbohydrate levels 
influence serum concentrations of 
thyroid hormones. Because the MOD 
diet fed in this study contained 
slightly more carbohydrate than the 
US74 diet (58 en% vs. 48 en%, 
respectively), it was of interest to 
investigate the influence of fat
modification on serum levels of the 
two hormones, T3 and T4.
Procedures
T3 and T4 were assayed in 
serum samples by radioimmunoassay 
with kits obtained from Amersham 
Corporation. Control sera provided 
by Amersham (Arlington Heights, IL) 
were used to assess accuracy of the 
procedures.
Results
Diet did not influence serum 
T3 and T4 levels (Tables 8-1 and 
8-2). There were significant carry­
over and race effects for both T3 and 
T4. Chinese subjects tended to have 
lower values for these parameters.
Serum T3 and T4 had 
significant associations with 15 and 
22, respectively, of the 179 variables 
making up the correlation matrix.
The correlation between T3 and T4 
was strong (r = 0.73). Some interest­
ing and moderate associations were 
noted between T3 and various white 
blood cell measurements in Iowa 
subjects, including white blood cell 
count (r = 0.45), lymphocytes (r = 
-0.47), monocytes (r = 0.57), and 
basophils (r = 0.41). There also was a 
moderate association between T3 and 
hemoglobin in Iowa subjects (r =
0.55) and between T3 and urinary
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total norepinephrine (r = 0.51) and 
urinary free norepinephrine (r = 0.48) 
in all subjects. There was a strong 
association between T3 and urinary 
manganese in Nebraska subjects (r =
0.74). There was a very weak, but 
significant, association between T3 
and dietary energy (r = 0.28).
T4 had similar, but weaker, 
associations with some of the white 
blood cell parameters in Iowa subjects 
and a strong association with urinary 
manganese in Nebraska subjects. 
Interestingly, T4, but not T3, was 
weakly and negatively associated with 
serum HDL2 and total HDL choles­
terol (both, r = -0.28, p < 0.03).
Discussion
There was no evidence in 
this study that the small changes in 
dietary carbohydrate level associated 
with a switch from a typical American 
diet to a fat-modified diet influence 
serum thyroid hormone levels. There 
was some evidence that dietary 
energy has an influence; there was a 
weak association between calories 
and serum T3 concentrations. The 
positive association between the 
thyroid hormones and the white blood 
cell parameters seems logical, in that 
an elevation in both sets of variables 
may be a response to infection.
nRHRS
Plasma triiodothyronine concentrations 
(ng/ml) of Caucasian (CA) and Chinese (CH) 
women consuming diets containing different 
amounts and types of fat (mean ±$£M).
SS US74 MOD
Sequence 1
CA (n = 8) 1.08 ±
CH (n = 3) 1.05 ±
Sequence 2
CA (n = 6) 0.98 ±
CH (n = 2) 0.73 ±
0.06 0.77 ± 0.06 0.97 ± 0.09
0.18 0.94 ±0.12 1.1910.05
0.11 0.76 ± 0.09 0.99 ±0.11
0.10 0.61 ± 0.06 0.981 0.03
Plasma thyroxine concentrations (pg/100 ml) 
of Caucasian (CA) and Chinese (CH) women 
consuming diets containing different 
amounts and types of fat (mean ± SEM).
ss US74 MOD
Sequence 1
CA (n = 6) 6.63 ± 0.69 6.29 ± 1.04 7.02 ± 0.50
CH (n = 3) 6.37 ± 0.47 5.47 ± 0.52 7.011 0.47
Sequence 2 
CA (n = 8) 6.01 ± 0.37 5.11 ±0.60 6.11 ±0.57
CH (n = 2) 5.06 ± 0.27 4.65 ± 0.96 5.60 ± 1.04
Similarly, the positive association 
between thyroid hormones and 
norepinephrine seems appropriate 
because both sets of hormones 
enhance thermogenesis.
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Effect of Dietary Fat ---- ~4*
Modification on Serum T 
Prolactin Concentrations 
in Healthy Women
Introduction
Prolactin, a hormone 
released from the anterior pituitary, 
plays a vital role in the initiation of 
breast secretory activity. Breast tissue 
is the main target of prolactin activity, 
although other targets, such as ovarian 
and liver cells, also have been 
observed. It has been suggested that 
prolactin participates in the initiation 
and promotion of mammary tumors in 
mice and rats (1,2). Experimental 
studies in animals link high-fat diets, 
elevated serum prolactin levels, and 
increased mammary tumor incidence 
(3,4). Some epidemiologists have 
correlated high fat intakes with breast 
cancer incidence and mortality 
(1,5,6), but there is limited research 
on the relationship between diet and 
serum prolactin levels in humans. For 
this reason, the relative effects of two 
diets on serum prolactin levels of 
college women were of interest. The 
diets studied were a typical American 
diet with a moderately high level of 
fat (41 en%, US74) and a diet where 
the amount of fat was adjusted to 
conform to the Dietary Goals (29 
en%, MOD).
Procedures
Serum samples obtained 
from fasting subjects at the end of the 
7-day self-selected period, the first 4- 
week experimental period, and the 
second 4-week experimental period 
were analyzed for prolactin by using a 
RIA kit obtained from Amersham 
(Arlington Heights, IL). With this 
procedure, the smallest amount of 
prolactin that can be distinguished 
from zero is approximately 1.5 ng/ml.
The within-assay reproducibility 
ranged from 2.4 to 4.3% for the three 
control sera tested. The between- 
assay reproducibility ranged from 4.6 
to 5.8%.
Results
The most notable finding 
was the consistently greater amount 
of serum prolactin noted in Chinese 
compared with Caucasian subjects 
and in Nebraska Caucasian subjects 
compared with Iowa Caucasian 
subjects (Tables 9-1 and 9-2). The 
differences between sites and races 
were highly significant (p < 0.01). 
There was a significant residual effect 
of previous diet when all races were 
analyzed together but not when the 
Caucasians were analyzed separately. 
The US74 diet produced somewhat 
higher serum prolactin levels in both 
ethnic groups in sequence 1, but the 
dietary effect was obscured by the 
concomitant carry-over effect.
Serum prolactin concentra­
tions were significantly correlated 
with 20 of the 179 variables studied. 
Strongest associations were with 
urinary manganese in Nebraska 
subjects (r = 0.51), white blood cell 
count (r = 0.43), and thromboxane 
formation in isolated platelets 
stimulated with 5 mM calcium + 
thrombin (r = 0.41). There were 
positive relationships between serum 
prolactin and urinary total norepi­
nephrine (r = 0.34) and free norepi­
nephrine (r = 0.31).
4* 
9 ft
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Discussion
Although there was a 
suggestion of higher serum prolactin 
levels on the higher fat (US74) diet, 
the main dietary effect was obscured 
by the carry-over effect. The higher 
serum prolactin levels observed in 
Nebraska subjects were remarkable; 
several explanations can be offered 
for this phenomenon.
First, approximately 50% of 
prolactin secretion occurs from 12 
a.m. to 7 a.m. (7). Although blood 
samples were drawn from subjects at 
approximately the same time of day 
(6:30 a.m.), Nebraska samples were 
drawn before the subjects arose; Iowa 
subjects had to travel from their 
homes to the laboratory for blood
sampling. This explanation is 
supported by the finding that Cauca­
sian subjects at Nebraska had higher 
prolactin levels than Caucasian 
subjects at Iowa.
Second, subjects at the two 
locations varied in age, body size, and 
race. All these variables, particularly 
race, may influence serum prolactin 
concentrations (1,8,9). Chinese 
subjects had prolactin values about 
five times higher than those of 
Caucasian subjects in sequence 1 and 
60% higher in sequence 2.
It has been suggested 
previously that stress influences 
prolactin levels (10). This suggestion 
is supported by the weak, but signifi­
cant, association noted between serum 
prolactin and urinary norepinephrine 
in subjects participating in this study.
i f
Plasma prolactin concentrations (ng/mi) of 
Caucasian (CA) and Chinese (CH) women 
consuming diets containing different 
m amounts and types of fat (mean ± SEM).
SS US74 MOD
Sequence 1 
CA (n = 8) 
CH (n = 3) 
Sequence 2 
CA (n = 8) 
CH (n = 2)
7.73 + 1.83 
32.67110.27
9.8812.0
16.0010.50
6.3011.55 
39.17117.32
7.1911.21
12.0014.0
4.41 1 0.72 
24.33110.63
8.4411.66 
16.2511.98
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Electrolyte Balance — 
of Healthy Women as 
Affected by Dietary Fat
Abstract
The objective of the current 
project was to determine effects of 
changing level and kind of dietary fat 
on sodium and potassium retention of 
healthy adult subjects. The 20 adult 
female subjects were fed laboratory- 
controlled diets for 56 days. During 
the two experimental periods of 28 
days each, subjects were fed two 
experimental diets—-one resembling 
typical Caucasian diets in total fat, 
cholesterol, and saturated fat content 
(HANES I, US74 diet) and the other 
resembling diets recommended by the 
U. S. Dietary Guidelines/Goals in fat 
level and kind (modified diet or MOD 
diet). Sodium and potassium content 
of feces and urine were analyzed by 
atomic absorption spectrophotometry.
Results indicated that feed­
ing low-fat diets may reduce body 
retention of potassium and possibly 
sodium in comparison with results 
when higher-fat diets were fed.
Introduction
Hypertension is a well- 
established risk factor for major 
cardiovascular diseases and thus a 
great challenge in modem public 
health care (1). Because many people 
have “high normal” or “borderline” 
blood pressure, there is an urgent 
need for nonpharmacological control 
of high blood pressure in this large
segment of the population. The most 
commonly proposed dietary change is 
reduction of salt intake (2-6). More 
recently, the possible role of dietary 
fat (1, 7-12) has aroused interest.
The objective of this study 
was to determine sodium and potas­
sium utilization as affected by level 
and source of dietary fat.
Materials and Methods
The electrolyte contents of 
the basal diet and of urine and feces 
were measured by using a Varian 
Techtron Atomic Absorption Spectro­
photometer Model 1275. Urine 
samples were diluted with lanthanum 
chloride (LaCl3) and then analyzed. 
Food and fecal samples were first 
ashed, then digested with HC1 and 
diluted before analysis.
Results
Mean daily urine excretions 
of sodium and potassium for each 
subject were corrected by ratio to the 
overall mean creatinine excretion for 
each individual subject. It was as­
sumed that any variation of creatinine 
among periods for each subject was 
due to errors, either in urine collection 
and/or in processing. Hence, other 
components of urine, such as sodium 
and potassium, would vary to the 
same degree as did the creatinine ex­
cretion. To minimize this effect, and 
thus define treatment effect more ex­
actly, the potassium and sodium uri­
nary excretion values were corrected 
by the method just described.
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Similarly, it was assumed 
that dry fecal weights of each subject 
for all periods while receiving the 
US74 diet would be similar. The 
same would be true for each subject 
for all periods while receiving the 
MOD diet. Hence, variations would 
be due to errors in fecal collections, 
division of feces into period lots, and 
(or) processing of feces. Therefore, 
for the study done at Nebraska, fecal 
potassium and sodium losses were 
corrected by ratio for each individual 
as appropriate to the mean fecal dry 
weight for either the US74 or MOD 
diet for that individual. Because only 
fecal composites for the first and final 
7-day periods of high- and low-fat
feeding were available from the 
portion of the study done at Iowa, this 
correction calculation was not 
possible for these data. Because there 
were statistically significant site 
differences, these data are reported 
separately (Table 10-1).
Mean sodium intake was 
calculated to supply 3,526 mg/day in 
the US74 diet and 3,761 mg/day in 
the MOD diet (significantly different 
at p < 0.05), but analyses of the foods 
fed at Nebraska indicated mean 
sodium intakes were 3,600 mg/day for 
the US74 diet and 2,796 mg/day for 
the MOD diet (significantly different 
at p < 0.05). Urinary excretions of 
sodium were similar for subjects
¡g ig f
I ■
Parameter__________________________ Sodium mg/day1______Potassium mg/day1
Intake (analyzed)2 Nebraska
US74 3600 ± 102 3024 ± 46
MOD 2796^ ± 352 2724b ± 60
Intake (calculated)2 Iowa
US74 3526a ± 0 3119a ± 0
MOD 3761b ± 0 4133b ± 0
Nebraska
Urinary excretion 
US74 3226 ±913 2677 ± 572
MOD 3236+1078 2795 ± 568
Fecal excretion
US74 76 ±37 359 ± 150
MOD 74 ±38 355± 158
Balance (analyzed intake) 
US74 298a ± 885 -12a ±589
MOD -514b ± 1068 -426b ±603
Balance (calculated intake) 
US74 224 ±910 83a ±596
MOD 451 11078 983b ± 609
Iowa
Urinary excretion 
US74 2758 ± 759 1966a ±550
MOD 2653 ± 609 2303b ± 442
Fecal excretion
US74 92 ±20 345± 119
MOD 99 ±41 407± 146
Balance (analyzed intake) 
US74 750a ± 640 713a ±519
MOD 44b ± 687 14b ±396
Balance (calculated data) 
US74 676 ± 640 808a ±519
MOD 1009 ±687 1423b ±396
1 Means with different superscripts are significantly different at p < 0.05.
2lntake data analyzed values provided by Nebraska and calculated values 
provided by Iowa for experimental diets as served, not including ad lib table salt.
while receiving the high- and low-fat 
diets at Nebraska (3,226 vs. 3,236 
mg/day, p = NS) as were the fecal 
sodium losses (76 vs. 74 mg/day, p = 
NS). For Iowa subjects, mean urinary 
sodium losses were also similar while 
receiving the US74 and MOD diets 
(2,758 vs. 2,653 mg/day, p = NS), 
but were somewhat less than mean 
urinary sodium excretions at Ne­
braska. Fecal sodium excretion was 
influenced little by high- or low-fat 
feeding of the Iowa subjects (p = NS).
Sodium balances at both 
sites were greatly influenced by 
whether analyzed or calculated 
sodium intake figures were used. If 
analyzed sodium intake figures were 
used, mean sodium balances for 
Nebraska subjects while receiving the 
US74 and MOD diets were 298 and 
-514 mg/day (significantly different at 
p < 0.05), respectively. For Iowa 
subjects, the mean balance figures if 
the analyzed Nebraska diet figures are 
used were 750 and 44 mg/day 
(significantly different at p < 0.05), 
respectively. If calculated sodium 
intake figures are used, however, 
mean balances while receiving the 
US74 and MOD diets at Nebraska 
were 224 and 451 mg/day (p = NS), 
respectively, and at Iowa were 676 
and 1,009 mg/day (p = NS), respec­
tively.
Generally, analyzed dietary 
intake figures are considered more 
accurate estimations of intake than are 
calculated figures based on handbook 
values. If this is accepted, then 
feeding different levels of dietary fat 
may influence body sodium retention. 
If calculated sodium intake figures are 
used, however, then level of dietary 
fat apparently has no effect on body 
sodium retention.
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In Study I, analyzed potas­
sium intakes for the Nebraska 
subjects while receiving the US74 and 
MOD diets were 3,024 and 2,724 mg/ 
day (significantly different at p <
0.05), respectively, whereas calcu­
lated intakes for the Iowa subjects 
were 3,119 and 4,133 mg/day 
(significantly different at p < 0.05), 
respectively. At Nebraska, mean
urinary excretions of potassium while 
receiving the US74 and MOD diets 
were 2,677 and 2,795 mg/day (p = 
NS), respectively. Iowa values were 
1,966 and 2,303 mg/day (significantly 
different at p < 0.05), respectively. At 
both sites, urinary potassium loss 
tended to increase with the feeding of 
the MOD diet. Fecal losses of 
potassium while the US74 and MOD
diets were fed at Nebraska were 359 
and 355 mg/day (p = NS), respec­
tively, and at Iowa were 345 and 407 
mg/day (p = NS), respectively.
If analyzed potassium intake 
values are used, mean potassium 
balances when feeding the US74 and 
MOD diets at Nebraska were -12 and 
-426 mg/day (significantly different at 
p < 0.05), respectively, and at Iowa
4 »
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Correlations between fecal so- 
V C l U l w  dium and potassium and other 
1 0 - 2 .  parameters of metabolism.
Sodium
r __P________
Parameter
BILI DIR -0.33 0.05
CA ION 0.32 0.05
RBC 0.47 0.04
ALKPHOS 0.43 0.009
TOT SAT -0.32 0.05
OLEIC 0.32 0.05
LINO 0.32 0.05
CHOL -0.32 0.05
P/S 0.32 0.05
CARBCAL 0.37 0.02
FATCAL -0.34 0.03
UR CREA 0.39 0.01
FEC DWT 0.65 0.0001
FEC WWT 0.83 0.0001
FEC K 0.49 0.0001
UR NA -0.34 0.03
FEC MG 0.47 0.002
FEC MN 0.48 0.03
HGB 0.53 0.02
HCT 0.48 0.03
FECAL EN 0.43 0.005
DOPA F 0.32 0.05
DOPAT 0.50 0.001
COPRNOL -0.38 0.02
TOTAL NEUTRAL STEROL -0.37 0.02
B MUR -0.32 0.04
VLDLTG -0.33 0.04
PLAT140 -0.32 0.04
RBC204 -0.49 0.03
TBAD 0.31 0.05
TSC -0.33 0.04
Potassium______________
LDH 0.35 0.04
T4 0.36 0.02
CARNI FR -0.48 0.002
TOTSAT -0.30 0.06
FEC DWT 0.66 0.0001
FEC WWT 0.53 0.02
FEC NA 0.49 0.001
FEC MN 0.57 0.001
FEC EN 0.48 0.002
COPRNOL -0.39 0.02
TOTAL NEUTRAL STEROL -0.37 0.02
RBC PL204 -0.46 0.05
TSC -0.40 0.01
Sodium Potassium
r P r _J2_____
Parameter
CREAT -0.44 0.007 -0.34 0.04
UR CREA -0.36 0.02 -0.44 0.005
AG RATIO -0.35 0.03 - NS
BLIPO NS1 -0.48 0.03
PREBLIP 0.60 0.006 0.44 0.05
FEC NA -0.34 0.03 NS
UR NA NA2 0.57 0.0001
UR K 0.57 0.0001 NA
UR MN 0.82 0.0001 0.66 0.0002
WB5 NS 0.55 0.01
U DC NS 0.33 0.04
NOREPI F 0.40 0.01 NS
NOREPIT 0.48 0.002 NS
EPI F 0.36 0.02 . NS
EPI T 0.40 0.01 NS
O MUR NS 0.39 0.01
h d l 3 NS 0.39 0.02
TOT HDL NS 0.33 0.04
TBARS 0.52 0.003 0.69 0.0001
TAURINE 0.33 0.04 0.35 0.03
COPRNONE -0.39 0.01 -0.38 0.01
TOTAL TG 0.37 0.02 0.33 0.04
VLDLTG 0.36 0.02 0.36 0.02
FFA140 -0.40 0.01 -0.34 0.03
PLAT181 0.31 0.05 NS
PLAT182 NS 0.31 0.05
RBC141 -0.53 0.0004 -0.43 0.006
RBC160 NS -0.32 0.04
RBC204 0.34 0.03 NS
1 NS = Not significant p > 0.05. 
2NA = Not applicable.
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were 713 and 14 mg/day (signifi­
cantly different at p < 0.05), respec­
tively. Thus, feeding a low-fat diet 
may result in a decrease in body 
potassium retention. But if calculated 
potassium intake figures are used to 
calculate the potassium balances, 
potassium balances while receiving 
the US74 and MOD diets at Nebraska 
were 83 and 983 mg/day (signifi­
cantly different at p < 0.05), respec­
tively, and at Iowa were 808 and 
1,423 mg/day (significantly different 
at p < 0.05), respectively. If these 
values are used, then the opposite 
conclusion on the effect of alteration 
of level of dietary fat intake on body 
potassium retention must be reached.
Discussion
Urinary and fecal sodium 
and potassium excretions were 
significantly correlated with numer­
ous other parameters measured in this 
project, as shown in Tables 10-2 and 
10-3. Strong positive correlations 
were found between fecal sodium 
losses and wet fecal weight (r = 0.83, 
p < 0.0001) and dry fecal weight (r = 
0.65, p < 0.0001), as well as between 
fecal potassium losses and wet fecal 
weights (r = 0.53 p < 0.02) and dry 
fecal weights (r = 0.66, p < 0.0001). 
Fecal losses of sodium and potassium 
also were strongly and positively 
correlated (r = 0.49, p < 0.0001). 
These correlations between fecal 
weight and fecal losses of sodium and 
potassium may, in part, explain the
apparent negative effect of the 
modified fat diet on decreased 
retention of sodium and potassium. A 
decrease in dietary fat necessitated an 
increase in dietary carbohydrate to 
maintain equality in caloric intake 
between the two experimental diet 
regimes. The increase in carbohy­
drate intake tended to increase fiber 
intake and, concurrently, tended to 
increase fecal mass.
Conclusion
In conclusion, it seems that 
reducing fat intake may result in 
decreases in both sodium and potas­
sium retention. The data, however, are 
more clear cut for potassium than for 
sodium. Because sodium and 
potassium are thought to have 
opposite effects on blood pressure, the 
ultimate effect of reduction of both 
sodium and potassium as a result of 
feeding low-fat diets cannot be 
predicted, but these findings suggest 
interesting approaches for future 
research. These results also empha­
size the hazards of using calculated 
rather than analyzed sodium and 
potassium intake figures.
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Calcium, Magnesium — 
and Manganese 
Utilization by Healthy 
Females as Affected by 
Dietary Fat Alterations
Abstract
Two groups of healthy 
young adult women were fed two 
different laboratory-controlled diets. 
One was modeled to resemble the 
usual diet of Caucasians (HANES I, 
US74 diet) in total fat, saturated fat, 
and cholesterol contents, and in the 
other one these characteristics were 
modified (MOD diet) to meet current 
recommendations. Calcium, magne­
sium, and manganese contents of 
food, feces, and urine were analyzed 
by atomic absorption spectrophotom­
etry and balances were calculated. 
Calculated values for calcium and 
magnesium tended to be more 
positive, indicating greater retention 
of these mineral nutrients with the 
US74 diet than with the MOD diet; 
results for manganese, however, were 
less clear cut.
Introduction
Appreciable attention has 
been given in the past few years to the 
importance of various minerals in 
human health. Particular interest has 
been centered on calcium because of 
the high incidence of bone loss with 
aging. Other minerals such as 
manganese and magnesium also are 
contained in bone tissue. Primary or 
secondary calcium deficiencies have 
been associated with such diseases as 
osteoporosis, osteomalacia, and
rickets. The HANES I survey showed 
that calcium intakes of adult North 
Americans were less than the 1980 
National Research Council Recom­
mended Dietary Allowances (1) for 
this nutrient.
In addition to recommenda­
tions for increasing calcium consump­
tion, other dietary changes are being 
recommended. Among these are the 
desirability of changing amounts and 
patterns of dietary fat intake to 
decrease risk of development of 
atherosclerosis and coronary disease 
as well as certain types of cancer. 
Individual nutrients are not absorbed 
and metabolized in a vacuum. Rather, 
interactions among nutrient and non­
nutrient components of foods may 
result in unpredictable physiological/ 
biochemical results. This laboratory 
and others have reported that the kind 
and amount of dietary fat may affect 
the utilization of such mineral 
nutrients as calcium, magnesium, and 
manganese (2-5). The objective of 
the project was to determine the effect 
of changes in dietary fat and choles­
terol levels on calcium utilization of 
human adults.
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Materials and Methods
The calcium and magnesium 
contents of the basal diet and of urine 
and feces were measured by using a 
Varian Techtron Atomic Absorption 
Spectrophotometer Model 1275.
Urine samples were diluted with 
lanthanum chloride (LaCl3) and then 
analyzed for calcium and magnesium 
contents. Food and fecal samples 
were first ashed, then digested with 
HC1 and diluted before analysis. 
Manganese was analyzed by using a 
graphite furnace attachment on the 
spectrophotometer. Urine samples 
were prepared for creatinine determi­
nations (6). Alkaline phosphatase 
activity in serum was determined by 
using an automated SMAC procedure.
Results
The balance method has 
been used extensively as a measure­
ment of the amount of nutrients 
retained in the body. This method has 
received criticism because of a 
tendency to overestimate the intake 
and underestimate output (7). In 
addition, it is sometimes referred to as 
a “black box” evaluation because 
improvement or decline in nutritional 
status can be defined, but little or no 
information is provided to explain 
why these responses are occurring. 
Nevertheless, it is a noninvasive 
research approach for which no better 
methodology has been found.
Parameters associated with 
calcium utilization are shown in Table
11-1. The US74 diet provided 
approximately 150 mg per subject per 
day more calcium than did the MOD 
diet. Both diets, however, exceeded 
the 1980 NRC Recommended Dietary 
Allowance (1) of 800 mg calcium per 
day for young women. Because of 
the widespread occurrence of bone- 
loss diseases in older American 
women, some interest in raising the 
recommended intakes of calcium has 
been expressed. Because some 
adjustments in calorie intakes were 
made for subjects in the Nebraska 
section for weights to be maintained, 
some variations in calcium, as well as 
in magnesium and manganese, 
occurred with these subjects.
Fecal losses of calcium were 
considerably greater among the 
Nebraska subjects than among the 
Iowa subjects (p < 0.006). Within 
both groups, however, fecal calcium 
losses were somewhat greater with 
the feeding of US74 diet than with the 
MOD diet (p < 0.05). This would 
suggest that a higher level of fat, a 
higher level of cholesterol, or greater 
saturation of the fat in combination or 
a separate entity might reduce the 
utilization of dietary calcium. But the 
US74 diet contained a higher level of 
calcium than did the MOD diet, so 
this might be another logical explana­
tion. Fecal calcium losses tended to 
reflect dietary calcium intakes.
Urinary losses of calcium by 
the Iowa subjects were significantly 
greater than were those of the 
Nebraska subjects (p < 0.0275). 
Clearly, the Iowa subjects also were 
absorbing more calcium as observed 
from their smaller fecal calcium 
losses. But no differences were 
defined in either group that could be 
attributed to changes in kind and 
amount of fat from the experimental 
diets.
Calcium retention by the 
Iowa subjects also was numerically 
greater than was that of the Nebraska 
subjects, although this apparent 
difference was not statistically 
significant. The Iowa subjects were 
somewhat younger and larger than
US74 (mg Ca/day) MOD (mg Ca/day)
Parameter
Intake
Nebraska 1,2813 + 11 1,133b± 16
Iowa 1 ,2 8 ia ± o 1,133b±0
Mean 1 ,2 8 ia ± 5 1,133b±8
Fecal Excretion
Nebraska 1,060a ± 66 940 b ±47
Iowa 864a ± 38 761b ±40
Mean 962a ±45 851b ± 42
Urinary Excretion
Nebraska 80 + 31 83 ±26
Iowa 185 ±24 188 ± 12
Mean 133 ±27 136± 15
Balance
Nebraska 141 ±74 110 ± 81
Iowa 232 ± 33 184 ±42
Mean 186 ±48 146 ±52
1 For each set of horizontal entries, values with different letter superscripts 
are significantly different (p < 0.05).
were those from Nebraska, which 
might account for their greater 
tendency to retain calcium. Calcium 
balances tended to be more positive 
with the feeding of the US74 diet than 
with the feeding of the MOD diet, 
although these effects were not 
statistically significant.
Magnesium intakes of 
subjects at both Iowa and Nebraska 
were slightly, but significantly, 
greater when the US74 diet was fed 
than when the MOD diet was used (p 
< 0.001) (Table 11-2). Fecal magne­
sium losses, however, did not follow 
the same pattern. Magnesium losses 
were numerically greater with the 
feeding of the MOD diet than with the 
feeding of the US74 diet for both 
groups of subjects. Although these 
differences were not statistically 
significant (p < 0.08), greater absorp­
tion of magnesium from the higher-fat 
US74 diet than from the MOD diet is 
suggested. In contrast to calcium 
fecal loss pattern, the Iowa subjects 
were losing significantly more 
magnesium in feces than were the 
Nebraska subjects (p < 0.05).
Urinary losses of magnesium 
were not significantly different with 
the feeding of the two test diets. 
Magnesium losses in urine also were 
similar between the subjects at Iowa 
and those at Nebraska.
Mean magnesium balances 
of subjects were significantly superior 
when subjects at both test sites were 
fed the US74 diet than when the 
MOD diet was fed. Although 
subjects approached or were in 
positive balance when receiving the 
US74 diet, indicating some magne­
sium retention, nearly all were in 
distinct negative magnesium balance 
when receiving the MOD diet. 
Because the errors of balance studies 
tend to favor falsely high positive 
balances, these negative balances are 
cause for concern. Magnesium
intakes provided by these diets were 
greater than those usually eaten by 
American women and met the 1980 
NRC Recommended Dietary Allow­
ance (1) for this age/sex group.
Nevertheless, magnesium needs for 
many subjects were evidently not 
being met.
Parameters of manganese 
utilization as measured in this study
US74 (mg Mg/day) MOD (mg Mg/day)
Parameter
Intake
Nebraska 394 a ±7.54 348 b ±7.47
Iowa 387 a ± o.O 341 b± 0.0
Mean 390 a ±3.88 344 b± 3.75
Fecal Excretion
Nebraska 270 ± 40.3 286 ± 55.2
Iowa 303 ± 43.4 333 ± 43.4
Mean 286 ±41.5 309149.3
Urinary Excretion
Nebraska 81 ± 66.5 106 ±34.3
Iowa 91 ±31.9 74 ± 27.9
Mean 86 ± 43.3 90 ±30.1
Balance
Nebraska 43a ±41.1 -44b ±35.6
Iowa -7a ± 68.4 -66 b ±55.5
Mean 18a ±53.7 -55b ±45.0
1For each set of horizontal entries, values with different 
letter superscripts are significantly different (p < 0.05).
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US74 (mg Mn/day) MOD (mg Mn/day)
Parameter
Intake
Nebraska 4.97 ± 0.24 5.48 ± 0.24
Iowa 4.97a ± 0.0 5.81 b ± 0.0
Mean 4.97a ±0.07 5.65b ± 0.07
Fecal Excretion
Nebraska 4.81 ±1.15 4.42 ±0.99
Iowa 4.66a ± 0.90 5.55b ±0.46
Mean 4.73 ± 1.02 4.98 ± 0.65
Urinary Excretion
Nebraska 0.088 ± 0.03 0.087 ± 0.02
Iowa 0.027 ±0.01 0.026 ±0.01
Mean 0.058 ± 0.02 0.057 ±0.01
Balance
Nebraska 0.07a ± 0.46 0.97° ±0.97
Iowa 0.28 ± 1.52 0.23 ± 2.54
Mean 0.18 ±0.98 0.61 ±1.73
1For each set of horizontal entries, values with different 
letter superscripts are significantly different (p < 0.05).
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are given in Table 11-3. The MOD 
diet with Iowa subjects provided 
significantly more manganese than 
did the US74 diet. It is not surprising, 
therefore, that the MOD diet resulted 
in significantly greater fecal manga­
nese losses in the Iowa subjects. With 
the Nebraska subjects, however, fecal 
manganese losses were numerically 
greater with the US74 diet than with 
the MOD diet.
■  K Ü 3 U Ë 1
Alkaline phosphatase <IU/I) levels of 
women fed altered diets by site, diet, 
1 1  « 4 .  anci race (mean ± SEMI).1
s s MOD U S74
Site (n)
IA (10) 70 .20 ±  7.03 64.78 ±  6.73 61.71 ± 3 .8 4
NE (10) 54.60 ±  3.38 51.20 + 3.38 51.50 ± 2 .31
Race (n)
Ca (8) 67.00 ±  5.25 60.08 + 5.13 58.64 ±  2.77
Ch (5) 49 .00  ±  4.91 49 .40  ±  5.30 48.00 ±  3.56
1ANOVA Site Race Diet
All subjects ** **
Caucasian only **
p < 0.05; ** p < 0.01
r P
Parameter
KCAL 0.26 0.06
CALCIUM 0.33 0.01
ALBUMIN 0.42 0.001
CHOLEST -0.36 0.006
LDH 0.59 0.0001
AG RATIO 0.42 0.001
CA ION 0.28 0.038
UR CREA 0.36 0.006
HDL -0.42 0.02
FEC NA 0.43 0.009
FEC MG 0.41 0.013
HCT 0.39 0.03
WB3 0.44 0.026
FECAL STEROLS 
LC 0.36 0.007
DC 0.36 0.006
AMUR -0.30 0.024
TOT CHOL -0.37 0.005
LDL -0.29 0.04
h d l 2 -0.38 0.005
h d l3 -0.38 0.005
Very little manganese is 
excreted in the urine, but urinary 
losses of manganese tended to be 
greater in the Nebraska subjects than 
in the Iowa subjects.
Mean balances of manganese 
tended to be more positive in the 
Nebraska subjects with the MOD diet 
than with the US74 diet. A similar 
trend was not noticed with the Iowa 
subjects. Why a difference in 
response among these two groups of 
subjects occurred is unknown.
Blood serum aklaline 
phosphatase increases with increases 
in bone turnover. Hence, this 
measurement may be used as an 
indirect index of calcium status.
Blood serum aklaline phosphatase 
concentrations were significantly 
influenced by race, with Caucasians 
having higher levels than did Chinese 
(Table 11-4). Among Caucasians, a 
significant effect of dietary change on 
blood serum alkaline phosphatase 
concentration was defined. Signifi­
cant correlations of alkaline phos­
phatase levels with other parameters 
measured in this project are given in 
Table 11-5.
Discussion
In individuals with sprue, 
steatorrhea, biliary fistula, and other 
conditions in which fat is poorly 
absorbed, calcium malabsorption also 
occurs (8-11). When the malabsorp­
tion of fat is corrected, calcium 
absorption returns to normal (9). For 
many years this decrease in calcium 
absorption was credited to the 
formation of calcium-fat soaps (Ca- 
fatty acid salts). Gacs and Baltrop (5)
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demonstrated that the availability of 
calcium from these soaps becomes 
less as the chain length and the degree 
of unstaturation of the fatty acid 
decreases. Thus, long-chain saturated 
fatty acids would be expected to have 
a greater negative effect on calcium 
absorption than would short-chain and 
polyunsaturated fatty acids. But, 
according to Patton and Carey (12), 
calcium soap is a normal product 
necessary for the digestion of fat. 
Particles formed during the digestive 
process include pancreatic lipase, 
colipase, and bile salts, with calcium 
as a component of one of the phases.
Several earlier reports 
indicate a possible favorable effect of 
dietary fat on calcium absorption. 
Given (8) found that lipid digestion 
and absorption are dependent on the 
amount of calcium present in the 
intestines. In addition, Wermer and 
Luthak (13) found that at least some 
fat must be present for calcium 
absorption to occur. Harkins et al.
(14) and Lutwak et al. (15) investi­
gated the effects of feeding similar 
levels of fat but different levels of 
calcium and found parallel changes 
between fat and calcium absorption. 
But no relationship between calcium 
and fat absorption or between 
magnesium and fat was found in other 
research with humans (3,4,16-20).
Very high amounts of dietary 
fat have been found to adversely 
affect utilization of both calcium and 
magnesium (21,22). When human 
subjects were fed 100 g or 40 g of 
dietary fat, calcium and magnesium 
excretion were greater for subjects fed 
100 g of fat than for those fed 40 g 
(23). Calcium absorption has been 
related to the amount of fat in the diet 
and also to the type of fat. As the 
length and degree of saturation 
increased (increase in melting point), 
calcium absorption was impaired. 
Some reports indicate that the 
presence of some unsaturated fatty 
acids, such as oleic acid, improves 
calcium absorption (5,24-28).
In addition to the formation 
of soaps that might inhibit or enhance
calcium absorption and enhance or 
impair fat absorption, relationships of 
calcium to pancreatic lipase and to a 
decrease in bile acid synthesis have 
been reported (29,30). Interactions 
between level of ionization achieved 
by the fatty acids and the concentra­
tion of calcium have been demon­
strated by Patton and Carey (12). A 
high degree of ionization in the 
presence of high concentrations of 
calcium evidently increase chances of 
more soap formation and less absorp­
tion of fat and calcium.
In several studies conducted 
on infants, the degree of fat absorp­
tion has varied. Several formulas 
have been evaluated for absorbability 
by using different fat sources and 
mixtures. A major constraint in the 
absorbability of fat from formulas is 
the type of fatty acid and the position 
of the fatty acid in the triglyceride 
structure. Pancreatic lipase is known 
to preferentially hydrolyze fatty acids 
from positions 1 and 3; 2-mono­
glycerides are easily absorbed. 
Calcium excretion in infants increased 
in the presence of long-chain satu­
rated fatty acids (25). When these 
fatty acids were randomized in the 
triglyceride structure, no relationship 
between calcium excretion and fat 
excretion was found (31). The idea of 
decreasing the chain length of fatty 
acids in the fat fraction of formula to 
improve fat absorption, not only in 
infants but also in patients suffering 
from cirrhosis and gastrectomies, has 
been investigated. When medium- 
chain triglycerides were included in 
the fat fraction of the formula, both 
magnesium and calcium absorption 
were improved (32).
Recent studies conducted by 
Kies (33) suggested that high levels of 
fat and increased chain length of fatty 
acids in diets of humans impaired 
calcium balance; in other studies from 
the same laboratory (2), however, a 
moderate level of dietary fat im­
proved calcium and manganese 
relative to diets containing less fat.
The Caucasian subjects were larger
and younger than were the Chinese 
subjects and, hence, had greater 
urinary creatinine excretions. Thus, 
there was a positive correlation 
between urinary creatinine and 
aklaline phosphatase concentrations 
(r= 0.36, p < 0.006) but a negative 
correlation of alkaline phosphatase 
with total cholesterol levels (r= -0.37, 
p < 0.005). Individuals in a nonfat, 
body-mass growth stage usually have 
increased alkaline phosphatase 
concentrations because of increased 
bone mass, but have a decrease in 
blood serum cholesterol. This also 
may explain the negative correlations 
between concentrations of blood 
serum alkaline phosphatase and 
several other lipid fractions.
Conclusion
The results of this study 
indicated that calcium and magnesium 
utilization tended to be greater when 
the higher-fat rather than the lower-fat 
diet was fed. Because these changes 
were partly related to differences in 
fecal bulk produced by feeding diets 
with different fat content, it may be 
that the increased fecal bulk produced 
by diets with more carbohydrates, 
rather than the reduced fat content of 
the diets, was the primary factor 
influencing decreased apparent 
calcium absorption.
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Urinary Excretion of 
Catecholamines in 
Women Fed Diets 
Differing in Fat 
Content and Fatty 
Acid Composition
Introduction
The importance of the 
sympathetic nervous system in 
regulation of metabolic processes has 
been known for many years. More 
recently it has been demonstrated that 
diet can influence activity of this 
system (1). Fasting suppresses 
sympathetic nervous system activity, 
and overeating accelerates activity. 
Composition of the diet fed also 
influences catecholamine release. In 
humans, intake of carbohydrate seems 
to cause greater increases in plasma 
norepinephrine (an indicator of 
sympathetic nervous system activity) 
than does intake of fat or protein (2- 
5). In animal studies, consumption of 
low-protein diets accelerates sympa­
thetic nervous system activity, as 
assessed by measurements of norepi­
nephrine turnover in selected organs 
(6-8). Low-protein diets by necessity 
contain more carbohydrate or fat. 
Direct comparisons of norepinephrine 
turnover in rats fed diets with various 
carbohydrate-to-fat ratios indicated 
that these energy sources had equal 
effects on the sympathetic nervous 
system (7).
It is unclear why humans 
seem to respond specifically to 
carbohydrate, whereas the sympa­
thetic nervous systems of laboratory 
animals respond equally to carbohy­
drate and fat. The studies with 
humans usually involved feedings (or 
sometimes intravenous administra­
tion) of single nutrients followed by 
measurements for only a few hours.
In contrast, laboratory animals have 
been fed balanced diets for periods of 
days to weeks before assessment of 
sympathetic nervous system activity. 
The NC-167 cooperative study gave 
us an opportunity to assess the 
influence of moderate changes in fat- 
to-carbohydrate ratio in diets fed to 
human subjects for 4 weeks on 
urinary catecholamine excretion; 
catecholamine excretion is an 
indicator of sympathetic nervous 
system activity.
Materials and Methods
The introduction to this 
bulletin provides information on 
experimental design, subject charac­
teristics, and diet composition.
Briefly, the 20 women subjects 
consumed diets containing 41% fat 
and 44% carbohydrate (termed US74 
diet) or 30% fat and 54% carbohy­
drate (MOD diet) for 4 weeks each, in 
a crossover design.
Quantitative urine collec­
tions were made during the last week 
of each 4-week dietary period. Urine 
was assayed for total and free 
catecholamines as previously de­
scribed (8).
Results
Urinary excretion values of 
norepinephrine, epinephrine, and 
dopamine are presented in Table 12-1. 
Catecholamines are excreted in the 
free form or conjugated primarily as 
sulfate esters in humans (9). Ap­
proximately 70% of the cat­
echolamines excreted were in the 
conjugated form in this study, in 
agreement with literature values (9). 
Excretion of norepinephrine was 
unaffected by diet, whereas excretions 
of epinephrine and dopamine were 
slightly greater in subjects consuming 
the MOD diet. Location and race of 
the subjects seemed to influence some
of these values, with values from 
Nebraska being higher than those 
from Iowa. All the Chinese subjects 
(n = 5) lived in Nebraska.
Discussion
Activity of the sympathetic 
nervous system has been assessed by 
various approaches (10). In experi­
mental laboratory animals, it is 
possible to measure rates of norepi­
nephrine turnover in specified organs. 
This approach has the obvious 
advantage of providing an index of 
sympathetic tone in organs of interest. 
In humans, measurements of plasma 
norepinephrine concentration or 
turnover, or urinary excretion of 
norepinephrine, provide relatively 
noninvasive approaches, but are 
unable to provide information on 
specific organ(s) responsible for any 
observed changes in sympathetic 
tone. Urinary excretion of norepi­
nephrine was selected as the method 
for assessment of sympathetic tone in 
the present study because, unlike 
measurements of plasma norepineph­
rine, which are subject to abrupt 
minute-to-minute fluctuations, this 
approach provided values integrated 
over time (7 days in the present 
study).
Urinary epinephrine excre­
tion provides an indicator of 
sympathoadrenal activity because 
urinary epinephrine originates largely 
from the adrenals. The origin of 
urinary dopamine has not been clearly 
defined. Urinary dopamine has been 
used as a marker of activity of the 
renal dopaminergic system (11). Our 
values for urinary excretion of 
catecholamines are in the same 
general range as others have reported 
( 12).
The main finding of the 
present study is that a moderate shift 
in the dietary fat-to-carbohydrate ratio 
did not influence sympathetic tone (as 
assessed by urinary excretion of 
norepinephrine) in young, healthy 
female subjects. These results 
support data from animal experiments
E iU P S I| Urinary catecholamine excretion.1
US742(|ig/d) MOD2(ug/d) Sig. Effect
Free norepinephrine 
Iowa 17.2± 1.5 16.9± 1.3 Site
Nebraska 21.1 ±2.2 20.6 ±2.4
Total norepinephrine 
Iowa 44.2a ±5.3 60.4b± 6.0 Site
Nebraska 83.1 ±6.6 83.6 ±8.3
Free epinephrine 
Caucasian 2.19 ±0.24 2.87 ±0.30 Race
Chinese 3.14 ±0.70 2.86 ± 0.53
Total epinephrine 
Caucasian 9.40 ± 0.65 11.8 ± 1.1 Diet, race
Chinese 11.8 ± 1.8 13.0 ±2.2
Free dopamine 
Caucasian 151.2 ±7.9 159.8 ± 10.2 Race, site
Chinese 135.0 ± 15.6 151.8 ± 18.8
Total dopamine 611.8 ±27.1 741.6 ±36.8 Diet
1 Twenty subjects were studied, 10 housed in Iowa and 10 in Nebraska, and each subject 
received each diet in a crossover design.
2Mean ± SEM. Means with different superscripts are significantly different (p < 0.05).
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in which more marked shifts in 
dietary fat-to-carbohydrate ratio also 
failed to influence sympathetic 
nervous system activity as assessed 
by measurements of norepinephrine 
turnover in selected organs (7).
The physiological signifi­
cance, if any, of the slightly elevated 
epinephrine and dopamine excretion 
in subjects fed the MOD diet remains 
to be established. Site and race 
effects on catecholamine excretion are 
confounded because all Chinese 
subjects were from one site.
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Other Parameters 
in the Human 
Study
White blood cell (WBC) x 103/mm3
SS 1 US741 MODI
All (n = 20)
By Race 
Ca (n = 14)
Ch (n = 5)
By State
Nebraska (n = 10) 
Iowa (n = 10)
6.07 ± 0.253
6.07 ± 0.29 
6.20 ± 0.65
6.36 ±0.41 a 
5.77 +0.293
5.35 ± 0.28b
5.14 ±0.35 
6.06 ± 0.46
5.86 ±0.41 a,b 
4.84 ± 0.33b
5.39 ± 0.27b
5.34 ± 0.35 
5.68 ± 0.44
5.57 ± 0.44b 
5.21 ± 0.32a,b
1 Mean ± SEM; numbers in the same line with different superscripts are significantly 
different (p < 0.05).
■illMMlWMlllfll|
SS US74 MOD Sig. Effects_______
Glucose (n = 20) (mg/dl) 75.1 ± 3.4 a 84.2 ± 1.2b 83.4 ± 1 .Ob Diet
Blood urea N (mg/dl)
Iowa 13.2 ±0.90 13.3 ±0.64 14.1 ±1.27 Site, diet
Nebraska 11.8 ± 1.37 12.3 ±0.80 13.6 ±0.91
Creatinine (mg/dl
Iowa 1.01 ±0.04 0.99 ± 0.03 1.02 ±0.04 Site
Nebraska 0.88 ± 0.02 0.88 ± 0.02 0.93 ± 0.03
Uric acid(mg/dl)
Caucasian (n = 14) 3.85 ± 0.24 4.04 ± 0.20 4.12 ±0.20 Site,diet, race
Chinese (n = 5 4.22 ± 0.35 4.78 ±0.19 4.86 ± 0.32
Total protein (g/dl)
6.95 ±0.12 RaceCaucasian (n = 14 7.08 ±0.16 7.16 ± 0.12
Chinese (n = 5) 7.34 ±0.17 7.26 ±0.14 7.50 ±0.13
Albumin (g/d)
SiteIowa 4.36 ± 0.92 4.39 ±0.12 4.39 ± 0.09
Nebraska 4.22 ±0.10 4.18 ±0.06 4.22 ± 0.09
Bilirubin (total mg/dl)
Diet,SiteIowa 0.56 ± 0.12a 0.89 ± 0.24b 0.60 ± 0.06a
Nebraska 0.57 ± 0.07 0.58 ± 0.05 0.53 ± 0.05
SGOT (AST [IU/I])
Iowa 21.1 ±5.21 20.6 ± 4.01 20.6 ± 3.36 Site
Nebraska 15.6 ± 1.77 18.0 ±0.82 18.1 ±0.95
SGPT (AHT [IU/I])
SiteIowa 30.6 ±10.06 17.6 ±5.79 17.9 ±3.47
Nebraska 12.9 ± 1.45a 19.8 ± 2.38b 19.1 ± 1.93b
LDH (mg/dl)
SiteIowa 215.1 ±7.15 189.3 ±5.74 199.8 ± 11.36
Nebraska 170.5 ± 8.65 171.6 ±6.24 176.7 ±10.91
Globulin (g/dl)
Caucasian 2.79 ±0.11 2.85 ±0.1 2.66 ± 0.08 Race
Chinese 3.12 ±0.09 3.08 ± 0.06 3.20 ± 0.07
Ionized CA (mg/dl)
RaceCaucasian 4.21 ± 0.03 4.23 ± 0.05 4.27 ± 0.03
Chinese 4.12 ±0.06 4.06 ± 0.07 4.02 ± 0.07
1Mean ± SEM; numbers in the same line with different superscripts are significantly different (p < 0.05).
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Statistical Analysis
I. General
The General Linear Model 
(GLM) procedure of SAS produces 
output as shown in table 14-1. This 
includes an overall analysis of 
variance (ANOVA) table, miscella­
neous basic statistics, and results for 
TYPE I (SEQUENTIAL) and TYPE 
III (PARTIAL) tests. We will not, at 
this time, be concerned about the 
overall ANOVA table. (All refer­
ences are to the attached output.)
The basic statistics include 
R2 (R-SQUARE), coefficient of 
variation (C.V.), standard deviation 
(ROOT MSE), and variable mean 
(TOT CHOL). R-SQUARE measures 
how much of the variation of TOT 
CHOL is accounted for by the 
variables in the model and is a 
decimal fraction between 0 and 1. In 
this case, R2 of 0.886 or almost 90% 
of the variation in TOT CHOL is 
accounted for by the model, which 
includes GROUP, RACE, SUBJECT 
(GROUP * RACE), DIET, X, and 
X2. The mean, 156.6, is the statistical 
mean of the values for TOT CHOL. 
ROOT MSE of 13.42 is the standard 
deviation for TOT CHOL after taking 
out the variation accounted for by the 
model. Coefficient of variation is an 
alternate measure of variation and is 
equal to 100 times the standard 
deviation divided by the mean. In our 
example, the C.V. of 8.6 means the 
standard deviation is less than 1/10 
the mean and shows that there is little 
variation in the variable TOT CHOL 
after that accounted for by the model 
is taken out. These statistics may be 
used in summarizing the data. But 
means (and the accompanying 
statistics) other than the overall mean, 
such as treatment means, will be more 
important in interpreting the results of 
this study.
Our primary focus here is on
the results for TYPE I (SEQUEN­
TIAL) and TYPE III (PARTIAL) 
tests. These are different ways to 
divide the sums of squares (SS) for 
the entire model into portions 
accounted for by each of the vari­
ables. TYPE I, or SEQUENTIAL, 
measures incremental SS as variables 
are added one at a time to the model. 
Looking at our example, the SS for 
TOT CHOL = GROUP is 627.27. 
(The other variables are not consid­
ered at all.) Adding RACE to the 
model increases the SS by 6,194.95 
(in other words, the variable RACE 
accounts for an additional 6,194.95 of 
the total regression SS after GROUP 
but ignoring SUBJECT, DIET, X^ 
and X2). Then adding SUBJECT ’ 
accounts for 35,913.05 and DIET an 
additional 7,075.73. Last, X| and X2 
after GROUP, RACE, and SUBJECT 
account for 316.97 and 38.63.
On the other hand, TYPE III, 
or PARTIAL, (the series we are most 
interested in) looks at each variable as 
though it were the last added to the 
model and is adjusted for all other 
effects. Because of interrelationships 
among variables and the calculations 
involved, the TYPE III SS do not add 
up to the model sum of squares as in 
TYPE I, the SS for each variable will 
be different from that for the TYPE I, 
and the significance levels may be 
different. In our example, SS for 
GROUP is 92.48 after the other five 
effects have been accounted for. 
RACE after the other five effects 
accounts for 6,169.55, not much 
different from after just GROUP in 
TYPE I. SUBJECT SS is 35,444.29. 
DIET SS has been reduced to 
1,984.06 and X, to 0.70.
The last line of TYPE III 
will always be the same as the last 
line of TYPE I because the SS for 
both types for the last variable is 
calculated after all other variables.
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Thus, SS for X2 is 38.63 for TYPE III 
just as it was for TYPE I.
In our analysis, we are most 
interested in the TYPE III division of 
the SS. We need to account for 
differences due to 1) site or GROUP 
(NE vs. IA), 2) RACE, 3) individuals
(SUBJECTS within GROUP and 
RACE), and 4) DIET-usual U.S. diet 
(US74), modified diet (MOD), or 
self-selected diet. We are interested 
in these effects after each of the 
variables is adjusted for the others 
rather than as single effects or
ignoring the others. We also can 
examine possible PERIOD or time (is 
the 1-month difference in measure­
ment time important?) or RESIDUAL 
or carry-over effects as outlined:
Dependent Variable: TO T CHOL
Source DF Sum of Squares Mean Square F Value PR > F R-Square C.V.
Mode 23 50166.6000000 2181.15652174 12.12 0.0001 0.885586 8.5664
Error 36 6481.3333333 108.03703704
Corrected Total 59 56647.9333333 Root Mse TO T CHOL mean
13.41778808 156.63333333
Source DF Type I SS F Value PR > F DF Type III SS F Value PR > F
Group 1 627.26666667 3.48 0.0701 1 92.48000000 0.51 0.4782
Race 2 6194.95000000 17.20 0.0001 2 6169.55136612 17.13 0.0001
Subject (Group*Race) 16 35913.05000000 12.47 0.0001 16 35444.28513189 12.30 0.0001
Diet 2 7075.73333333 19.65 0.0001 2 1984.05714286 5.51 0.0082
X 1 1 316.97142857 1.76 0.1929 1 0.70000000 0.00 0.9506
X 2 1 38.62857143 0.21 0.6460 1 38.62857143 0.21 0.6460
Calculation of F for residual effect ; s s X i + S S xg ^ EMS = 316.97142857 + 38.62857143 + 180.03703704 = 177 8 = 0.98757
A. If no residual effects are present (that is, if the response to diet B is not different following diet A
from the response following self-selected, which can be checked by doing the analysis outlined in B), 
the analysis of variance (ANOVA) table would be:
d.f. without d.f. with
Source pretreatment pretreatment
GROUP (IA vs. NE) 1 1
RACE 2 2
SUBJECT within GROUP*RACE 16 16
PERIOD 1 (1 vs. 2) 2(1 vs. 2 vs.3)
DIET 1 (A vs. B) 2 (A vs. B vs.C)
ERROR 18 36
39 59
Pretreatment is the 1 week of self-selected diet. The sums of squares (SS), F values, and probability of a 
greater F (PR > F) are found under the TYPE III or PARTIAL (right hand) side of the output, which is 
produced by the GLM procedure of SAS as follows:
1) Each observation is coded and entered with state identification, subject number, period, 
and diet. Initial self-selected diets may be treated as a 3rd period and diet.
Example 1: 17011 is group = 1, subject number = 70, period = 1 and diet = 1.
Example 2: 26722 is group = 2, subject number = 67, period = 2 and diet = 2.
2) SAS programming to follow the appropriate JCL and input.
PROC GLM;
CLASSES GROUP RACE PERIOD DIET;
MODEL Y = GROUP RACE SUBJECT (GROUP * RACE) PERIOD DIET;
Y is the variable, such as fecal copper, urinary taurine, or serum cholesterol, etc.
See a current SAS Users Guide for other options available under the GLM procedure, such as means to get 
treatment means.
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B. If residual effects are present, or to test for residual effects (that is, to test if the response to diet 
B is different following diet A from following self-selected), the analysis of variance 
(ANOVA) table would be:
1. For two periods (when US74 or the MOD diets were served; no self-selected data):
Source df.
GROUP (IA vs. NE) 1
RACE 2
SUBJECT (GROUP * RACE) 16
DIET (adjusted for residual effects) 1
RESIDUAL (adjusted for diet effects) 1
ERROR 18
39
The sums of squares (SS), F value, and probability of a greater F (PR > F) are found under 
the TYPE III or PARTIAL side of the output, which is produced by the GLM procedure of 
SAS as follows:
a) Each observation is coded with state identification, subject number, diet and 
residual (residual = 0 if period = 1; residual = -1 if period = 2 and diet = 1; 
residual = 1 if period = 2 and diet = 2) OR residual values may be assigned by 
use of IF-THEN control statements:
IF PERIOD = 2 AND DIET = 1 THEN RESIDUAL = -1;
IF PERIOD = 2 AND DIET = 2 THEN RESIDUAL = 1;
IF PERIOD = 1 THEN RESIDUAL = 0;
b) SAS programming to follow JCL and input:
PROC GLM;
CLASSES GROUP RACE DIET;
MODEL Y = GROUP RACE SUBJECT(GROUP * RACE) DIET RESIDUAL;
2. For three periods (when the diets were self-selected, US74, and MOD):
Source d L
G ROUP 1
RACE 2
SUBJECT (GROUP * RACE) 16
DIET 2
»  =Residual = X-j + X2
X2 1 J
ERROR 36
59
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To obtain this table:
«»
a»
v
k
A) Enter data as before, with each observation coded for site, student ID and diet (self-selected,
US74 or MOD) as previously and also for X ] and X2
Xj and X2 represent residual or carry-over response and are coded as:
X] = 0 and X2 = 0 if there is no prior diet (for data obtained during prediet or self-selected diet)
Xj = -1 and X2 = -1 if self-selected diet is the prior diet (for period = 1)
Xj = 0 and X2 = l if US74 diet is the prior diet (for period = 2 and diet during period 2 was the 
MOD diet)
X, = 1 and X2 = 0 if MOD diet is the prior diet (for period = 2 and diet during period 2 was 
US74)
B) SAS programming to follow JCL and input:
PROC GLM;
CLASSES GROUP RACE DIET;
MODEL Y = GROUP RACE SUBJECT (GROUP * RACE) DIET X, X2;
Note: Period and residual effects are confounded and cannot be separated. The overall residual 
effect may be found by:
1) add TYPE I SS for X] and X2 — the last 2 lines if entered as in B.
2) divide total in 1) by 2.
3) use the mean square for error to divide into the result of (2).This gives an F value 
with 2 and 36 d.f., which you may look up in a table of significance.
The rest of the ANOVA table should be completed from the TYPE III side of the output.
i1
II. Interpretation of State Effects
Preliminary results indicated some significant site differences. This does not necessarily mean that there were 
differences simply due to the site, but may reflect the differences in the groups of subjects and in the methods used in the 
blood drawing. All women in the Iowa group were Caucasian and were, in some instances, considerably larger than the 
women in the Nebraska group, which included some Asian and smaller women. Because of the differences in the 
groups, the Iowa group lost weight when first put on the experimental diet. There also were differences in the protocol 
for the mornings on which blood was drawn that may result in different laboratory results.
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III. Interpretations of Residual Effects
o
A. Residual (Xj and X2 in ANOVA tables)
Sequence 1 Self-selected US74 MOD
Sequence 2 Self-selected MOD US74
Xj asks: Is the response to US74 diet different following self-selected than from following MOD?
X2 asks: Is the response to MOD diet different following self-selected than from following US74?
The sum of these two is the residual, or carry-over, effect. A significant residual effect indicates that the response 
we measured is not only a response to the present diet but also to the previous diet.
B. Analysis of Variance (ANOVA) for sequence and sequence by diet interaction.
DIET
Sequence 1 Self-selected US74 MOD
Sequence 2 Self-selected MOD US74
X
ss
X mod XUS74 
DIET DIFFERENCES
X,seq.
Xseq. 2}
sequence
difference
«»
The ANOVA table would appear as:
Source i f .
Group 1
Race 2
Sequence 1
Group * Sequence 1
Subject w/Group * Seq 14
Diet 2
Diet * Sequence 2
Error 36
Total 59
} - equivalent to subjects w/group with 16 d.f. in residual ANOVA
11
Site, race, and diet effects are as in residual analysis. The other sources may be explained as:
Sequence _
The mean for sequence 1 (XseqA) is simply the mean of all responses for subjects in sequence 1 (similarly for 
sequence 2). No attention is paid to the various diets or any other factors within the sequence. This difference 
(or lack of difference) is not of interest because we are interested in responses to the diets themselves.
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Group * Sequence
This interaction also is not of interest. Briefly, this asks if the responses on sequence 1 at Iowa are different 
from those at Nebraska. Note that it is comparing responses to sequence (average across diets) and not re­
sponses to diets.
Subjects w/ Group * Sequence
This term accounts for individual variability—from one person to another—at the same site and on the same 
sequence. Because sequence is not of interest, this term may be combined with the two previous terms 
(sequence and group by sequence) as subjects within group with 16 d.f.
Diet * Sequence
This interaction asks the question: Is the response to the US74 diet the same in sequence 1 as in sequence 2? 
And, similarly, is the response to the MOD diet the same in sequence 1 as in sequence 2? Interestingly, these 
are the same questions asked by the residual term in the first analysis, and our computations show identical 
sums of squares for the two terms.
C. Conclusion
In summary, if the two analyses (residual vs. diet sequence analysis) are asking similar questions and giving the 
same results, does it matter which is used? Yes, it does and I will try to briefly explain.
First, our design is a modified crossover design: the periods when the US74 and MOD diets were fed is a 
crossover design. We simply added a self-selected diet period for a baseline before feeding our experimental diets. The 
analysis of variance that looks at interactions between factors is appropriate for a factorial design.
We do not have a factorial experiment (two factors, such as fat and exercise, each at two levels and applied as 
treatments). A diagram of a factorial design could be:
Factor 1 : Exercise
Factor 2: Fat Level
Low
High
low fat 
no exercise
low fat 
+ exercise
high fat 
no exercise
high fat 
+ exercise
This design gives us four distinct diets (as given in the four cells). In the human core study, we do not have four distinct 
diets because we do not have two factors (the two diets are one factor but sequence is not a second factor; it does not 
vary independent of diet). Thus, the residual effect and terminology is correct for our design.
Second, a residual, or diet carry-over, effect implies that if the length of feeding is extended, we may be able to 
measure a response to the experimental diet that is not still influenced by the previous diet (no significant residual 
effect). A diet-by-sequence interaction effect implies that the responses are a result of the sequence in which the diets 
were fed as much as a response to the diets per se. The interaction also does not imply that a time factor may be in­
volved.
So, even though residual and diet by sequence interaction are mathematically the same, the interpretations are 
different. Discussing residual effect is appropriate for our design; using interactions would be appropriate for a factorial 
design.
Summary of —  
ANOVA Results 
Obtained from 
Analysis of Data 
Collected in the 
Human Study
As we proceeded with the 
statistical analyses, the possibility that 
race differences may be responsible 
for some of the site differences was 
suggested. Indeed, when race was 
included as a source of variability 
with site, diet, and residual, some 
interesting results came out: a) for 
some variables, site differences 
remained significant, whereas race 
differences were significant for some, 
but not all; and b) for some variables, 
site differences were no longer 
significant, whereas race differences 
again were either significant or not.
In other words, for some variables, 
race differences were the underlying 
reason for seeing significant site 
differences, but for other variables, 
there is a site difference regardless of 
race. These results are summarized in 
Table 15-1 as the top of the pair of 
lines on the left half of the page.
To try to clarify the situation, 
we did additional analyses in which 
the one Iranian subject was excluded. 
These results are given as the second 
of the pair of lines on the left side of 
the page—marked no IR. In some
instances (VLDL, HDL2, etc.), the 
race differences were due to this one 
subject. When significant race 
differences remain, the difference is 
because of differences between 
Caucasian (n = 10 at IA + 4 at NE) 
and Chinese (n = 5 at NE).
Finally, we looked at only 
the Caucasian data (summarized on 
the right half of the table).
Not all of these analyses 
were possible for all the data. As you 
look through the tables, you will 
notice that some data are available 
only on the Nebraska subjects, 
whereas only Iowa data are available 
for other variables. Also, for some 
measures, data from the self-selected 
period were not included, so the diet 
comparison is between the two 
experimental diets. Nutrient intake 
variables were not included here. All 
of this is in addition to the usual 
missing data we often encounter in 
research.
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Caucasian + Chinese ± Iranian Caucasian only
60 observations possible 42  observations possible
n site race diet residual n site diet residual
B lo o d  L ip id s  P a r a m e t e r s 1
Lipoprotein Profile
TOT CHOL 60 — ** ** — 42 - — —
No IR2 57 -- ** ** --
VLDL 58 _ * _ _ 40 _ _• _
No IR 55 -- -- * --
LDL 58 _ ** * _ 40 __ __ _
No IR 55 -- ** * --
HDL2 58 * ** _ _ 40 _ _
No IR 55 * -- -- --
HDL3 58 _ * ** 40 _ __ *
NoIR 55 -- -- * **
TOT HDL 58 ** ** _ ** 40 * *
No IR 55 ** -- -- **
TOT TG 59 * _ _ 41 ** _ _
No IR 56 ** -- -- --
VLDLTG 59 ** * _ _ 41 ** _ _
No IR 56 ** -- -- --
APO A-| 58 ** ** _ 40 ** ■_ _
No IR 55 ** -- --
APO A2 58 ** ** _ _ 40 ** _
No IR 55 ** ** -- --
Triglyceride fatty acids
TG 14:0 60 — — — — 42 — — ■ — .
No IR 57 -- -- -- --
TG 14:1 60 all values were zero _ _ 42 __
No IR 57 - -- -- --
TG 16:0 60 — _ _ _ 42 _ ..
No IR 57 - -- -- --
TG 16:1 60 - _ _ _ 42 _ _
No IR 57 - -- -- --
TG 18:0 60 - * _ 42 „ **
No IR 57 - * * * - -
TG 18:1 60 ~ _ * * _ 42 „ * *
No IR 57 — - - * * - -
1 - p > 0.05
* p < 0.05
** p < 0.01
2One Iranian subject excluded
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(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ± Iranian 
60 observations possible
Caucasian only 
42 observations possible
n site race diet residual n site diet residual
Blood Lipid Parameters1
(Triglyceride fatty acids cont.)
TG 18:2 60 — — * - 42 - - -
No IR2 57 -- -- * --
TG 20:3 60 _ _ __ __ 42 __ __ __
No IR 57 -- -- -- --
TG 20:4 60 _ _ ** * 42 __ __
No IR 57 -- -- ** *
Free fatty acids
FFA 14:0 60 ** - - - 42 * ~ -
No IR 57 ** -- -- --
FFA14:1 60 _ _ __ __ 42 * __ —
No IR 57 -- -- -- --
FFA16:0 60 * __ __ __ 42 * — —
No IR 57 * -- -- --
FFA16:1 60 __ __ __ __ 42 — — —
No IR 57 -- -- -- --
FFA18:0 60 _ __ __ * 42 — — _
No IR 57 -- -- -- *
FFA 18:1 60 _ _ ** __ 42 __ ** —
No IR 57 -- -- ** --
FFA 18:2 60 * _ * __ 42 — * —
No IR 57 -- * --
FFA 20:3 60 _ _ __ __ 42 __ — —
No IR 57 -- -- -- --
FFA 20:4 60 _ _ __ __ 42 — — —
No IR 57 -- -- -- --
Platelet fatty acids
PLAT 14:0 56 - - - - 38 -- - --
No IR 53 -- -- -- *
PLAT 14:1 56 __ __ __ __ 38 * — -
No IR 53 -- -- -- --
PLAT 16:0 56 _ __ __ * 38 — — -
No IR 53 -- -- *
PLAT 16:1 56 _ __ _ * 38 .. — -
No IR 53 * -- -- --
PLAT 18:0 56 _ _ __ __ 38 — — -
No IR 53 - - - -
1 - p > 0.05 
* p < 0.05
**p<0.01
2One Iranian subject excluded
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(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ± Iranian Caucasian only
60 observations possible 42 observations possible
n site race diet residual n site diet residual
Blood Lipid Parameters1
(Platelet fatty acids cont.)
PLAT 18:1 56 * — . . 38 ** — —
No IR2 53 ** * -- --
PLAT 18:2 56 _ * _ _ 38 _ _ *
No IR 53 -- -- -- --
PLAT 20:3 56 . . „ _ „ 38 _ „ „
No IR 53 -- -- -- --
PLAT 20:4 56 _ 38 „ „
No IR 53 -- -- -- --
Red blood cell fatty acids
RBC 14:0 50 — — — — 32 — — —
No IR 47 -- -- -- --
RBC 14:1 50 ** .. „ 32
No IR 47 ** -- -- --
RBC 16:0 50 _ _ _ 1 32 „ __ ..
No IR 47 -- -- -- --
RBC 16:1 50 32
No IR 47 -- -- -- --
RBC 18:0 50 __ __ „ 32
No IR 47 -- -- -- --
RBC 18:1 50 | .. 32 *
No IR 47 -- -- -- *
RBC 18:2 50 _ .. .. - 32
No IR 47 -- -- -- --
RBC 20:3 50 _ .. * 32
No IR 47 -- -- -- --
RBC 20:4 50 _ .. „ 32
No IR 47 — -- -- --
Red blood cell phospholipid fatty acids
RBCPL 16:0 29 IA CA ** - 29 ** ** —
only only
RBCPL 18:0 29 IA CA ** „ 29 ** _
only only
RBCPL 18:1 29 IA CA * ** 29 * * **
only only
RBCPL 18:2 29 IA - CA * __ 29 * * __
only only
1 - p > 0.05
* p < 0.05
**p<0 .01
2One Iranian subject excluded
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(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ± Iranian 
60 observations possible
Caucasian only 
42 observations possible
n site race diet residual n site diet residual
Blood Lipid Parameters1
(Red blood cell phospholipid 
RBCPL 20:3
fatty acids cont.)
29 IA CA 
only only
-- 29 IA
only
-- --
RBCPL 20:4 29 IA
only
CA
only
-- 29 IA
only
-- --
RBCPL 20:5 29 IA
only
CA
only
** 29 IA
only
-- **
RBCPL 22:4 29 IA
only
CA
only
-- 29 IA
only
-- --
RBCPL 22:6 29 IA
only
CA
only
-- 29 IA
only
-- -
RBCPL 24:1 29 IA
only
CA
only
* 29 IA
only
* *
Thromboxane synthesis 
Serum 
NoIR2
60
57
**
*
-- 42 * -- --
Whole blood Unchallenged 30 IA
only
CA
only
** 30 IA
only
*★ **
5mM Ca + Collagen 30 IA
only
CA
only
** 30 IA
only
**
”
5mM Ca + Thrombin 30 IA
only
CA
only
* 30 IA
only
-- *
10mM Ca + Collagen 30 IA
only
CA
only
** 30 IA
only
--
”
10mM Ca + Thrombin 30 IA
only
CA
only
-- 30 IA
only
-- --
Fecal Lipid Parameters
Fecal steroid excretion
Coprostonol 58 - - - * -- 42 -- *
No IR 57 -- -- * --
Cholesterol/Cholestanol 60 ** _ 42 ** -
No IR 57 ** - -- -
Coprostanone 60 ** — — - 42 ** -
No IR 57 **' - - —
Total Neutral steroids/g 60 * * ** _ 42 * **
No IR 57 * * ** *
Lithocolic/d 60 * __ — — 42 * -
No IR 57 * - -- -
Deoxycholic/d 60 ** — — — 42 * -
No IR 57 ** - - --
1 - p > 0.05 
* p < 0.05
** p < 0.01
2One Iranian subject excluded74
(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ± Iranian 
60 observations possible
Caucasian only 
42 observations possible
n site race diet residual n site diet residual
Fecal Lipid Parameters1
(Fecal steroid excretion cont.)
Chenodeoxycholic/d 60 - * - -- 42 -- - *
No IR2 57 -- -- * *
Cholic/d 60 — — * — 42 — — --
No IR 57 -- - --
U rsodeoxychol ic/d 60 — — — — 42 - - -
No IR 57 -- -- - -
Alphamuricholic/d 60 — * — — 42 - — -
No IR 57 -- - -
Omegamuricholic/d 60 — * — — 42 - — -
No IR 57 -- * -- -
Betamuricholic/d 60 __ * — — 42 * — —
No IR 57 -- -- -- --
Total bile acids/g 60 ** * ** * 42 § * *
No IR 57 *★ ** **
Total bile acids/day 60 * — ~ — 42 * * —
No IR 57 -- - --
Total neutral steroid/day 60 ** — * 42 ** * --
No IR 57 ** -
Total steroid excretion/g 60 ** * * — 42 — —
No IR 57
Total steroids/day 60 ** — — — 42 ** -- —
No IR 57 .** -- - --
Urinary Prostaglandins
p g i2 60 - - ** * 42 - **
No IR 57 -- ■ - ** *
PG Ei 60 — __ 42 „ ** **
No IR 57 -- -- ** -- •
PG E2 60 ** — __ — 42 ** — --
No IR 57 ** -- -- --
t x b 2 60 * * — -- 42 — __
No IR 57 * -- -- --
PG P2(x 60 — ** . * 42 — ** **
No IR 57 -- *★ ** *
PG metF2a 60 — — ** ** 42 — **
No IR 57 - - ** **
1 - p > 0.05 
* p < 0.05
** p < 0.01
2One Iranian subject excluded
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( T a b l e  1 5 - 1 .  c o n t . )
Caucasian + Chinese ± Iranian Caucasian only
60 observations possible 42 observations possible
n site race diet residual n site diet residual
Urinary Prostaglandins1
Urinary Na 60 *
NoIR2 57 *
42 -
Blood Analyses by SMAC and CBC
GLUCOSE 56 - - * - 38 - ** -
No IR 53 -- -- * --
BUN 56 ** — — — 38 * . — —
No IR 53 * -- -- --
CREAT 56 ** — — — 38 * — —
No IR 53 ** -- - --
SODIUM 56 — — — — 38 — ~ —
No IR 53 -- -- - --
POTASSIUM 56 * — — — 38 * — —
No IR 53 * -- - --
CHLORIDE 56 * — — — 42 * — —
No IR 53 * -- -- --
TG 60 — — — — 42 — -1 —
No IR 57 -- -- -- --
CHOLESTEROL 60 — ** _ — 12 * — -
No IR 57 -- ** -- --
HDL 30 NE ** __ ** 38 NE — —
No IR 27 only ** -- ** only
URIC 56 ** ** — 38 ** — -
No IR 53 ** ** ** --
CALCIUM 56 ** * — — 38 * - -
No IR 53 ** -- -- -
PHOSP 56 — — — — 38 — - -
No IR 53 -- -- -- --
TPROT 56 — * — — 38 — - -
No IR 53 -- ** -- --
ALBUMIN 56 ** — — — 38 ** - -
No IR 53 ** -- -- --
BILIT 56 * — * — 38 * ** -
No IR 53 * -- -- --
ALKPHOS 56 ** ** — — 38 ** * -
No IR 53 ** * - -
1 - p > 0.05 
* p < 0.05
** p < 0.01
2One Iranian subject excluded
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y(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ± Iranian 
60 observations possible
Caucasian only 
42 observations possible
n site race diet residual n site diet residual
Blood Analysis by SMAC and CBC1
SGOT 55 ** .. — 37 * — —
No IR2 52 -- --
SGPT 55 * __ — 37 * — —
No IR 52 * -- --
LDH 55 :** __ __ 37 ** — —
No IR 52 ** -- --
IRON 56 * * 38 * * —
No IR 53 * *  * --
BILI DIR 56 __ * — 38 __ — __
No IR 53 -- * --
BILI IND 56 __ — __ 38 __ ** __
No IR 53 -- -- --
GLOBULIN 56 __ ** __ 38 _ __ __
No IR 53 -- ** --
AG RATIO 56 ** __ 38 ** __ __
No IR 53 ** ** --
BUN CR R 56 __ __ __ 38 __ _ _
No IR 53 -- - --
CA ION 56 __ ** __ 38 _ _ _
No IR 53 - ** --
CL PR 56 __ __ __ 38 _ _ _
No IR 53 -- -- -
WBC 60 B *  ** _ 42 ** ** _
No IR 57 ** --
RBC 40 ** ** _ 22 * _ __
No IR 37 ** **
HEMO 30 IA CA __ 30 IA ** _
only only only
SEGNEUT 30 IA CA __ 30 IA * _
only only only
LYMPH 30 IA CA — 30 IA ** _
only only only
MONO 30 IA CA — 30 IA ** _
only only only
EOS 30 IA CA __ 30 IA _ _
only only only
BASO 30 IA CA __ 30 IA ** _
only only only
1 - p > 0.05 
* p < 0.05
** p < 0.01
2One Iranian subject excluded
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(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ± Iranian Caucasian only
60 observations possible 42 observations possible
n site race diet residual n site diet residual
Blood Analysis by SMAC and CBC1
Beta lipoprotein 30 IA CA .. 30 IA —
only only only
pre-Beta lipoprotein 30 IA CA .. 30 IA __
only only only
Alpha lipoprotein 30 IA CA .. 30 IA —
only only only
FE MAN 30 NE ** — 12 NE *
No IR2 27 only * -- only
FE BIND 30 NE — .. 12 NE __
No IR 27 only - -- only
HGB 30 NE — 12 NE __
No IR 27 only ** - only
HCT 30 NE ** __ 12 NE
No IR 27 only *★ -- only
MCV 30 NE ** — 12 NE
No IR 27 only - -- only
MCH 30 NE ** ** 28 NE
No IR 27 only ** ** * only
MCHC 30 NE — -- 28 NE --
No IR 27 only - * only
Mineral Excretion
FECAL NA 40 ** - no3- 28 ** -
No IR 38 ** -- S S - -
FECAL K 40 __ __ no* 28 __ __
No IR 38 -- - SS*
URINARY Na 40 incomplete set; see urinary NA with PG data above
URINARY K 40 ** no - 28 * „
No IR 38 * - S S - -
FECAL Mg 40 * no - 28 __ —
No IR 38 * S S - -
FECAL Mn 40 — — no - 28 __ —
No IR 38 - - S S - -
URINARY Mg 26 — — no- 28 — —
No IR 24 - - S S - -
UIRINARY Mn 26 ** __ no - 28 ** —
No IR 24 ** S S - -
3Data not available for Self-selected (SS) diet; comparison is for US74 vs Modified diets.
(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ± Iranian 
60 observations possible
Caucasian only 
42 observations possible
n site race diet residual n site diet residual
Hormone Levels1
Blood:
T3 60 - ** - ** 42 - - **
No IR2 57 - — --
T4 60 * ** — ** 42 __ __ __
No IR 57 -
PROLACTIN 60 ** ** — ** 42 ** — —
No IR 57 -- *
Urine:
NOREPI FREE 40 ** - no3— - 28 ** - -
No IR 38 ** — S S - -
NOREPI TOTAL 40 ** — no - — 28 ** * __
No IR 38 ** -- S S - -
NOREPI %FREE 40 — no3— — 28 ** * __
No IR 38 ** - S S - -
EPI Free 40 — ** no - — 28 __ __ __
No IR 38 -- - S S - -
EPI TOTAL 40 * ** no** __ 28 _ * _
No IR 38 * - SS** -
EPI % FREE 40 — — n o - — 28 __ _ _
No IR 38 -- ' - S S - -
DOPA FREE 40 ** no - 28 * _ _
No IR 38 -- S S -
DOPA TOTAL 40 — — no* — jj 28 __ ** _
No IR 38 - SS** -
DOPA % Free 40 — — no - — 28 * * _
No IR 38 - - S S - -
Miscellaneous Measurements
Plasma:
TBARS 50 - - - - 38 - — ■ ..
No IR 48 - - - “
FERRITIN 59 ** ** ** ** 42 ** *
No IR 56 ** ** **
CARNI FR 57 — — — * 40 - _ ..
No IR 54 — -  : " -
CARNI T 56 — — — * 39 - „ *
No IR 53 - " “ *
- p > 0.05
* p < 0.05
** p < 0.01
2One Iranian subject excluded
3 Data not available for Self-selected (SS) diet; comparison is for US74 vs Modified diets.
(Ta b le  15-1.  c o n t.)
Caucasian + Chinese ±  Iranian Caucasian only
60 observations possible 42 observations possible
n site race diet residual n site diet residual
M iscellaneous Measurem ents1
V IT A 60 ** - - 42 ** * -
No IR2 57 ** -- -
V IT  E 60 — — * — ■ 42 — —
No IR 57 — - -
Urine:
TAURINE 60 — ** * — 42 — — —
No IR 57 -- ** * -
CREATIN INE 60 ** * — — 42 ** * **
No IR 57 ** ** -
Feces:
FEC DRY W T 60 - -- -- ~ 42 -- ~ -
No IR 57 — — — --
FEC W ET W T 30 NE — — — 12 NE * —
No IR 27 only — — — only
FECAL ENERG Y 40 - * no** — 28 — ** —
No IR 38 — -- SS** --
Blood Pressure:
SYSTOLIC 30 IA CA — ** 30 IA — **
only only only
DIASTOLIC 30 IA CA — — 30 IA — —
only only only
1 - p > 0.05  
* p < 0.05
** p < 0.01
2 One Iranian subject excluded
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Dietary Fat and--------
Cholesterol Effects on 
Cholesterol Metab­
olism In CBA/J and 
C57BR/cdJ Mice1
Abstract
The aim of this study was to 
determine how small differences in 
dietary fats affect cholesterol metabo­
lism in mice hypo- (CBA/J) and 
hyperresponsive (C57BR/cdJ) to diet- 
induced hypercholesterolemia. Six- 
wk-old male mice were fed either a 
diet corresponding to the U.S. average 
gross composition (US74, 40 en % as 
fat, 347 mg cholesterol/1000 Kcal, P/ 
S = 0.24) or a modified-fat diet (30 en 
% as fat, 46 mg cholesterol/1000 
Kcal, P/S = 0.91). After 8 wk of 
feeding, neither strain had developed 
hypercholesterolemia. CBA/J mice 
had higher concentrations of serum 
total and high-density lipoprotein 
(HDL) cholesterol and a higher 
esterified-to-free ratio than did 
C57BR/cdJ mice. CBA/J mice 
maintained a constant serum choles­
terol concentration mainly by 
adjusting the hepatic hydroxy - 
methylglutaryl coenzyme A reductase 
(HMGR) activity, whereas C57BR/ 
cdJ mice did so by changing the fecal 
excretion of cholesterol. Compared to 
the modified-fat diet, the US74 diet 
caused an increase in the ratio of total 
to HDL serum cholesterol, liver 
microsomal free cholesterol, fecal 
cholesterol and hepatic microsomal 
cholesterol 7a-hydroxylase activity 
and a decrease in hepatic microsomal 
HMGR activity. We conclude that 
the metabolic responses to small
differences in dietary fat are different 
in CBA/J and C57BR/cdJ mice.
Introduction
There is a wide variation 
among individuals in response to 
dietary fat and cholesterol (1). Some 
individuals are especially susceptible 
(hyperresponders) to diet-induced 
(high cholesterol, high saturated fat) 
hypercholesterolemia while some are 
particularly resistant 
(hyporesponders) (2). Although this 
phenomenon has been known for 
some time, the underlying mecha­
nisms are still unknown, probably 
because of the limitations of research 
with human subjects. The Dietary 
Goals for the United States (3) 
suggest reducing average dietary fat 
to 30% of total energy, reducing 
cholesterol to 300 mg per day, and 
increasing the polyunsaturated to 
saturated fatty acid ratio (P/S) to 1.0. 
How this change would affect 
metabolism and how metabolism 
differs between hyper- and 
hyporesponders is not known. An 
appropriate animal model can be used 
to determine specific biochemical 
events.
Roberts and Thompson (4) 
screened 13 strains of inbred mice by 
feeding them an extremely high fat 
and cholesterol diet (30 wt% cocoa
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butter, 5 wt% cholesterol). They 
found that the C57BR/cdJ strain was 
very susceptible to and that the CBA/J 
strain was resistant to dietary choles­
terol and saturated fat-induced 
hypercholesterolemia and atheroscle­
rosis. Walker (5) confirmed their 
results. Mulvihill and Walker (6) 
further characterized C57BR/cdJ mice 
and found that the serum cholesterol 
concentration was inversely related to 
the dietary P/S ratio. These phenom­
ena are similar to those that occur in 
humans (2). The C57BR/cdJ and 
CBA/J strains of mice, therefore, may 
be good animal models to study
cholesterol metabolism as related to 
genetic differences in response to 
dietary fat manipulation. In this 
study, the effects of dietary fat and 
cholesterol on cholesterol metabolism 
in C57BR/cdJ and CBA/J mice were 
investigated. A diet high in total fat 
and cholesterol with a low P/S ratio 
like the average American diet in 
1974 [(7) 40 % of total energy from 
fat, 600 mg cholesterol/2000 Kcal, P/ 
S ratio of 0.3] and one moderate in 
total fat and cholesterol with a high P/ 
S ratio as suggested by the U. S. 
Dietary Goals [(3) 30 % of energy
Compositions of US74 
and modifled-fat diets.
US74___________  modified_________
Ingredient_______________________wt% energy%_______ wt% energy%
high-nitrogen casein 1 19.2 16.7 18.0 16.7
DL-methioninei 0.32 0.3
AIN76 mineral mixture2 5.3 5.0
AIN76 vitamin mixture2 1.11 1.0
choline chloride1 0.21 0.2
beef tallow3 17.3 33.7 7.2 15.0
corn oil4 3.5 6.9 7.3 15.2
sucrose5 23.4 20.4 27.0 25.0
corn starch 5 21.3 18.5 25.0 23.1
dextrin2 4.5 3.9 5.5 5.1
cellulose 1 3.7 3.48
cholesterol3 0.14 0.012
L-ascorbic acid2 0.01 0.01
Kcal/ g diet 4.6 4.32
fat (%Kcal) 40.6 30.2
cholesterol (mg/1,000 Kcal) 347 46
P/S ratio 0.24 0.91
1 Purchased from United States Biochemical, Cleveland, OH.
2Purchased from ICN Biochemicals, Cleveland,| OH. Ingredients in mixes are as
described in J. Nutr. 107:1340-1348.
3 Purchased from the Meat Laboratory, Iowa State University, Ames, I A. 
4Mazola, Englewood Cliffs, NJ.
5ISU Food Service (Argo corn starch, Crystal sugar).
6Purchased from Sigma Chemical, St. Louis, MO.
from fat, < 300 mg cholesterol/2000 
Kcal, P/S ratio of 1 were compared.
Materials and Methods
Experimental design
C57BR/cdJ mice (suscep­
tible to diet-induced atherosclerosis) 
and CBA/J mice (resistant) were 
purchased from the Jackson Labora­
tory (Bar Harbor, ME) and bred in the 
Animal Care Facility of the Food and 
Nutrition Department, Iowa State 
University. The breeders and the 
postweaning offspring were fed a 
nonpurified diet (Purina Breeder 
Chow, St. Louis, MO). At 6 wk of 
age, male mice were caged singly in a 
room with a reversed light cycle 
(light: 1700-0500 h; dark: 0500- 
1700 h) and fed either the US74 or the 
modified-fat diet (Table 16-1). There 
were eight mice in each treatment 
group. The two experimental diets 
had the same amount of protein, 
vitamins and minerals on an energy 
basis. They varied in fat and carbohy­
drate composition (8). The dietary fat 
composition was calculated using the 
USDA Agriculture Handbook No. 8-4 
(9) and was similar in energy to that 
of a human study done in our depart­
ment (10,11). The US74 diet had a 
fat content and composition similar to 
that of the average American diet in 
1974 in accordance with the HANES 
I survey (7) whereas the modified-fat 
diet was designed to meet the Dietary 
Goals for the United States (3). The 
feeding lasted for 8 wk. Feces 
excreted during the last 3 d of the 
dietary treatments were collected and 
frozen for later analysis of neutral 
sterols. Food consumption was also 
determined during the last 3 d.
Diet analyses
The experimental diets were 
analyzed for fatty acid and neutral
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sterol composition. Lipids were 
extracted with chloroform/methanol 
(2:1, v/v) and saponified in 10% 
ethanolic KOH at 60°C for 1 h. 
Neutral sterols were extracted with 
petroleum ether, silylated with Sil- 
prep (Alltech-Applied Science, 
Newark, DE), and analyzed using a 
gas chromatograph equipped with a 
flame ionization detector and a 2.4 m 
x 31.2 mm OD, 2 mm ID glass 
column packed with 5% OV210, 80- 
100 mesh (Beckman, Palo Alto, CA). 
Instrument settings were: column 
temperature 220°C, detector tempera­
ture 250°C, inlet temperature 260°C, 
detector line temperature 270°C, and 
nitrogen flow 20 ml/min. 
Trimethylsilyl (TMS) derivatives of 
neutral sterols were identified by 
comparison of retention times with 
those of silylated standards. 
Quantitation was done by comparison 
with an internal standard, 5 a- 
cholestane.
The ethanolic fraction was 
acidified to pH < 5 with 6 N HC1, and 
fatty acids were extracted with 
petroleum ether and methylated with 
borontrifluoride/methanol (Alltech- 
Applied Science). The methylated 
fatty acids were extracted with hexane 
and separated using a Beckman gas 
chromatograph equipped with a flame 
ionization detector and a 1.8m x 31.2 
mm stainless-steel column packed 
with Altex Chrom WAW 10% CS10, 
100-120 mesh (Anspec, Ann Arbor, 
MI). Instrument settings were: 
column temperature 180°C, detector 
temperature 250°C, inlet temperature 
220°C, detector line temperature 
250°C, and nitrogen flow 20 ml/min. 
Fatty acid methyl esters were identi­
fied by comparison of retention times 
with those of known methylated 
standards.
Tissue preparation
At the end of the feeding 
period, fed mice were anesthetized 
with ether and killed by decapitation 
at 1000-1100 h. Blood was collected 
and allowed to clot at room tempera­
ture. Serum was prepared by centri­
fuging the blood at 2,000 x g for 10 
min (Beckman Model J-6B cen­
trifuge) and stored at -80°C until 
analysis. Livers were excised, and 
microsomes were prepared (12). 
Liver microsomes were stored at - 
80°C until analysis.
Serum. Very-low-density 
lipoprotein (VLDL) and low-density 
lipoprotein (LDL) were precipitated 
with sodium phosphotungstate and 
magnesium chloride (13) by using a 
kit from Sigma Chemical Co. (St. 
Louis, MO). The enzymatic method
of Allain et al. (14) was used to 
determine the total, free, and high- 
density lipoprotein (HDL) -choles­
terol in serum.
Liver. The activities of 
hydroxymethylglutaryl coenzyme A 
reductase (HMGR) and cholesterol 
7a-hydroxylase (COH) in liver 
microsomes were determined by 
using methods described by 
Nordstrom, Rodwell and Mitschelen
(15) and Dodd, Sizer and Dupont
(16) , respectively. The HMGR 
activity was measured in the absence 
of sodium fluoride and phosphatase. 
The Lowry method (17) as modified 
by Peterson (18) was used to deter­
mine the protein content of the 
microsomes. Liver microsomal lipid 
was extracted with chloroform/ 
methanol (2:1, v/v) and washed with 
0.05 M NaCl and 0.36 M CaCl2/ 
methanol (1:1, v/v). The enzymatic 
method (14) as modified by Carlson 
and Goldfarb (19) was used to
fattv acid 1
diet fat source
US74 modified corn oil beef tallow
14:0 2.7 1.6 0.1 3.3
15:0 0.7 0.4 trace 0.8
16:0 23.5 18.7 11.0 29.8
18:0 28.9 15.3 1.2 12.7
18:1(n-9) 30.6 31.4 26.9 52.8
18:2(n-6) 13.0 31.9 58.9 0.2
18:3(n-3) 0.6 0.7 1.9 0.4
neutral sterol up/p
cholesterol dihydrocholesterol 1600 200 27 736
ergosterol 52 123 1970 -
ß-sitosterol 270 480 5550 155
Number of carbons: number of double bonds, location of terminal double bond.
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determine the total and free choles­
terol in liver microsomes.
Feces. Dried feces were 
ground in a mortar. An aliquot was 
extracted twice with 0.5 N  HC1 in 
absolute ethanol by incubation at 
37°C for 1 h (20). The fecal extract 
was then saponified in 10% KOH in 
ethanol at 60°C for 1 h. Neutral 
sterols were extracted with petroleum 
ether, silylated with Sil-prep, and 
analyzed by gas chromatography 
(GC). The GC conditions were the 
same as those used for analyzing 
dietary neutral sterols.
Statistical analyses. The 
mean and standard deviation of each 
parameter measured were calculated 
for each treatment group. The SAS 
(Statistical Analysis System) com­
puter program for analysis of variance 
was used to test the diet effect, the 
strain effect, and the diet by strain 
interaction. When there was signifi­
cant diet by strain interaction, post- 
hoc simple effect comparisons were 
done to analyze the interaction. 
Pearson correlation coefficients 
between parameters were calculated.
Results
The results of diet analyses 
are shown in Table 16-2. The US74 
diet had a saturated:monoun- 
saturatedrpolyunsaturated fatty acid 
ratio of 1.0:0.55:0.24 as opposed to 
the calculated 1.0:0.9:0.31, and the 
modified-fat diet had a ratio of 
1.0:0.87:0.91 as opposed to the 
calculated 1.0:1.05:1.0. The discrep­
ancies between the calculated and the 
analyzed fatty acid composition were 
due to the different fatty acid compo­
sitions of com oil and beef tallow that 
was used compared with the values in 
USDA Agriculture Handbook No. 8-4 
(9) and to other dietary ingredients
H M
111— Body and liver weights, and food intake 
of two strains o f mice fed diets with 
different fat compositions.1
body liver food intake2
Strain diet weight2 (g) weight 3(g) (g/day)
CBA US74 45.8 ±2.2 2.72 ± 0.53 3.501 0.34
CBA modified 43.8 ± 3.2 1.86 ±0.31 3.321 0.06
C57BR US74 39.1 ±4.2 1.62 ± 0.24 2.69 ±0.14
C57BR modified 37.613.8 1.35 ±0.17 2.43 ±0.19
1 Values are means ± SD, n = 8/group.
2 Significant strain effect (P < 0.01).
3 Significant strain effect (P < 0.01), diet effect (P < 0.01), and strain x diet interaction 
(P < 0.05). Within CBA, US74 > modified (P < 0.01); within C57BR, US74 > modified 
(P < 0.05). With US74 diet, CBA> C57BR (P < 0.01); with modified diet, CBA> 
C57BR (P<0.01).
EÜH3H Serum cholesterol of two strains of mice fed diets with different fat compositions.1
serum cholesterol pg/g ratio pg/g
Strain diet total2 free HDL^ EC/free2 total/HDL3
CBA US74 
CBA modified 
C57BR US74 
C57BR modified
157 ±17  26.3 ±7.7 132 ±10  
152 ±13  25.1 ±3.2 143 ±15 
140 ± 19 28.6 ± 5.0 118 ± 18 
135 ±14  27.0 ±4 .0  117 ±10
5.2 ±0.9
5.1 ±0.7
4.1 ±0.7
4.2 ±0.4
1.20 ±0.14 
1.07 ± 0.06 
1.19 ±0.06 
1.15 ±0.05
1 Values are means ± SD, n = 8/group. 
2Significant strain effect (P < 0.01).
3Significant diet effect (P < 0.05).
that might contain some fat that was 
not included in the calculation. The 
analyzed cholesterol values, however, 
were the same as the calculated 
values. The US74 diet had 347 mg, 
and the modified-fat diet had 46 mg 
cholesterol per 1000 Kcal. The 
modified-fat diet was higher in 
phytosterol content because of its 
natural occurrence in com oil.
The body and liver weights 
and food intakes of CBA/J and 
C57BR/cdJ mice are summarized in 
Table 16-3. CBA/J mice were 
heavier, had bigger livers, and ate 
more than did C57BR/cdJ mice.
Mice fed the modified diet had 
smaller livers than did those fed US74 
diet.
Neither US74 nor modified 
fat diet induced hypercholesterolemia 
in either strain. C57BR/cdJ mice had 
less semm total and HDL cholesterol, 
and a lower esterified (EC) to free 
cholesterol ratio than did CBA/J mice 
(Table 16-4). Mice fed the modified 
diet had a lower total to HDL semm 
cholesterol ratio than those fed US74 
diet.
The activities of HMGR 
(Table 16-5) and COH were deter­
mined in liver microsomes. C57BR/ 
cdJ mice had less cholesterol synthe­
sis but greater cholesterol degradative 
activities than did CBA/J mice, as 
reflected by lower HMGR activity 
and greater COH activity. Compared 
with mice fed modified diet, those fed 
US 74 diet had lower HMGR activity 
but higher COH activity as an 
adapatation to the cholesterol content 
of the diet. CBA/J mice showed a 
tenfold response to diet while C57BR/ 
cdJ mice only had a twofold response 
in terms of HMGR activity.
As shown in Table 16-6, the 
US74 diet induced an accumulation of 
total and free cholesterol in liver 
microsomes. Correlation analysis 
using pooled data showed a negative 
correlation between HMGR activity 
and total cholesterol in liver micro­
somes (r = -0.63, P < 0.01) but when 
data within a treatment were used no 
significant correlations were found.
No significant correlations between 
COH activity and cholesterol concen­
tration in liver microsomes or serum 
were found.
The US74 diet caused 
greater fecal cholesterol excretion 
than did the modified-fat diet (Table 
16-7). C57BR/cdJ mice showed an 
especially enhanced response. Mice 
fed the modified diet excreted more 
ergosterol and b-sitosterol than those 
fed the US74 diet because of the high 
phytosterol content of the modified- 
fat diet.
Discussion
Diets of different fat contents 
can be made isoenergetic by modify­
ing the content of fiber. It is known 
that fiber can affect cholesterol 
metabolism (8,21-23). Adolf (24) and 
Dupont (25) have reported that rats 
are able to adjust their energy intakes 
in relation to the energy density of the 
diet. The experimental diets used in 
this study were formulated to be 
identical in proteins, vitamins, and 
minerals rather than isogenergetic in 
order to eliminate the effect of fiber. 
The mice had no significant differ­
ences in consumption of the two diets.
Mice were killed in their 
mid-dark cycle without fasting in 
order to maximize the differences in 
hepatic microsomal HMGR activities 
between groups. Dupont et al. (8) had 
shown that hepatic microsomal 
HMGR activity in mice showed 
diurnal variations and was higher in 
the mid-dark cycle than in the mid­
light cycle. The postprandial state of 
the mice, however, would not affect 
serum cholesterol levels. Paigen et al. 
(26) reported that mice tested with 
and without fasting showed no 
difference in mean cholesterol levels 
(152 ± 10 unfasted vs. 154 ± 16 mg/dl 
fasted).
Roberts and Thompson 
(4,27) reported that the C57BR/cdJ
mouse was susceptible and the CBA/J 
mouse was resistant to an atherogenic 
diet-induced (30 wt% cocoa butter, 5 
wt% cholesterol, and 30 wt% protein 
from casein) hypercholesterolemia 
and atheromatous lesions. Morrisett 
et al. (28) reported similar results. In 
contrast to the extremely high fat, 
high saturated fat, and high choles­
terol diets used in the above studies, 
the present study used more moder­
ate-fat diets which are comparable to 
human diets. They had 15-20 wt% 
beef tallow and com oil, 0.01-0.14 
wt% cholesterol, and 18-19 wt% 
casein. We found that the C57BR/cdJ 
mouse had less serum cholesterol than 
did the CBA/J mouse, and there was 
no significant diet effect on serum
W E fW H ñ m  
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Liver microsomal hydroxymethyl- 
glutaryl CoA reductase activity (HMGR) 
and cholesterol a~hydoxylase activity 
(COH) In two strains of mice fed diets 
« with different fat compositions. 1
Strain
HMGR2
nmol mevalonate
formed/30 min COH3 
per mg %conversion/ (0.7 mg 
Diet protein per liver protein •40 min)
CBA US74 0.38 ± 0.08 12.0 ±2.7 1.55 ±0.24
CBA modified 3.24 ± 1.04 57.7 ±23.3 1.13 ± 0.22
C57BR US74 0.19 + 0.03 3.2 ±0.5 1.74 ± 0.36
C57BR modified 0.35 ±0.13 5.2 ±2.1 1.50 ±0.37
1 Values are means ± SD, n = 8/group.
2 Significant strain effect (P < 0.01), diet effect (P < 0.01), and strain x diet 
interaction (P < 0.01). Within CBA, modified > US74 (P < 0.01); within 
C57BR, modified > US74 (P < 0.01). With US74 diet, CBA > C57BR (P < 
0.01); with modified diet, CBA> C57BR (P < 0.01).
3Significant strain effect (P < 0.05) and diet effect (P < 0.01).
86
cholesterol. Therefore, mice 
hyperresponsive to a diet that is 
extremely high in fat and cholesterol 
may not be hyperresponsive to a 
moderate-fat diet in terms of serum 
cholesterol level. Furthermore, cocoa 
butter, as used in the studies of 
Roberts and Thompson (4, 27), has a 
very different fatty acid composition 
from that of beef tallow and com oil. 
Therefore, it is likely that cocoa butter 
exerts a different effect from beef
tallow and com oil. The reported 
diets (4, 27) are also deficient in 
essential fatty acids.
Aubert et al. (29) reported 
that CBA/JOrl mice fed a 
hypercholesterolemic diet containing 
11 wt% coconut oil and 1 wt% 
cholesterol from 5-9 wk of age 
became hypercholesterolemic, 
whereas Paigen et al. (26) reported 
opposite results. However, Walker 
(5) demonstrated that the C57BR/cdJ
mouse was more responsive to diet- 
induced (10 wt% fat as lard, olive- 
sunflower oil, or hydrogenated 
soybean-sunflower oil) elevation of 
plasma cholesterol than was the CBA/ 
J mouse. The different results 
obtained by others and in our study 
may be due to differences in diet 
composition, cholesterol content and 
fat sources. In addition, mouse age 
and treatment period are other 
possible factors. In the present study, 
6-wk-old mice were used, compared 
with 16- to 18-wk-old mice in 
Walker’s study, and our treatment 
period lasted 8 wk instead of 11 wk. 
Studies with rats hyper- and hypo- 
responsive to diet-induced (1.5 wt% 
cholesterol, 0.5 wt% sodium cholate) 
hypercholesterolemia (30) showed 
that the genetic defects in 
hyperresponders were masked when 
they were young but were revealed in 
the aging process. Whether the 
C57BR/cdJ mouse shows a similar 
aging effect on cholesterol metabo­
lism is not known. Future research 
shall investigate the changes in 
cholesterol metabolism during the 
aging process.
Consistent with the report of 
Breckenridge, Roberts and Kuksis 
(31), most of the plasma total choles­
terol in both strains of mice in this 
study was in the HDL fraction. The 
modified-fat diet caused a signifi­
cantly lower total to HDL cholesterol 
ratio than did the US74 diet. This 
result is consistent with Mulvihill and 
Walker’s finding (6) that the ratio of 
serum total to HDL cholesterol 
decreased with increasing P/S ratio in 
the diet.
In this experiment, C57BR/ 
cdJ mice maintained constant serum 
cholesterol concentration as well as 
the CBA/J mice although the mecha-
Liver microsomal total (TC) ani 
free cholesterol (FC) in two str 
of mice fed diets 
compositions
Ml
Strain diet TC2(pg/g liver) FC3(pg/g liver)
CBA
CBA
C57BR
C57BR
US74
modified
US74
modified
303 ± 26 
188 ±20 
285 ± 51 
244 ± 48
249 ± 37 
171 ± 16 
234 ± 50 
189 + 36
1 Values are means ± SD, n = 8/group.
2 Significant diet effect (P < 0.01) and strain x diet interaction (P < 0.05). Within CBA, 
US74 > modified (P < 0.01); within C57BR, no significant difference between US74 
and modified. With US74, no significant difference between CBA and C57BR; with 
modified diet, C57BR > CBA (P < 0.01).
3Significant diet effect (P < 0.01).
chol2 ergo- sito4
Strain diet (pg/50g body wt/d)
CBA
CBA
C57BR
C57BR
US74
modified
US74
modified
646 ± 89 
536 ± 76 
2580 ± 631 
519 ±93
150 ±24  
352 ± 52 
140 ±31 
409 ± 43
514 ±57  
1070 ±128 
543 ± 82 
1080± 127
1 Values are means ± SD, n = 8/group.
2 Cholesterol. Significant strain effect (P < 0.01), diet effect (P < 0.01), and strain x diet 
interaction (P < 0.01). Within CBA, US74 > modified (P < 0.05); within C57BR, US74 > 
modified (P < 0.01). With US74 diet, C57BR > CBA (P < 0.01); with modified diet, no 
significant difference between CBA and C57BR.
3 Ergosterol. Significant diet effect (P < 0.01) and strain x diet interaction (P < 0.01). 
Within CBA, modified > US74 (P < 0.01); within C57BR, modified > US74 (P < 0.01). 
With US74 diet, no significant difference between CBA and C57BR. With modified 
diet, C57BR > CBA (P < 0.05).
4 p-sitosterol. Significant diet effect (P < 0.01).
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nism was different. CBA/J mice 
responded to US74 diet by decreasing 
hepatic cholesterol synthesis as a 
result of suppression of HMGR 
activity. On the other hand, C57BR/ 
cdJ mice responded by increasing 
fecal cholesterol excretion. Because 
both strains of mice had efficient 
mechanisms to respond to the 
experimental diets, 
hypercholesterolemia did not occur in 
either strain.
C57BR/cdJ mice had a lower 
hepatic HMGR activity than did the 
CBA/J mice. Dietschy (32) compared 
hepatic cholesterol synthesis in 
several species and concluded that 
species with high rates of hepatic 
cholesterol synthesis (e.g., the rat) can 
more readily adapt to large changes in 
the flux of cholesterol into and out of 
the body than can species with much 
lower rates of hepatic cholesterol 
synthesis (e.g., the hamster and man). 
Moreover, Nestel and Poyser (33) 
reported two groups of human 
subjects with differing metabolic 
responses to increased dietary 
cholesterol intake. Increased fecal 
excretion of cholesterol was the 
predominant change in one group, and 
reduction in cholesterol synthesis was 
the predominant change in the other 
group. However, a rise in the plasma 
cholesterol level was prevented only 
when cholesterol synthesis was 
suppressed.
McNamara et al. (1) also 
observed heterogeneity in their human 
volunteers, both in terms of dietary fat 
and cholesterol sensitivity, and in the 
regulatory responses. They reported 
that people who failed to suppress 
endogenous cholesterol synthesis 
showed increases in plasma choles­
terol upon intake of high cholesterol 
diets. The metabolic differences 
between.CBA/J and C57BR/cdJ mice
were consistent with the characteristic 
of the hyper- and hypo-responders in 
humans and other species.
The US74 diet caused an 
accumulation of both free and total 
cholesterol in liver microsomes 
compared with the modified-fat diet. 
The US74 diet also decreased the 
activity of HMGR and increased the 
activity of COH in the liver micro­
somes compared with the modified- 
fat diet. Because both HMGR and 
COH are membrane-bound enzymes, 
it is possible that their activities are 
modulated by the cholesterol present 
in the microsomal membranes.
Correlation analysis of pooled 
data showed a negative correlation 
between HMGR activity and choles­
terol concentration in the liver 
microsomes but, when data within a 
treatment were used, no correlation 
was found. This suggests that 
cholesterol concentration may be one 
factor in the gross control of HMGR 
activity but that fine tuning of the 
enzyme activity is effected by other 
factors. No correlation was found 
between COH activity and liver 
microsomal cholesterol concentration. 
Balasubramaniam, Mitropoulos and 
Myant (34) demonstrated that there 
were compartments of cholesterol in 
the rat liver microsomes accessible to 
COH. It is likely that compartmental- 
ization for metabolic channeling 
obscured a possible correlation 
between COH activity and COH- 
accessible cholesterol in the liver 
microsomes.
In summary, this study has 
demonstrated marked differences in 
the metabolic response to small 
changes in dietary cholesterol and fat 
in CBA/J and C57BR/cdJ mice, 
although both strains have effective 
feedback control mechanisms to 
maintain their serum cholesterol 
levels at the young age used. The 
major control mechanism in the CBA/ 
J mouse is to adjust the rate of
endogenous cholesterol synthesis, 
whereas that in the C57BR/cdJ mouse 
is to change cholesterol excretion. 
How such feedback mechanisms are 
affected by the aging process is not 
known and merits further study.
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Calcium Status of Mice 
as Affected by Dietary 
Fat, Cholesterol Levels, 
and Dietary Calcium
—
Source
Abstract
Effects of two levels of total 
dietary fat and two levels of choles­
terol on utilization of calcium from 
two sources were investigated 
according to a 2x2x2 factorial design. 
Retired male breeder mice were 
divided into groups of nine mice each 
and fed the experimental diets for 35 
days. Mice fed the high-fat diets 
gained more weight and were more 
feed efficient than were those fed 
low-fat diets. Animals fed the high- 
fat diet had greater bone weight, but 
bone calcium content was dependent 
upon interactions between fat and 
calcium source: bone calcium content 
was greater in animals receiving 
calcium as calcium lactate but was 
less in animals receiving calcium as 
calcium carbonate. Removal of 
cholesterol from diets was associated 
with improved calcium balances. 
Evidently, effects of fat and choles­
terol on calcium utilization differ 
between humans and mice.
Introduction
As discussed in Chapter 11 
in this bulletin (1), calcium utilization 
may be influenced by intake of total 
fat, by intake of cholesterol, and/or by 
degree of unsaturation of the fatty 
acids of which the fat is composed.
In that study, young women utilized 
calcium more efficiently from a diet 
modeled to resemble the typical 
American diet in total fat and choles­
terol contents and in proportions of 
fatty acids according to the HANES I 
survey (US74 diet) than from a diet
modified in these components to 
current dietary change recommenda­
tions (MOD diet).
The objective of this study 
was to examine the effect of two of 
these variables (cholesterol and total 
fat intake) on calcium utilization from 
two different sources on calcium 
status of retired male breeder mice.
Materials and Methods
Seventy-two male, albino 
C3H/HENHSD, retired breeder mice 
weighing from 19 to 29 grams were 
purchased from Harlan/Sprague 
Dawley Co., Madison, WI. Mice 
were housed in stainless steel cages in 
groups of five and were fed a standard 
mouse chow (Purina Mice Chow Co., 
St. Louis, MO) and fluids ad libitum 
for 3 days to allow them to adjust to 
the new environment and to recover 
from travel stress. The temperature 
was kept between 20 and 25° C, and 
artificial light was provided from 
0700-1900 hours, alternating 12 hours 
of light with 12 hours of darkness. 
Relative humidity was kept between 
50 and 55%.
Mice were randomly 
assigned to individual metabolic 
cages and to the eight different dietary 
treatment groups, nine mice per 
group, so that the initial mean weights 
of each group were similar.
Two sources of calcium 
(calcium carbonate, from TUMS 
antacid, Norcliff Thayer Inc., Tucka- 
hoe, NY 10707, and calcium lactate, 
from Formula 81, PLUS calcium,
PLUS Products, Irvine, CA 92714) 
were fed to provide calcium at 0.5% 
of the diet by weight, each fed with 
two levels of dietary fat from com oil 
(5% or 15% of the diet by weight) and 
two levels of cholesterol (0% or 2% 
of diet) in a complete random design 
(CRD), a 2x2x2 factorial arrangement 
of treatments (Table 17-1).
Composition of the experi­
mental diets and treatment variations 
is shown on Table 17-2. Ingredients 
for the diet treatments were purchased 
from ICN Nutritional Biochemicals 
(Cleveland, OH). Constant amounts 
of casein (vitamin free), ICN mineral 
mix (calcium free), ICN vitamin mix 
(calcium free), and BHT were fed.
Animals were fed daily and 
were allowed feed and distilled 
deionized water ad libitum for the 
duration of the study (35 days). Feed 
intakes were recorded on a weekly 
basis for each animal by determining 
the difference between feed weighed 
at the beginning and end of each 
week. Spillage was collected, 
weighed, and subtracted from the 
initial feed weight. Urine was 
collected in acid-washed containers 
for each of 7 days. Feces for each 
animal were collected daily, separated 
from wasted feed, weighed to 
determine weekly output, dried, 
reweighed, and ground to a fine 
powder. Animals were weighed
weekly on an Ohaus Autogram 1000 
balance (Ohaus Scale Co., Union,
NJ).
Mice were maintained on 
their respective treatments for 5 
weeks. At the end of the 35-day 
feeding period, the animals were 
fasted for 12 hours, weighed in 
random order, and asphyxiated with 
carbon dioxide gas. Blood was 
collected by heart puncture. Both 
femur bones were surgically removed 
from each animal. Bones were frozen 
in polyethylene 4" bags at 4°C for 
later analysis. Livers of each animal 
were excised and frozen with dry ice.
Bone breaking strength was 
determined by using an Instron Ma­
chine. Fecal, bone, and feed samples 
were ashed at 600°C for 8 hours and 
diluted with deionized, distilled water 
before analysis. Calcium contents of 
bone, feces, urine, and feed were ana­
lyzed by using a Varian Techtron 
Atomic Absorption Spectrophotom­
eter Model 1275 by methods de­
scribed earlier (1).
Liver cholesterol contents 
were enzymatically determined by a 
modification of the Folch procedure 
(2). Blood total cholesterol levels 
also were assayed. Fecal fat was 
analyzed by using the Goldfisch 
method (3). Fecal fat analyses were 
performed on dried weekly collec-
Experimental plan: Diet variations 
to determine interactions of source 
of calcium and levels of fat and 
cholesterol on parameters of calciu 
status in mice ( 2 x 2 x 2  factorial 
arrangement of treatments).
Two sources of Calcium: Calcium
Carbonate(C)*
Calcium 
Lactate (L)*
Two levels of Fat
Two levels of Cholesterol:
5% 15% 5% 15%
(i r (h)* (I)* (h)*
0% 2% 0% 2% 0% 2% 0% 2%
(-)* (+)* (-)* (+)* (-)* (+)* (-)* (+)*
Abbreviations used in later tables for indicating dietary variations.
HkHSHH'm Composition of dietary treatment
Diet"!
Ingredients (%) Ch+ Ch- CI+ Cl- Lh+ Lh- LI+ LI-
Casein 24.00 24.00 24.00 24.00 24.00 24.00 24.00 24.00
Sucrose 53.75 55.75 63.75 65.75 51.76 53.60 61.60 63.60
Corn oil 15.00 15.00 5.00 5.00 15.00 15.00 5.00 5.00
Cholesterol 2.00 0.00 0.00 2.00 2.00 0.00 2.00 0.00
Salt mix2 
Calcium
3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00
carbonate3
Calcium
1.25 1.25 1.25 1.25 0.00 0.00 0.00 0.00
lactate 0.00 0.00 0.00 0.00 3.40 3.40 3.40 3.40
Vitamin mix4 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
BHT3 tr tr tr tr tr tr tr tr
1 Diet code: C = calcium carbonate L = calcium lactate
h = high fat (15%) I = low fat (5%)
+ = with cholesterol - = without cholesterol
2 ICN Mineral Mix (calcium free), (ICN Nutritional Biochemicals, Cleveland, Ohio).
3 To supply 0.5% of calcium by weight in all diets.
4 Pantothenol replaced calcium pantothenate (ICN Nutritional Biochemicals, Cleveland, Ohio). 
5 Added at 0.01 % of oil. Report of the American Institute of Nutrition Ad
Hoc Committee on Standards for Nutritional Studies. J. Nutr. 107:1340, 1977.
91
tions for each animal. Fat-extracted 
samples were then ashed and prepared 
for mineral determination.
Data pertaining to blood 
cholesterol, liver cholesterol, bone 
calcium, urine calcium, fecal calcium, 
feed calcium, fecal fat, bone weight, 
and body weight change were 
subjected to statistical analysis by 
using the Statistical Analysis System 
(SAS) (4). Because of possible 
relationships or correlations among 
the responses obtained from the same 
experimental units during consecutive 
periods of time, an autocorrelation 
analysis was performed on the data 
before the analysis of variance 
(ANOVA). To detect variation as a 
result of dietary treatment, the 
ANOVA was performed. Least 
squares means were then used to 
identify differences among mean 
values.
Results and Discussion
Because 99% of body 
calcium is found in bones and teeth, 
bone calcium concentration and bone 
resistance to breaking have been used 
as measurements of calcium 
bioavailability and nutritional calcium 
status (5,6). In the present study, 
these two analyses were performed on 
fat-extracted (dry) and unextracted fat 
(wet) femurs.
Wet and dry femur bone 
strength means are given in Table 17-
3. An increase in wet bone strength 
may be interpreted as an increase in 
the flexibility of bone because of a 
decrease in bone mineral content, but 
not a decrease in total bone mass as 
occurs in rickets or osteomalacia. In 
this situation, bones bend but do not 
break. In the present study, no 
significant effect was found on wet 
bone femur strength as a result of the 
various dietary treatments. Numeri­
cally, however, the greatest wet bone 
strength (2.90 kg) was found in mice 
fed calcium lactate, a low-fat diet, 
and no cholesterol, whereas the least
wet bone strength (2.54 kg) was 
found in mice fed calcium carbonate, 
a high-fat diet, and no cholesterol (p 
< 0.20). High-fat diets tended (p <
0.15) to produce bones with lower 
wet bone strengths than did low-fat 
diets. This suggests that bone 
mineralization tended to be superior 
in mice fed high-fat rather than low- 
fat diets and that tendencies toward 
osteomalacia were shown by mice fed 
the low-fat diets.
Dry bone femur strength 
tends to reflect the total mineralized 
bone mass. Poor dry bone femur 
strength is indicative of osteoporosis, 
a lack of both collagen and mineral 
content. Greatest bone strength was 
found in mice fed calcium lactate, a 
high-fat diet, and cholesterol, whereas 
the least dry bone strength was found 
in mice fed calcium carbonate, a high- 
fat diet, and cholesterol. This 
suggests that effects of level of fat 
and/or cholesterol on bone strength 
may differ, depending upon the 
source of dietary calcium. Interac­
tions among these three variables 
(calcium source, fat, and cholesterol 
levels) were found. Bone strength 
(dry) in the absence of cholesterol 
increased in mice fed calcium 
carbonate with high-fat diets but 
decreased in mice fed calcium 
carbonate with low-fat diets. But 
bone strength in the presence of 
cholesterol increased when mice were 
fed calcium lactate with high-fat diets 
and decreased in those fed calcium 
lactate with low-fat diets (p < 0.03).
Calcium content of dry 
bones, expressed as a percentage of 
dry weight or ash, was not affected by 
the source of calcium, or by fat or 
cholesterol levels in the diet. Calcium 
content of wet bone expressed as dry 
weight or ash was significantly 
affected (p < 0.02) by the interaction 
between calcium source and fat level. 
Calcium content of bone on a dry- 
weight basis for animals fed calcium 
carbonate decreased (p < 0.06) as the 
level of fat increased. The opposite
effects were observed in animals fed 
calcium lactate. That is, increased 
dietary fat resulted in an increase in 
the bone calcium content on a dry- 
weight basis. Mean bone calcium 
content expressed as a percentage of 
ash followed the same trend as did the 
calcium expressed on a dry-weight 
basis. For the calcium carbonate and 
high-fat diet, the bone calcium 
content was 50.9%, a value that did 
not differ significantly from the 
53.7% found in mice on calcium 
carbonate and a low-fat diet. For 
mice fed calcium lactate at the high 
level of fat intake, calcium content of 
bone was 54.4%. This value was 
greater (p < 0.04) than the 50.6% 
obtained for the animals fed the 
calcium lactate and the low level of 
fat. In both wet and dry bone 
samples, calcium concentration as a 
percentage of dry-weight or ash 
tended to be greater in mice fed 
calcium lactate, a high-fat diet, and no 
cholesterol than in mice fed the 
calcium carbonate, a high-fat, and no 
cholesterol.
Neither calcium source nor 
levels of fat or cholesterol in the diet 
affected bone weight. As would be 
expected, unextracted samples 
weighed more than did extracted 
samples, with a mean of 0.046 g for 
the dry and 0.048 g for the wet 
samples.
Bone dry matter and ash 
percentages did not differ among 
treatments for dry and wet bone 
samples (Table 17-3). In wet 
samples, smaller amounts of ash 
matter were associated with calcium 
lactate, a low-fat diet, and no choles­
terol, and the least bone ash was 
found in the animals fed calcium 
carbonate, a high-fat diet, and no 
cholesterol. A slightly greater dry 
matter content was observed for the 
unextracted bone samples (91.8%) 
when compared with the dry samples 
(90.8%), but this was not observed for 
bone ash, with means of 66.4 and 
66.5% for wet and dry bones,
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respectively. One possible explana­
tion for this seeming increase in 
moisture content for the extracted 
bones is that the absence of fat may 
have increased the capacity of bones 
to absorb moisture.
Effects of dietary calcium 
source and levels of fat and choles­
terol on fecal weights and fecal losses 
of fat and calcium also were exam­
ined (Table 17-4). Greatest fecal fat 
(% of dry weight) occurred when 
mice were fed calcium carbonate, a
high-fat diet, and cholesterol or 
calcium lactate, a low-fat diet, and 
cholesterol; excretions were least 
when calcium carbonate, a low-fat 
diet, and no cholesterol were fed. A 
significant interaction was found 
among calcium source, fat level, and 
cholesterol (p < 0.02) on fecal fat 
when expressed as a percentage of 
fecal dry weight. Animals fed high- 
fat diets excreted feces with a greater 
percentage of fat than did those fed 
low-fat diets. The presence of
cholesterol in the diet influenced the 
percentage of fecal fat and interacted 
with the calcium source and fat level 
in the diet. Because type of diet fed 
significantly influenced weight of 
feces produced, percentage of fat in 
feces was not the total determinant of 
weekly fecal fat losses. Greatest fecal 
fat losses were found in animals fed 
calcium carbonate, a high-fat diet, and 
cholesterol or calcium lactate, a high- 
fat diet, and cholesterol, whereas the 
least weekly fecal fat losses occurred
Table 17-3.
Femur bone weights, composition, and breaking strength as affected 
by dietary calcium source and levels of fat and cholesterol.
Diet1
Measurement Ch+ Ch- CI+ Cl- Lh+ Lh- LI+ LI-
Dry bone weight (g) 0.047
±0.0012
0.047 
± 0.002
0.044
+0.002
0.043 
± 0.003
0.049 
± 0.002
0.046 
± 0.003
0.047 
± 0.002
0.044 
± 0.002
Wet bone weight (g) 0.049 
± 0.002
0.049 
± 0.002
0.046
+0.002
0.045 
± 0.003
0.051 
± 0.002
0.047 
± 0.003
0.049 
± 0.002
0.046 
± 0.002
Dry bone dm (%) 90.8
±0.48
91.0
±0.18
91.1
+0.3
90.3
±0.39
90.9
±0.29
90.7
±0.38
90.9
±0.43
91.0
±0.2
Wet bone dm (%) 91,9ab 
±0.72
92.4a
±0.94
92.73
+0.96
93.1a 
±1.14
92.5a 
±1.17
92.5a 
±0.93
91.8ab
±0.89
87.3b
±0.91
Dry bone ash (%) 66.6
±0.58
66.6
±0.61
66.7
+0.85
67.6
±0.89
66.2
±0.39
66.6
±0.61
66.4
±0.94
68.0
±1.02
Wet bone ash (%) 66.5ab
±1.17
64.8b
±1.2
66.0ab
+1.94
67.1 ab 
±1.16
65.1b 
±0.93
66.4ab
±1.3
66.0ab
±1.16
68.9
±1.37
Dry bone Calcium (% of d wt) 23.2
±0.62
22.6
±0.46
23.2
+0.71
23.1
±0.47
22.8
±0.55
24.2
±0.82
23.3
±0.59
23.3
±0.64
Wet bone calcium (% of d wt) 34.0ab
±1.33
32.8b
±0.94
35.9ab
+0.82
35.6ab
±1.08
34.2ab
±1.32
37.2a
±1.96
33.5b
±0.9
34.5ab
±1.47
Dry bone calcium (% of ash) 34.8
±0.83
33.9
±0.84
34.9
+1.06
34.2
±0.88
34.4
±0.88
36.3 
± 1.04
35.1
±0.63
34.2
±0.87
Wet bone calcium (% of ash) 51.0b
±1.71
50.8b
±1.62
54.4ab
+1.86
53.0ab
±1.12
52.6ab
±2.17
56.1a 
±2.8
50.8b 
±1.16
50.3b
±2.03
Dry bone strength (kg) 2.56b
±0.2
2.72ab
±0.12
2.91 ab 
+0.16
2.70ab
±0.14
3.02a
±0.14
2.63ab
±0.21
2.70ab
±0.14
2.92ab
±0.17
Wet bone strength (kg) 2.71 
± 0.23
2.54
±0.14
2.78
+0.19
2.88
±0.29
2.73
±0.15
2.61
±0.4
2.84
±0.11
2.9
±0.14
1 Diet code: C = calcium carbonate L = calcium lactate
h = high fat 
+ = cholesterol included
I = low fat 
- = cholesterol excluded
2 Mean ± SD (n = 9). Values with different letter superscript are significantly different (p < 0.05).
Analysis of sources of variation p values
Bone calcium (% of ash) wet bones: Calcium lactate + high fat > calcium lactate + low fat 0.0412
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in animals fed calcium carbonate, a 
low-fat diet, and no cholesterol or 
calcium lactate, a low-fat diet, and no 
cholesterol. On the basis of collective 
means, weekly fat excretion was 
greater (p < 0.01) for animals fed 
high-fat diets than for those fed low- 
fat diets. Addition of cholesterol to 
the diet increased fat excretion from 
0.11 g/week without cholesterol to 
0.42 g/week with cholesterol.
Greatest fecal fat percentage and 
weekly fecal fat excretion occurred in 
mice fed calcium carbonate, a high-fat 
diet, and cholesterol.
Fecal calcium excretion (mg/ 
week) was greatest in animals fed 
calcium carbonate, a high-fat diet, and 
cholesterol and was least in animals 
fed calcium carbonate, a low-fat diet, 
and no cholesterol or calcium lactate, 
a high-fat diet, and no cholesterol 
(Table 17-4). Analyses of source of 
variation indicated that calcium 
carbonate .produced greater losses 
than did calcium lactate, that high-fat 
diets produced greater losses than did 
low-fat diets, and that adding choles­
terol to high- or low-fat diets pro­
duced greater losses than did high- or 
low-fat diets without cholesterol.
Fecal excretion of calcium in 
mice was significantly affected by the 
fat and cholesterol levels in the diet (p 
<0.0001). Animals on high-fat diets 
excreted, on an average, 2.06 g/week 
in comparison with 1.64 g/week for 
animals fed low-fat diets, regardless 
of calcium and cholesterol level in the 
diet. The presence of cholesterol in 
the diet resulted in a fecal excretion of 
2.17 g/week, compared with 1.52 g/ 
week excreted in the absence of 
cholesterol. Moisture content of feces 
from animals fed the high-fat diet was 
greater (13.8%) than the moisture 
content of feces from animals fed the 
low-fat diet (12.2%). The effect of 
cholesterol on dry-matter content was 
less, but followed the same trend as 
level of fat. These results indicated 
that high levels of fat and, probably, 
cholesterol in the diet increased fecal 
excretion and produced feces with 
greater moisture content.
The effect on fecal excretion 
of level of fat and cholesterol in the 
diet also was dependent on the 
calcium source, as indicated by the 
significant (p < 0.004) interaction of 
these three factors. When cholesterol
was removed from the diet, reduction 
of fecal excretion was greater for 
animals fed calcium carbonate and 
low-fat diet (from 2.07 to 1.14 g/ 
week) than for animals fed calcium 
carbonate and high-fat diets (from 
2.34 to 1.72 g/week). The opposite 
was observed for animals fed the 
calcium lactate diets. When the high- 
fat diet was offered, the removal of 
cholesterol from the diet decreased 
fecal excretion from 2.51 to 1.67 g/ 
week. This decrease was greater than 
when cholesterol was removed from 
the low-fat diet, 1.77 to 1.56 g/week.
Dry-matter content of feces 
also was affected by the source of 
calcium (p < 0.06). Animals fed 
calcium carbonate diets excreted feces 
with more dry matter (87.7%) than 
did those fed calcium lactate diets 
(86.3%).
Fecal ash percentage was 
affected by the calcium source (p < 
0.0007) and fat (p < 0.0001) and 
cholesterol levels (p < 0.0001) in the 
diet, and a significant interaction 
among these three nutrients was 
detected. When animals were fed 
calcium carbonate in combination 
with a high-fat diet, the presence or
Fecal losses of calcium in mice as affected by diets 
calcium source and levels of fat and cholesterol.
Measurement
Diet1
Ch+ Ch- CI+ CL- Lh+ Lh- LI+ LI-
"As is" feces excretion 2.34ab2 1.72d 2.07bc 1.14e 2.51a 1.67d 1.77cd 1.56d
(g/week) ±0.13 ±0.11 ±0.11 ±0.05 ±0.16 ±0.10 ±0.09 ±0.13
Fecal dry matter 86.8ab 88.0a 87.6a 88.4a 84.2b 85.8ab 87.7a 87.5a
(%) ±1.15 ±1.03 ±0.95 ±1.14 ±1.13 ±0.99 ±1.10 ±1.05
Fecal ash 23.4bc 25.9b 27.0b 35.1a 20.6c 24.5b 26.4b 26.8b
(%) ±0.26 ±0.30 ±0.35 ±0.28 ±0.33 ±0.40 ±0.33 ± 0.26
Fecal fat 21.4a 6.8 e 17.8C 4.7e 18.9bc 7.8d 20.9ab 4.6e
(%) ±1.37 ±0.63 ±1.38 ± 0.60 ±1.31 ±0.71 ±1.04 ±0.57
Fecal fat excretion 0.52a 0.13C 0.37b 0.06d 0.46a 0.14C -0.36b -0.09cd
(g/week) ±0.04 ±0.03 ±0.03 ±0.01 ±0.03 ±0.02 ±0.02 ±0.02
Fecal calcium 47.2 e 54.7bc 49.5cd 68.2a 42.0e 52.3bcd 52.5bcd 57.0b
(mg/g of dry feces) ±2.27 ±  3.08 ±2.57 ±2.58 ±2.22 ±2.77 ±2.33 ±3.15
Fecal calcium excretion 89.1a 75.0bcd 82.4ab 66.3d 81.lab 66.3d 76.8bc 69.2cd
(mg/week) ±3.86 ±3.27 ±3.93 ±2.42 ±3.82 ±2.81 ±3.25 ± 3.77
1 Diet Code: C = calcium carbonate L = calcium lactate
h = high fat I = low lat
+ = cholesterol Included - = cholesterol excluded 
2Mean ± SD (n = 9). Values with different letter superscript are significantly different (p < 0.05).
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Analysis of source of variation p value
"As is" feces excretion (g):
High fat > low fat
With cholesterol > without cholesterol
High fat + calcium carbonate or lactate > low fat + calcium carbonate or lactate 
Cholesterol with calcium carbonate or lactate > no cholesterol
0.0001
0.0001
0.0018
with calcium carbonate or lactate 0.0001
High fat with cholesterol > low fat with cholesterol > high fat 
without cholesterol > low fat without cholesterol 0.0492
Fecal dry matter (%):
Low fat > high fat
Calcium carbonate + high or low fat, calcium lactate + low fat > calcium lactate + high fat 
Calcium carbonate without cholesterol > calcium lactate with cholesterol 
Low fat with or without cholesterol > high fat with cholesterol
0.0342
0.0254
0.0383
0.0480
Fecal ash (%):
Calcium carbonate > calcium lactate 
Low fat > high fat
Without cholesterol > with cholesterol
0.0007
0.0001
0.0001
Calcium carbonate + low fat > calcium carbonate + high fat, calcium 
lactate + high or low fat
Calcium lactate + low fat > calcium lactate + high fat 
Calcium carbonate without cholesterol > calcium carbonate with
0.0011
0.0029
cholesterol, calcium lactate with or without cholesterol 0.0004
Low fat without cholesterol > low fat with cholesterol, high fat 
without cholesterol > high fat with cholesterol 0.0205
Fecal fat (% of dry matter):
High fat > low fat
With cholesterol > without cholesterol
High fat + calcium carbonate or lactate > low fat + calcium carbonate 
Cholesterol with calcium carbonate or lactate > no cholesterol with
0.0181
0.0001
0.0420
calcium carbonate or lactate 0.0001
Cholesterol with high or low fat > no cholesterol with high fat 
> no cholesterol with low fat 0.0107
Total fat exertion (g/week):
High fat > low fat
With cholesterol > without cholesterol
High fat + calcium carbonate or lactate > low fat + calcium carbonate or lactate 
Cholesterol with calcium carbonate or lactate > no cholesterol
0.0001
0.0001
0.0036
with calcium carbonate or lactate 0.0001
Cholesterol with high fat > cholesterol with low fat > no cholesterol 
with high fat > no cholesterol with low fat 0.0084
Fecal calcium (mg/g of dry feces):
Calcium carbonate > calcium lactate 
Low fat > high fat
Without cholesterol > with cholesterol
Calcium carbonate + low fat > calcium carbonate + high fat, calcium lactate + high fat
Calcium lactate + low fat > calcium lactate + high fat
Calcium carbonate without cholesterol > calcium lactate without
0.0384
0.0001
0.0001
0.0031
0.0047
cholesterol > cholesterol with calcium carbonate or lactate 0.0186
Low fat without cholesterol > high fat without cholesterol,
low fat with cholesterol > high fat with cholesterol 0.0163
Fecal calcium excretion (mg/week):
Calcium carbonate > calcium lactate 
High fat > low fat
With cholesterol > without cholesterol
0.0484
0.0853
0.0001
Calcium carbonate + high fat > calcium carbonate + low fat, calcium 
lactate + high or low fat
Calcium carbonate with cholesterol > calcium lactate with cholesterol
0.0267
no cholesterol with calcium carbonate or lactate 
Cholesterol with high or low fat > no cholesterol with high or low fat
0.0498
0.0109
absence of cholesterol did not affect 
the ash percentage in the diet, 23.4 vs. 
25.9% with or without cholesterol, 
respectively. But the presence of 
cholesterol in the diet of animals fed 
calcium lactate in combination with a 
high level of fat significantly de­
creased (p< 0.05) the fecal ash 
content, 20.6 vs. 24.5% with and 
without cholesterol, respectively. On 
the other hand, the presence of 
cholesterol in the low-fat diet de­
creased fecal ash from 35.1% to 
27.0% in animals fed the calcium 
carbonate diet, but fecal ash did not 
differ with cholesterol content of diets 
when calcium lactate and a low-fat 
diet were fed. On the average, 
animals fed calcium carbonate 
excreted feces with a greater ash 
content than those fed calcium lactate,
27.8 and 24.6%, respectively. A high 
level of fat and the presence of 
cholesterol in the diet were associated 
with less fecal ash. Animals fed high- 
fat diets excreted feces with 24.6% 
ash, whereas animals fed low-fat diets 
excreted 28.8%. Animals fed high 
cholesterol levels excreted feces with 
24.4% of ash, whereas those fed diets 
without cholesterol excreted feces 
with 28.1% of ash.
The presence of a high level 
of fat in feces was related to a greater 
fecal dry weight excretion, but to a 
lesser percentage of fecal dry matter 
and ash. Cholesterol in the diet has 
been associated with greater excretion 
of other compounds, such as bile 
acids, in rats (7). Whether this was 
true in the present study is not known, 
but it is possible that increased dry-
matter excretions in diets with 
cholesterol were partly because of an 
increased loss of bile acids.
Once calcium is absorbed 
from the intestines, a major route of 
excretion is through urine. A rise in 
urinary calcium has been used to 
indirectly estimate calcium absorption 
with different oral calcium loads (8). 
Urinary calcium concentration was 
affected by calcium source and fat 
level in the diet (Table 17-5). When 
mice were fed calcium carbonate, 
urinary calcium concentration was not 
affected by the level of fat in the diet, 
but when mice were fed calcium 
lactate, the high-fat diet was associ­
ated with decreased urinary calcium 
concentration and the low-fat diet 
was associated with greater urinary 
calcium concentration.
Diet1
Measurement Ch+ Ch- CI+ Cl- Lh+ Lh- LI+ LI-
Urinary volume 5.14c2 8.71a 8.06a 7.51ab 4.57C 5.58c 5.54c 5.78bc
(ml/week) ±0.38 ±0.84 ±1.37 ±0.96 ±0.37 ±0.58 ± 0.66 ±0.70
Urinary calcium 522bc 392bc 545° 447c 536bc 628abc 823a 771ab
(ug/ml) ± 76.0 ±39.0 ±47.3 ±31.9 ±84.6 ±69.1 ± 189 ± 123
Urinary calcium loss 2.7ab 3.2ab 4.0ab 3.4ab 2.4t> 3.9ab 5.9a 4.6ab
(mg/week) ±0.4 ±0.4 ± 0.6 ± 0.6 ±0.3 ±0.9 ± 2.2 ± 1.1
Urinary calcium loss 11 ;5ab 14.1ab 18.1ab 15.3ab 9.7b 17.3ab 23.8a 19.6ab
(mg/35 d) ±1.53 ±2.65 ±3.48 ±2.30 ±1.48 ±4.33 ± 8.84 ± 6.22
Fecal calcium excretion 446 367 412 331 405 332 384 338
(mg/35 d) ± 22.2 ± 19.4 ±24.7 ±7.1 ± 17.7 ± 15.3 ± 15.8 ±24.6
Calcium intake 723 779 724 659 720 776 749 747
(mg/35 d) ± 19.6 ±82.4 ±51.0 ±41.2 ±64.8 ±67.7 ±52.6 ±37.5
Calcium balance 266b 398ab 294ab 313ab 305ab 427a 341ab 389ab
(mg/35 d) ±24.2 ±74.7 ±42.0 ±41.2 ±63.7 ±71.6 ±52.0 ±51.5
Blood cholesterol 196a 136b 129b 136b 148ab 133b 129b 116b
(mg/dl) ±29.7 ±28.1 + 12.3 ± 20.0 ± 11.5 ± 11.4 ±11.9 ±13.7
Liver weight(g) 1.07bc 0.86d 1,24ab 1 .0icd 1 ,20ab 0.97cd 1.29a 0.98cd
± 0.04 ±0.08 ±0.05 ±0.05 ±0.06 ±0.07 ±0.14 ±0.05
Liver cholesterol 12.07b 2.44c 16.09a 4.07C 11.711> 2.88° 12.16b 1 .86°
(mg/g) ± 2.00 ±0.24 ±1.13 ±0.44 ± 1.21 ±0.27 ±2.61 ± 0.35
1 Diet code: C = calcium carbonate L = calcium lactate
h = high fat I = low fat
+ = cholesterol included - = cholesterol excluded
2 Mean ± SD (n = 9). Values with different letter superscripts are significantly different (p < 0.05).
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Analysis of sources of variation p values
Urinary volume (ml/week):
Calcium carbonate > calcium lactate 0.0001
Without cholesterol > with cholesterol 0.0367
Calcium carbonate + high or low fat > calcium lactate + high fat 0.0110
Calcium carbonate + low fat > calcium lactate + low fat 0.0032
Calcium carbonate without cholesterol > calcium lactate with or without cholesterol,
calcium carbonate with cholesterol 0.0374
Calcium carbonate with cholesterol > calcium lactate with cholesterol 0.0325
High fat without cholesterol, low fat with or without cholesterol >high fat with cholesterol 0.0134
Urinary Calcium (ug/ml):
Low fat > high fat 0.0585
Calcium lactate > calcium carbonate 0.0012
Calcium lactate + low fat > calcium carbonate + high or low fat, calcium lactate + high fat 0.0220
Calcium lactate with or without cholesterol > calcium carbonate without cholesterol 0.0055
Low fat with cholesterol > high fat without cholesterol 0.0585
Urinary calcium excretion (mg/week):
Low fat > high fat 0.0332
Calcium lactate + low fat > high fat + calcium lactate or carbonate 0.0278
Low fat with cholesterol > high fat with cholesterol 0.0141
Urinary calcium excretion (mg/35d):
Low fat > high fat 0.0638
Calcium lactate + low fat > calcium carbonate + high fat, calcium lactate + high fat 0.0755
Low fat with cholesterol > high fat with cholesterol 0.0261
Fecal calcium excretion (mg/35 d):
Calcium carbonate > calcium lactate 0.0785
With cholesterol > without cholesterol 0.0001
Calcium carbonate + high fat > calcium carbonate + fat, calcium lactate + high or low fat 0.0757 
Calcium carbonate with cholesterol > calcium lactate with cholesterol
> calcium carbonate or calcium lactate without cholesterol 0.0792
High or low fat with cholesterol > high or low fat without cholesterol 0.0134
Calcium balance (mg/35 d):
Without cholesterol > with cholesterol 0.0429
Calcium carbonate with cholesterol > calcium lactate without cholesterol 0.0186
Low fat without cholesterol > high fat with cholesterol 0.0277
Calcium carbonate without cholesterol > calcium carbonate with cholesterol,
calcium lactate with cholesterol 0.0891
Blood cholesterol (mg/dl):
High fat > low fat 0.0567
Calcium carbonate + high fat > calcium lactate + low fat 0.0203
Calcium carbonate with cholesterol > calcium lactate without cholesterol 0.0424
High fat with cholesterol > high fat without cholesterol, low fat with or without cholesterol 0.0421
Liver weight (g):
Low fat > high fat 0.0234
With cholesterol > without cholesterol 0.0001
Low fat + calcium carbonate or lactate > high fat + calcium carbonate 0.0118
Cholesterol with calcium carbonate or lactate > no cholesterol with
calcium carbonate or lactate 0.0047
Low fat with cholesterol > high fat with cholesterol > no cholesterol with high or low fat 0.0453
Liver cholesterol (mg/g of liver):
With cholesterol > without cholesterol 0.0001
Calcium carbonate + low fat > calcium carbonate + high fat,
calcium lactate + high or low fat 0.0526
Cholesterol with calcium carbonate or lactate > no cholesterol with
calcium carbonate or lactate 0.0001
Cholesterol with high or low fat > no cholesterol with high or low fat 0.0001
Urinary calcium losses on a 
mg/week basis were significantly 
greater for mice fed calcium lactate, a 
low-fat diet, and cholesterol than for 
animals fed calcium lactate, a high-fat 
diet, and cholesterol (Table 17-5). 
Animals fed calcium lactate and low- 
fat diets absorbed more calcium than 
those fed calcium carbonate and high- 
fat diets.
Urinary volume was signifi­
cantly affected by the dietary varia­
tions used in this study. Analysis of 
source of variation indicated that 
calcium carbonate in the diet resulted 
in more (p < 0.001) urinary volume 
compared with that when calcium 
lactate was present in the diet. 
Cholesterol inclusion in the diets also
resulted in less urinary volume.
Calcium intake needs to be 
taken into consideration when 
calcium balance is used. In the 
present study, dietary variations did 
not affect total feed intake; hence, 
they did not affect total calcium 
intake.
When fecal calcium excre­
tion and urinary calcium losses were 
subtracted from calcium intake, a 
positive calcium balance was obtained 
for all treatments (Table 17-5). A 
significantly higher calcium balance 
was exhibited by mice fed calcium 
lactate, a high-fat diet, and no 
cholesterol than by animals fed 
calcium carbonate, a high-fat diet, and
cholesterol. Animals fed calcium 
lactate tended to have greater calcium 
retention than those fed calcium 
carbonate. Removal of cholesterol 
from the diet was associated with 
improved calcium balance.
It has been documented that 
dietary cholesterol influences blood 
levels of cholesterol (7). Significantly 
greater blood serum cholesterol 
concentrations were found in mice fed 
calcium carbonate, a high-fat diet, and 
cholesterol than in mice in all other 
groups. The mice in this group also 
exhibited the lowest calcium bal­
ances.
The presence of cholesterol 
in the diet tended to increase blood
mmmmz Weight gains, feed intakes, and feed efi affected by dietary calcium source and es of mice as of fat and cholesterol.
Measurement
Diet1
Ch+ Ch- CI+ Cl- Lh+ Lh LI+ LI-
Initial 25.89 25.68 25.51 25.11 25.78 26.12 25.49 25.18
weight ± 0.25 2 ±0.39 ±0.58 ±0.47 ±0.29 ±0.45 ±0.61 ±0.61
Final 31.71 a 31.52a 30.07ab 29.51 ab 31.39a 30.21 ab 27.23C 28.03bc
weight (g) ±0.46 ±1.47 ±0.97 ±0.88 ±0.79 ±0.95 ±1.12 ±0.75
Weight 5.82 a 5.84a 4.56ab 4.40ab 5.61 a 4.09ab 1.74C 2.86bc
gain (g) ±0.34 ±1.22 ±0.70 ±0.62 ±0.76 ±0.77 ±0.92 ±0.67
Feed 133.5 155.8 144.8 131.9 144.0 155.1 150.0 149.4
intake (g) ±3.92 ±16.48 ±10.2 ±8.25 ±12.95 ±13.54 ±10.52 ±7.50
Feed 25.3b 22.2b 39.0ab 37.4b 28.4b 33.9b 70.1 a 44.9ab
efficiency3 ±1.18 ±3.96 ±7.55 ±7.71 ±3.86 ±6.52 ±28.14 ±9.20
1 Diet code: C = calcium carbonate L = calcium lactate
h = high fat
+ = cholesterol Included
I = low fat
- = cholesterol excluded 
2Mean ± SD (n = 9). Values with different letter superscript are significantly different (p < 0.05). 
3Feed efficiency: feed intake (g)/weight gain (g).
Least squares means analysis of source of variation
p value
Final weight (g):
0.0439 Calcium carbonate > calcium lactate 
0 0010 High fat > low fat
0.0389 Calcium carbonate + high or low fat, calcium lactate + high fat >calcium lactate + low fat 
0.0446 High fat with or without cholesterol > low fat with or without cholesterol
Total weight gain (g):
.0060 Calcium carbonate > calcium lactate 
0.0008 High fat > low fat
0.0073 Calcium carbonate + high or low fat, calcium lactate + high fat >calcium lactate + low fat 
0.0398 Calcium carbonate with or without cholesterol > calcium lactate without cholesterol 
0.0099 High fat with cholesterol > low fat with or without cholesterol 
010241 High fat without cholesterol > low fat with cholestero
Feed efficiency (feed intake/weight gain):
0.0151 Low fat > high fat
0.0257 Calcium lactate + low fat > calcium carbonate + high fat, calcium lactate + high fat 
0.0250 Low fat with cholesterol > high fat with or without cholesterol
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cholesterol concentration. A more 
marked effect seemed to be related to 
a high-fat diet. One organ that plays 
an important role in cholesterol 
metabolism is the liver, where 
cholesterol is synthesized and stored. 
Liver cholesterol concentration was 
greater in mice fed cholesterol. In 
addition, cholesterol in the diet 
induced heavier livers and a peculiar 
(yellow) color that did not occur in 
the absence of cholesterol.
Because the animals in­
volved in this study were adult mice, 
weight gain was not considered an 
indication of growth, although mice, 
like rats, tend to gain weight through­
out their life-span. It was expected 
that feed consumption would be 
closely related to maintenance of 
body weight. Mean initial weights of 
the different treatment groups were 
not significantly different from one 
another (Table 17-6). Few individual 
animals lost weight during the 
experimental period; mean final 
weights of all groups were greater 
than were initial weights. According 
to analysis of source of variation, 
calcium source and fat level in the 
diet were the main factors affecting 
final weight of the animals. Animals 
fed the diets with calcium carbonate 
were heavier than those fed the diets 
with calcium lactate. Animals that 
consumed high-fat diets had a mean 
final weight of 31.6 g in comparison 
with 28.7 g for those that consumed 
the low-fat diets. Calcium carbonate 
and increased dietary fat were 
associated with greater weight gains
(p < 0.0001) when compared with 
diets containing calcium lactate and 
less dietary fat.
Differences in weight gain 
were not associated with differences 
in feed consumption. Throughout the 
study, feed consumption did not vary 
significantly among the experimental 
groups (Table 17-6). Feed consump­
tion during the 35-day experiment 
ranged from 131.9 g for animals fed 
calcium carbonate, a low-fat diet, and 
cholesterol to 155.8 g for animals fed 
calcium carbonate, a high-fat diet, and 
cholesterol. Because feed efficiencies 
were calculated to determine the 
grams of feed required for a 1 g 
weight gain, a decrease in numerical 
value was indicative of improvement 
in efficiency. The increased body 
weight for those animals fed the high- 
fat diets was because the energy value 
per weight unit of diet was greater for 
the high-fat diets than for the low-fat 
diets. The better weight gain for the 
animals fed the calcium carbonate 
diets relative to those fed the calcium 
lactate diet cannot be as easily 
explained. The energy value of the 
calcium carbonate diet was evidently 
slightly greater than was the energy 
value of the calcium lactate diet, 
4252.5 kcal/kg vs. 4164.0 kcal/kg, 
respectively, if it is assumed that the 
lactate portion of calcium lactate 
provides no energy. Because calcium 
carbonate provides more calcium per 
unit weight than does calcium lactate, 
in equalizing the diets for calcium 
content, more sucrose was used in the 
diets containing calcium carbonate
than in the diets containing calcium 
lactate. There was, however, a 
tendency for less consumption of the 
calcium carbonate diet. Furthermore, 
if it is assumed that lactate can be 
used for energy purposes, then the 
calcium lactate diets actually con­
tained slightly more energy than did 
the calcium carbonate diets. Another 
consideration is the ability of the adult 
mouse to digest lactose. Because 
milk is not usually a component of the 
adult rodent’s food pattern, it may be 
that its ability to secrete lactase 
declines with age. Lactase-deficient 
(lactose-intolerant) humans are 
advised not to use calcium lactate 
supplements because of the resulting 
gastrointestinal distress, including 
diarrhea, distention, cramps, and 
flatulence. Obviously, any factor 
causing diarrhea would be expected to 
decrease nutrient absorption and have 
an adverse effect on weight gain and 
maintenance.
The chemical composition of 
the calcium source clearly influences 
its availability; this was further 
affected by the level of fat in the 
diets. It has been documented that fat 
and calcium interact by forming 
insoluble soaps (9). The presence of 
high fat and a high pH, which could 
affect the ionization of both calcium 
and fat, may increase the formation of 
unabsorbable soaps (9-12). This could 
be the situation for the calcium 
carbonate and high-fat diets, where 
the presence of these soaps may 
impair calcium absorption, reducing 
the amount available for bone
deposition. With calcium lactate, the 
effect of the short chain length of 
lactate may allow a better absorption, 
as suggested by different researchers, 
who showed that reducing the length 
of fatty acids improved fat absorption 
(13-14).
Conclusion
In summary, animals fed 
high-fat diets gained more weight and 
were more efficient (intake/gain) than 
were those animals fed low-fat diets. 
Animals receiving high-fat diets in 
combination with calcium carbonate 
also presented greater bone weights, 
but less bone calcium content. On the 
other hand, a high-fat diet and 
calcium lactate produced bones with 
greater calcium concentration. This 
may be an indication that high-fat 
diets and calcium carbonate together 
reduce calcium bioavailability, which 
agrees with results in this study 
indicating greater fecal calcium 
excretion from these diets. Presence 
of cholesterol increased fecal calcium 
losses.
Urinary calcium losses were 
greater in mice fed calcium lactate 
and low-fat diets, an indication of a 
better utilization of calcium from 
these diets. Overall, calcium balance 
was high for animals fed calcium 
lactate diets. Cholesterol affected 
calcium balance more than fat. 
Removal of cholesterol from the diets 
was associated with improved 
calcium balance. Cholesterol in blood 
and liver reflected its presence in the
diets. Feeding diets containing 
cholesterol resulted in increased 
amounts of cholesterol both in blood 
and liver.
It is possible that the higher 
calcium balance and increased bone 
calcium concentration were associ­
ated with better calcium absorption. 
Reduction in calcium absorption from 
calcium carbonate was accentuated by 
the presence of high levels of fat or 
cholesterol in the diets.
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